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General introduction  
Early origins of health and disease 
Cardiovascular disease is a major public health problem worldwide and 
might originate in early life.1-3 The developmental origins hypothesis 
suggests that adverse exposures in fetal and postnatal life might lead to 
cardiovascular adaptations.4, 5 This enables the individual to survive in the 
short term, but these adaptations can also predispose individuals to 
cardiovascular disease later in life.5 Animal studies have shown that growth 
restriction in fetal life leads to adverse cardiovascular structure and 
function in later life.6, 7  
Large observational studies in humans have shown that fetal growth 
restriction, followed by increased infant growth, were associated with 
cardiovascular disease.3, 8, 9 These effects on the cardiovascular system are 
already present in childhood. Observational studies suggest that children 
with lower birth weight had higher blood pressure in childhood and altered 
cardiac structure.10-12 Not only fetal life, but also early postnatal life is 
important for cardiovascular health. Rapid infant growth and adiposity are 
also associated with cardiovascular disease in adulthood, and with 
cardiovascular adaptations in childhood.2, 13, 14 
Common risk factors for cardiovascular disease, such as blood 
pressure, lipid levels and obesity track from childhood to adulthood.15-17 
Tracking represents the maintaining of a given rank order relative to peers 
over time.18 This means that children with higher blood pressure, lipid 
levels or obesity are more likely to also become adults with these risk 
factors and are therefore more likely to develop cardiovascular disease. 
In summary, cardiovascular disease might originate in early life. 
Both an adverse fetal environment and an affluent postnatal environment 
seem to adversely affect cardiovascular health from childhood to 
adulthood. Identifying the risk factors and the sensitive periods in early life 
and the mechanisms through which early life affects cardiovascular health 
are important for future preventive strategies to ensure cardiovascular 
health later in the life course. Therefore, studies presented in this thesis 
were designed to identify fetal, infant and childhood factors associated with 
cardiovascular health outcomes in childhood (Figure 1.1). The studies are 
particularly focused on the role of growth and adiposity in specific early-
life periods. 
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Figure 1.1 Overview of hypothesis for the associations of maternal, fetal, 
infant and childhood factors with cardiac structure and cardiovascular 
health in childhood 
 
Cardiac development 
In fetal life, cardiac growth is mainly determined by myocardial cell 
hyperplasia, while in late pregnancy or after birth this switches to 
myocardial cell hypertrophy.7 Possibly, growth in utero affects cardiac size 
through altered hemodynamics and thus also wall stress, which can affect 
the maturation and sarcomere structure of cardiomyocytes.19-21 This could 
affect the number, size and function of the cardiomyocytes around the time 
of birth, and program cardiomyocyte development after birth. A reduced 
number of cardiomyocytes at birth could mean the heart is more vulnerable 
to stress and damage later in life.7 Postnatally, the heart grows rapidly to 
accommodate to the demands of the growing body. Physiological growth 
also occurs in response to physical activity and exercise.7 In children, one 
of the main determinants of cardiac size is lean body mass.22 Lean body 
mass is associated with an increase in blood volume, leading to a higher 
preload. Increase in volume and mass reduces wall stress that was caused 
by the increased demand, according to Laplace´s law.23, 24 However, on the 
long term, maladaptation to increased demand can cause geometric 
remodeling, increasing the risk for cardiac disease. It is unclear how 
childhood cardiac size and geometry relate to adult cardiac morbidity and 
Maternal environment 
Prepregnancy body mass index; gestational weight gain; placental circulation 
Growth in early life 
Fetal hemodynamics, fetal and infant growth 
Childhood adiposity 
Childhood body mass index, body composition, abdominal 
and organ fat 
Childhood cardiac structure and cardiovascular health 
Left ventricular mass and volume, right ventricular volume; cardiac function; 
blood pressure; cholesterol; triglycerides; insulin 
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mortality. We know that left ventricular mass tracks from childhood into 
young adulthood.17, 18, 25 This could mean that early life cardiac development 
can place an individual at risk for later cardiac disease.  
In adults, cardiac remodeling resulting in increased left ventricular 
mass, called hypertrophy is associated with cardiac disease and mortality.26, 
27 Based on the relationship between left ventricular size and wall 
thickness, one can distinguish different remodeling patterns. An increase 
in wall thickness, but normal left ventricular mass is called concentric 
remodeling. Increased left ventricular mass indicates hypertrophy, but 
when the wall thickness is not increased, this is called eccentric 
hypertrophy. When both are increased, it is called concentric 
hypertrophy.24 These changes in cardiac geometry, especially the 
concentricity measures, add additional prognostic value to left ventricular 
mass in predicting cardiac disease.27, 28 Many studies were performed using 
echocardiography or electrocardiography to determine hypertrophy. 
Cardiac Magnetic Resonance Imaging (cMRI) is a more precise method to 
assess cardiac measures than echocardiography and enables imaging of 
both left and right ventricular dimensions.29 Right ventricular size is 
associated with cardiac disease independently of left ventricular mass.30 A 
cMRI study in adolescents showed that preterm birth was associated with 
changes in cardiac geometry, which were more pronounced in the right 
than in the left ventricle.31 When focusing on early factors associated with 
later cardiac development, it is therefore important to also study the right 
ventricle. By using cMRI, we were able to study childhood right ventricular 
volume and function, left ventricular volume, mass, function and geometry.  
 
Cardiovascular health 
Both prenatal, antenatal and postnatal life contribute to later 
cardiovascular health. Factors in fetal life, such as maternal under- and 
overnutrition, gestational diabetes, pre-eclampsia and gestational 
hypertension, maternal smoking and alcohol use and stress all influence 
fetal nutrition, growth and birth weight. The underlying etiology of these 
stressors leading to increased cardiovascular risk are varied and could be 
different in distinct pregnancy periods.32 Children born of compromised 
pregnancies are not only at risk for cardiovascular disease, but also at risk 
for pregnancy complications, thus influencing intergenerational 
cardiovascular health.32 Parental lifestyle not only influences fetal health, 
but also childhood lifestyle and health. For example, parental policy, role 
modeling and accessibility influences childhood physical activity, healthy 
food and junk food intake.33 Childhood environment can also influence 
adult health. Higher socio-economic status and a non-smoking 
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environment in childhood predict better cardiovascular health in 
adulthood.34  
Although cardiovascular disease usually becomes apparent later in 
adulthood, precursors can be observed earlier in life. Many traditional 
cardiovascular risk factors, such as obesity, lipid levels and blood pressure 
track from childhood to adulthood.16 But increased childhood risk factors 
also influence adult cardiovascular health independently of adult obesity 
and blood pressure.35, 36 Lifelong exposure to high levels of LDL-cholesterol 
increases the risk for cardiovascular events.37 Increased blood pressure, 
overweight and obesity, high LDL-cholesterol and high triglycerides in 
adolescence are predictors of preclinical atherosclerosis.38 Higher glucose 
and insulin concentrations in childhood predicted higher glucose, insulin, 
blood pressure, lipid concentrations and preclinical atherosclerosis in 
young adulthood.39 Children with adverse glucose homeostasis were also 
more likely to develop diabetes, hyperglycemia, hypertriglyceridemia, and 
metabolic syndrome.40 It is therefore important to study early life factors 
contributing to childhood cardiovascular risk status, which can possibly 
predict adult cardiovascular risk.  
 
Growth and cardiovascular development 
Both low and high birth weight are associated with higher body mass index, 
higher blood pressure and altered cardiac structure in childhood and 
adulthood.11, 41-43 However, birth weight is only a proxy for fetal growth. 
Studies on fetal growth suggest that higher fetal growth in mid and late 
pregnancy are associated with lower blood pressure in childhood, while 
rapid infant growth is associated with higher childhood blood pressure and 
adverse body fat distribution.10, 44, 45 Children with low birth weight, or with 
low weight at the age of 1 year have higher left ventricular mass, and altered 
cardiac structure in adult life.46 Therefore, it is important to study early life 
growth and identify critical periods in early life.   
 
Adiposity and cardiac development 
Obesity is a growing public health problem worldwide. Obesity and 
excessive weight gain during pregnancy are associated with offspring 
obesity and an adverse cardiovascular health profile in childhood.47, 48 
Higher childhood body mass index is associated with adult left ventricular 
remodeling and larger left ventricular mass.35 Left ventricular remodeling 
and left ventricular hypertrophy are risk factors for cardiovascular 
morbidity and mortality.27, 49 Not just increased body mass index, but body 
composition might affect the cardiac remodeling. High body mass index 
reflects increases in both lean and adipose tissue. Lean body mass is most 
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strongly associated with the increase in left ventricular mass, that is often 
observed in obese adults.50 Visceral adipose tissue is more strongly 
associated with cardiovascular disease than subcutaneous adipose tissue.51 
In adults, visceral adipose tissue is associated with concentric remodeling 
of the left ventricle, in which the left ventricular mass-to-volume ratio is 
increased.52 Pericardial adipose tissue is a visceral fat depot directly 
attached to the heart and could possibly influence cardiac health directly. 
Observational studies in adults report associations of pericardial adipose 
tissue with higher cardiovascular morbidity and mortality and an adverse 
cardiovascular risk profile.53-55 However, it remains unclear if these 
associations are independent of visceral and general adiposity.  
In children, the associations of adiposity and body composition and 
cardiovascular health are not extensively studied. Obese children generally 
have a larger left ventricular mass and an adverse cardiovascular risk 
profile.56, 57 Lean body mass is a strong predictor of childhood left 
ventricular mass, but the effects of specific adipose tissue depots are not 
clear.22 It is important to obtain insight into the mechanisms and etiology 
of how body composition in childhood already influences cardiovascular 
health. This knowledge could help in developing more effective preventive 
programs and strategies to improve cardiovascular health throughout the 
life course.    
 
General aim of the thesis 
The general aim of this thesis was to identify early-life growth and adiposity 
related factors related to cardiac structures and adverse cardiovascular 
outcomes in children.  
 
General design and measurements 
The studies presented in this thesis were embedded in the Generation R 
Study, a population based prospective cohort study from fetal life until 
adulthood in Rotterdam, the Netherlands.58 The Generation R Study is 
designed to identify early environmental and genetic determinants of 
growth, development and health in fetal life and childhood.58 In total, 9778 
mothers with a delivery date between April 2002 and January 2006 were 
included in the study (Figure 1.2). The response at baseline was 61%.59 
Assessment in early-, mid- and late pregnancy were performed in the 
mothers, while their partners were assessed once. Assessments included 
parental physical examinations, fetal ultrasound examinations and self-
administered questionnaires. During the preschool period, information 
about anthropometrics was collected at each visit to the routine child 
health centers in the study area and parents received questionnaires. A 
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subgroup of children visited the dedicated research center for more 
extensive physical examinations and echocardiography.  
 In the school-age period, children visited the research center in the 
Erasmus MC – Sophia Children’s hospital at the ages of 6 and 10 years for 
extensive physical examinations, echocardiography and body composition 
measurements. At the age of 10 years, children also visited our Magnetic 
Resonance Imaging (MRI) center for brain and total body imaging.59 By 
using MRI, we were able to obtain detailed imaging of abdominal adiposity. 
In the 6 and 10 year follow up visits, we already collected information on 
total body and regional body composition by Dual-energy X-ray 
absorptiometry (DXA) scanner. However, studies in adults show that there 
are important differences between subcutaneous adipose tissue, and 
visceral adipose tissue in relation to cardiovascular disease.51 Visceral 
adipose tissue is more strongly linked to cardiovascular morbidity and 
mortality.54 With DXA-scanning, we were not able to obtain information 
on visceral adipose tissue, but we were able to distinguish the different 
adipose tissue depots with the help of MRI scanning.  
 Studies on the relation between cardiac structure and 
cardiovascular mortality and morbidity in adults often focus on left 
ventricular mass and concentricity of the left ventricle. Both increased left 
ventricular mass and increased concentricity are associated with 
cardiovascular disease.28 However, with echocardiography, these measures 
are not obtained directly. The diameter of the left ventricle, and the 
thickness of the ventricular walls are measured and used to calculate the 
mass of the ventricle (Figure 1.3). With cardiac MRI scanning, instead of 
measuring only the diameter and thickness of the ventricle, we can obtain 
multiple images from the base to the apex of both the left and the right 
ventricle. In these images we can distinguish the ventricular cavity and the 
ventricular wall, and thus measure the volume (Figure 1.4). Therefore, 
cardiac MRI imaging gives more precise information on left ventricular 
mass, and left and right ventricular volumes.   
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Figure 1.2 Design and data collection in the Generation R Study
Total cohort (n=9,778) 
Included in pregnancy (n=8,880) and at birth (n=898) 
Physical examinations: multiple fetal growth and placental vascular 
ultrasounds; multiple maternal weight measurements; paternal body mass 
index 
Questionnaires: parental social-demographic factors; health and lifestyle 
habits 
Focus cohort (n=1,232) 
Randomly selected subgroup of Dutch mothers 
Physical examinations: additional fetal 
ultrasounds 
 
Birth measurements (n=9,749) 
Midwife and hospital records: gestational age at birth; birth anthropometrics 
and pregnancy complications 
Preschool period (n=7,893*) 
Visits to childhood health care centers: child anthropometrics 
*Only children living within the definite study area were approached for the 
preschool period of follow up  
Focus group, preschool period (n=901) 
Physical examinations: additional 
echocardiography 
School period (n=8,305* at 6 years and n=7,393* at 10 years) 
Physical examinations: anthropometrics; body composition; blood samples; 
blood pressure; echocardiography; magnetic resonance imaging 
*All children from the original cohort were approached to participate in 
follow up studies independent of home address or participation in the 
preschool period  
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Figure 1.3 Echocardiography measurement 
 
Abbreviations: Echo: echocardiography transducer; LV: left ventricle; AR: aortic root 
diameter; LA: left atrium.  
 
The echocardiography transducer is put on the chest wall and creates a 
cross-section image of the heart, including the left ventricle, aortic root and 
the left atrium. One can measure the left ventricular wall thickness, left 
ventricular diameter, aortic root diameter and the left atrium diameter. A 
formula is used to calculate left ventricular mass and volume. However, in 
individuals where the shape of the ventricles differs from the norm, this 
formula might not be as accurate.  
 
Figure 1.4 Example of cardiac MRI measurements 
 
Legend: A: right ventricular outline; B: left ventricular epicardial outline; C: left ventricular 
endocardial outline.  
Cardiac MRI uses multiple sections to image the heart from apex to base 
and is therefore less sensitive to deviations from normal shape. In these 
images, endo- and epicardial borders were semi-automatically contoured. 
These contours are then used to calculate right and left ventricular volumes 
and mass. Since we cannot distinguish the wall of the right ventricle, no 
right ventricular mass can be calculated, only volume.   
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Outline of this thesis 
The general aim of this thesis is addressed in the several studies presented 
in this thesis.  
In Chapter 2 studies on fetal, infant and childhood growth on 
cardiovascular outcomes are described. In Chapter 2.1 the tracking of 
cardiac structure from infancy to childhood is described. The influence of 
growth patterns in fetal life and infancy on cardiovascular health are 
discussed in Chapter 2.2, while in Chapter 2.3 we have studied the 
associations of infant growth velocity patterns with cardiometabolic health 
in childhood. Chapter 2.4 focusses on fetal and childhood growth and 
cardiac structure, while Chapter 2.5 discusses the influence of fetal 
hemodynamics on childhood cardiac structure.  
 In Chapter 3 we present studies on the associations between 
maternal and child obesity and body composition on cardiovascular health. 
Chapter 3.1 discusses the associations between maternal obesity, 
gestational weight gain and childhood cardiovascular health. The 
associations of childhood adiposity and pericardial fat with cardiac 
structure and cardiovascular health are discussed in Chapter 3.2 and 
Chapter 3.3, respectively.  
 Finally, Chapter 4 provides a general discussion, in which the 
studies described in this thesis are described in a broader context. Also, 
implications and suggestions for future research are discussed.  
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ABSTRACT 
Objective: Cardiac structure and function are important predictors for 
cardiovascular disease in adults. Not much is known about tracking of 
cardiac measures, other than left ventricular mass, from early life onwards. 
We examined whether and to what extent cardiac measures track from 
infancy into school-age.  
Methods: We performed a population-based prospective cohort study 
among 1,072 children. Aortic root diameter, left atrial diameter, left 
ventricular mass, relative wall thickness and fractional shortening were 
measured repeatedly by echocardiography. We explored tracking between 
infancy (1.5, 6, and 24 months) and school-age (6 and 10 years).  
Results: Of all cardiac measures, aortic root diameter, left atrial diameter 
and left ventricular mass were significantly correlated between infancy and 
school-age (r=0.10-0.42, all p-values <0.01), with the strongest correlations 
between 24 months and 10 years. Of the different structures, aortic root 
diameter showed the strongest correlations. Approximately 30% of 
children who were in the lowest or highest quartile of a measure at the age 
of 1.5 months remained in that quartile at the age of 10 years. When 
analyzing the effects of the infant cardiac measures on the same outcomes 
at 10 years in conditional regression models, we observed effect estimates 
of the same size for the different age windows. 
Conclusion: Our results suggest moderate tracking of structural cardiac 
measures from early infancy until school-age, which become stronger at 
older ages, but not of relative wall thickness or fractional shortening. 
Moderate tracking of cardiac structures suggests that cardiac structures are 
at least partly determined in early life.  
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INTRODUCTION 
Cardiovascular disease is a major public health problem and seems to 
originate at least partly in early life.18, 25 Common risk factors for 
cardiovascular disease, including blood pressure and lipid levels track from 
childhood to adulthood.15, 16 Tracking represents the maintaining of a given 
rank order relative to peers over time.18 Previous studies have shown that 
left ventricular mass (LVM) tracks from childhood to adulthood.18, 25 
Longitudinal studies on tracking of LVM in children from the age of 7 years 
until the age of 22 years show correlation coefficients in the range of 0.4 to 
0.7.25 Previously, we have reported that tracking of LVM is also present 
during the first two years of life.60 Increased LVM is an independent 
predictor of cardiovascular disease and mortality in adults.28, 61 Next to 
LVM, an increase in aortic root diameter (AOD) is associated with 
increased risk for heart failure, whereas an increase in left atrial diameter 
(LAD) is associated with cardiovascular events, such as stroke, and 
cardiovascular mortality in adults.62, 63 The predictive value of increased 
LVM for cardiovascular events is higher when combined with information 
about relative wall thickness (RWT).28 To the best of our knowledge, no 
previous studies have analyzed tracking of these different cardiac structural 
and functional measures from infancy to childhood.  
We hypothesize that structural and functional cardiac measures 
already track from infancy onwards. Therefore, we examined the extent of 
tracking from infancy into school-age in a population-based prospective 
cohort study among 1,072 children followed from fetal life to the age of 10 
years. We measured cardiac structure and function repeatedly with 
echocardiography at the ages of 1.5, 6, and 24 months, and 6 and 10 years. 
Measures included LVM, AOD, LAD, RWT and FS.  
 
METHODS 
 
Design and study population 
This study was embedded in the Generation R Study, a population-based, 
prospective cohort study from fetal life onwards in Rotterdam, the 
Netherlands.64 All children were born between 2002-2006. Details of this 
study have been described previously.64 Detailed cardiovascular measures 
were performed in a subgroup of 1,106 Dutch children.64 Of the total of 
1,079 live born singleton children, we excluded 7 children from the analysis 
due to cardiac abnormalities (Flowchart given in Figure S.2.1.1). 
Echocardiograms were successfully performed in 85%-95% of the 
participating children at the different ages, with 24 months being the least 
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successful. Missing echocardiograms were mainly due to crying or 
unavailability of equipment or echo cardiographer. Written informed 
consent was obtained from parents of participants. The study has been 
approved by the local Medical Ethics Committee.  
 
Left cardiac structures until the age of 10 years 
Two-dimensional M-mode echocardiograms were performed when the 
children were aged 1.5, 6 and 24 months and at the age of 6 and 10 years in 
our dedicated research center. We used methods recommended by the 
American Society of Echocardiography.65 Intraobserver and interobserver 
intraclass correlation coefficients (ICC) were calculated previously in 28 
children with a median age of 7.5 years, (interquartile range 3.0-11.0) and 
varied between intraobserver ICC 0.91 to 0.99 and interobserver ICC 0.78 
to 0.96.66 We measured aortic root diameter (AOD), left atrium diameter 
(LAD), left ventricular end diastolic diameter (LVEDD), left ventricular 
posterior wall thickness (LVPWT), and interventricular septum thickness 
(IVS) and calculated fractional shortening (FS) and left ventricular mass 
(LVM).65, 67 To assess left ventricular concentricity, we calculated relative 
wall thickness (RWT) as (2*LVPWT)/LVEDD.68  
To account for differing body sizes, we additionally standardized all 
cardiac outcomes on body surface area (BSA) using Generalized Additive 
Models for Location, Size and Shape (GAMLSS) using R, version 3.2.0 (R 
Core Team, Vienna, Austria).69 These models enable flexible modelling, 
taking into account the distribution of the response variable.70 Worm plots 
and Akaike Information Criterion were used in sensitivity analyses to 
obtain the best model fit. Weight and length were measured at the cardiac 
ultrasound. BSA was computed using the Haycock formula (BSA 
(m2)=0.024265 x weight (kg)0.5378 x height (cm)0.3964.69  
 
Statistical analysis 
First, we used One-Way ANOVA and Chi-square tests to compare 
childhood characteristics between boys and girls. Second, to examine 
whether children maintain their position in the distribution of the different 
cardiac structure measures, we estimated the Pearson’s correlation 
coefficients. AOD, LAD and LVM were standardized on BSA to account for 
differing body sizes. Since RWT and FS are ratio’s between cardiac 
measures and not dependent on BSA, we constructed standard deviation 
scores (SDS) using this formula: (observed value-mean)/standard 
deviation. Third, we categorized the cardiac outcomes in quartiles and 
calculated the percentages of children that remained in the lowest or 
highest quartile between the measures at 1.5 and 10 years. Finally, we 
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performed conditional regression analyses to identify the independent 
associations of the cardiac measures at the different age windows with 
cardiac measures at age 10 years. We used standardized residuals obtained 
from regression of the cardiac structure measure at a specific age window 
on the previous measures.71 These standardized residuals are independent 
from each other and can be used in a regression model together. The R2 of 
these models gives insight in the amount of variability of the cardiac 
measure at the age of 10 years, explained by the cardiac measures of the 
previous age windows combined. There was no statistical interaction for 
sex in relation to tracking of any of the cardiac measures. Statistical 
analyses were performed using SPSS version 21.0 (IBM SPSS Statistics for 
Windows, Armonk, NY: IBM Corp). 
 
RESULTS 
Participant characteristics (Table S2.1.1) shows that boys had higher birth 
weight and had greater height and weight in infancy, but at school-age 
length and weight did not differ between boys and girls. The cardiac 
parameters are shown in Table 2.1.1.  
 
Table 2.1.2 shows that AOD, LAD and LVM correlated across all age 
windows, with correlation coefficients ranging between 0.10 and 0.42 (all 
p-values <0.01). The measures of AOD showed the strongest correlations 
across all age windows (r=0.27-0.42, all p-values <0.01). The correlations 
across infancy to school age were highest between 24 months and 10 years. 
Correlations within school-age (6 to 10 years) were higher than in infancy 
(1.5 to 24 months). The measures of RWT and FS correlated inconsistently 
between periods and the correlations were weaker than the correlations of 
the other measures.  
 
Figure 2.1.1 shows the distribution of children in quartiles of cardiac 
measures at the age of 10 for the children who were in the lowest quartile 
of the measure at the age of 1.5, and for the children who were in the highest 
quartile at 1.5 months. Of the children who were in the lowest quartile of 
AOD at 1.5 months 36% remained in the lowest quartile at the age of 10 
years, while 8% changed to the highest quartile. Of the children who were 
in the highest quartile at 1.5 months, 45% remained in the highest quartile, 
while 10% changed to the lowest quartile. AOD showed the strongest trend. 
The trends of children remaining in the lowest (30%) or highest (29%) LAD 
quartile and LVM quartiles (29% and 37%) from 1.5 months to 10 years were 
less clear. The distribution of RWT and FS did not show the same clear 
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trend. Distribution for all infant quartiles is shown in Table S2.1.2. Trends 
found for 24 months were stronger than those observed for 1.5 months 
(Figure S2.1.2).  
 
The results of the conditional regression analyses focused on identification 
of specific age windows for the cardiac outcomes at age 10 years did not 
show one clear age window for all outcomes (Figure S2.1.3). AOD at 1.5 
months had the strongest, independent association with AOD at 10 years. 
The other periods each had an additional, but less strong effect. The 
explained variability (R2) of the combined measures on AOD at 10 years 
was 31%. For LAD at 10 years, the strongest independent associations were 
observed at the age windows of 24 months and 6 years, the R2 of the model 
was 21%. The effect estimates of the different age windows of LVM on the 
measure at 10 years were of similar size, the R2 was 18%. RWT was in none 
of the age windows associated with RWT at 10 years, independently from 
the other age windows, the R2 was 2%. For FS, an independent association 
at the age of 24 months, with FS at 10 years was seen, the R2 of the model 
was 4%.  
 
DISCUSSION 
In this population-based prospective cohort study, we observed moderate 
tracking of AOD, LAD, and LVM between the ages of 1.5 months and 10 
years. Around 30% of the children who were in the lowest or highest 
quartiles at the age of 1.5 months remained in the same quartile at the age 
of 10 years. Tracking was not consistently seen in RWT and FS.  
 
Interpretation of main findings 
Tracking can be defined as the stability of a child’s rank in a distribution 
over time.72 Tracking of structural and functional cardiovascular measures 
suggests that cardiac structure originates at least partly in early life. 
Adverse cardiac structure in childhood could possibly place individuals at 
greater risk for cardiovascular disease in later life. Tracking can also be 
important for identifying individuals at risk for cardiovascular disease early 
in life.72 Longitudinal studies have shown tracking of common risk factors 
for cardiovascular disease including blood pressure, lipid levels and LVM 
from childhood to adulthood.15, 16, 18, 60 Tracking of cholesterol (r=0.53) and 
BMI (r=0.53) showed the strongest coefficients of tracking between 8 to 21 
years in a study among 354 participants, followed by tracking of 
triglycerides (r=0.33), diastolic blood pressure (r=0.28), HDL-cholesterol 
(r=0.26), and systolic blood pressure (r=0.21).16   
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Table 2.1.1 Structural and functional cardiac measures in boys and girls 
 
 Successful 
measures 
(N) 
Total group 
N=1,072 
Boys 
N=553 
Girls 
N=519 
P-
value 
Aortic root 
diameter, mm 
     
1.5 months 737 11.7 (1.2) 12.0 (1.2) 11.5 (1.1) <0.01 
6 months 728 13.7 (1.2) 14.0 (1.2) 13.4 (1.2) <0.01 
24 months 694 16.3 (1.5) 16.7 (1.5) 16.0 (1.4) <0.01 
6 years 817 19.2 (1.8) 19.7 (1.9) 18.6 (1.6) <0.01 
10 years 781 21.7 (1.8) 22.3 (1.7) 21.2 (1.7) <0.01 
Left atrial 
diameter, mm 
     
1.5 months 740 16.8 (1.9) 17.0 (1.8) 16.6 (1.9) 0.01 
6 months 731 18.0 (1.9) 18.0 (1.9) 18.0 (1.9) 0.78 
24 months 690 20.6 (2.4) 20.7 (2.5) 20.5 (2.4) 0.20 
6 years 812 25.0 (2.7) 25.4 (2.6) 24.6 (2.7) <0.01 
10 years 781 27.4 (2.7) 28.0 (2.6) 26.8 (2.7) <0.01 
Left ventricular 
mass, g 
     
1.5 months 659 14.5 (3.1) 15.2 (3.2) 13.8 (2.8) <0.01 
6 months 666 19.4 (4.0) 20.3 (4.0) 18.4 (3.7) <0.01 
24 months 645 31.3 (5.6) 32.6 (5.9) 30.0 (5.0) <0.01 
6 years 807 53.6 (11.1) 55.4 (11.3) 51.8 (10.7) <0.01 
10 years 779 72.5 (12.0) 75.6 (11.9) 69.5 (11.4) <0.01 
Relative wall 
thickness 
     
1.5 months 683 0.34 (0.07) 0.33 (0.07) 0.35 (0.07) 0.02 
6 months 693 0.32 (0.07) 0.33 (0.07) 0.32 (0.06) 0.33 
24 months 673 0.30 (0.07) 0.30 (0.07) 0.30 (0.06) 0.56 
6 years 817 0.30 (0.05) 0.30 (0.05) 0.30 (0.05) 0.20 
10 years 782 0.30 (0.03) 0.30 (0.03) 0.30 (0.03) <0.01 
Fractional 
shortening, % 
     
1.5 months 687 35.3 (5.0) 35.3 (4.8) 35.4 (5.3) 0.93 
6 months 695 37.1 (4.7) 37.2 (4.6) 37.1 (4.8) 0.72 
24 months 663 35.5 (4.6) 35.4 (4.6) 35.5 (4.7) 0.88 
6 years 817 35.3 (4.5) 35.5 (4.6) 35.1 (4.6) 0.23 
10 years 781 35.8 (4.5) 36.1 (4.6) 35.5 (4.3) 0.04 
Values are means (SD). P-value was estimated by using One-Way ANOVA test.  
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Table 2.1.2 Correlation tables of different age windows of structural and 
functional cardiac measures  
 
Aortic root diameter 
 1.5 months 6 months 24 months 6 years 10 years 
1.5 months 1     
6 months 0.37** 1    
24 months 0.32** 0.31** 1   
6 years 0.28** 0.27** 0.40** 1  
10 years 0.33** 0.38** 0.42** 0.41** 1 
 
Left atrial diameter 
 1.5 months 6 months 24 months 6 years 10 years 
1.5 months 1     
6 months 0.23** 1    
24 months 0.14** 0.23** 1   
6 years 0.16** 0.14** 0.24** 1  
10 years 0.13** 0.10** 0.25** 0.35** 1 
 
Left ventricular mass 
 1.5 months 6 months 24 months 6 years 10 years 
1.5 months 1     
6 months 0.38** 1    
24 months 0.22** 0.24** 1   
6 years 0.20** 0.31** 0.31** 1  
10 years 0.21** 0.32** 0.33** 0.29** 1 
 
Relative wall thickness 
 1.5 months 6 months 24 months 6 years 10 years 
1.5 months 1     
6 months 0.04 1    
24 months 0.01 -0.01 1   
6 years 0.11* 0.12** -0.01 1  
10 years -0.03 0.03 0.17** 0.07 1 
 
Fractional shortening 
 1.5 months 6 months 24 months 6 years 10 years 
1.5 months 1     
6 months 0.15** 1    
24 months 0.10* 0.20** 1   
6 years 0.24** 0.10* 0.13** 1  
10 years 0.02 -0.04 0.16** 0.18** 1 
Numbers are Pearson’s correlation coefficients. * p<0.05; ** p<0.01  
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Figure 2.1.1 (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bars represent the percentage of children with a cardiac measure in quartile groups, at the 
age of 10 years (x-axis). The first part represents the distribution of cardiac structure at the 
age of 10 years, for the children who were in the lowest quartile group at the age of 1.5 
months; while the second part represents the distribution of cardiac structure at 10 years, 
for the children who were in the highest quartile group at 1.5 months of age. For example, 
the bar on the left shows that of the children who were in the lowest quartile group of aortic 
root diameter at the age of 1.5 months, over 35% was still in that quartile group at the age 
of 10 years. Distribution for children who were in the lowest or highest quartile at 24 months 
is shown in Figure S2.1.2. 
 
Previously, we reported moderate tracking of cardiac structures and 
function between the ages of 1.5 and 24 months in the same study group as 
in the current study.60 Another study describes tracking of LVM in 
adolescents. This study followed 231 normotensive adolescents and 
reported a tracking coefficient for LVM of 0.41 between the ages of 11 and 
17 years.18 In line with this study, we observed moderate tracking of LVM. 
In our study we observed slightly lower tracking coefficients of LVM, than 
in the study on adolescents. This phenomenon has also been described in 
tracking of blood pressure.15, 72 Baseline age was an important predictor of 
tracking of blood pressure, with stronger tracking in (late) adolescence 
than in childhood.15, 72  
 To our knowledge, tracking of AOD, LAD, RWT and FS in children 
has not been studied before. In our study, we observed tracking of AOD 
and LAD, but we did not find consistent tracking of RWT and FS. Since 
AOD and LAD correlate with LVM, we expected these measures to track. 
Tracking of AOD was stronger than tracking of LAD and LVM. 
Echocardiography of LAD and LVM shows more intraobserver and 
interobserver variation than the measures on AOD.66 Larger measurement 
error in repeated measures causes underestimation of the true tracking 
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coefficients, which could explain the observed differences.72 RWT is used 
in clinic as an extension on LVM to determine geometry of the heart. It 
represents the ratio between LVPWT and LVEDD, and both are dependent 
on growth. We would have expected that the ratio between these two 
measures would be constant in a healthy child and would show tracking. 
However, this was not the case. The same was observed for FS. This 
measure is the percentage change in cavity diameter. It is possible that 
there is very limited variation of these measures between persons in this 
relatively healthy population, and that there is a high variability of the 
repeated measurements in a participant, due to factors such as 
measurement error, heart rate variability and blood pressure variability. 
This within person variability could be large enough to obscure any 
possible real tracking. Also, the explained variability of the first four 
measures on RWT and FS at the age of 10 years was very low. This would 
indicate that not the measures at earlier ages, but other factors at the time 
of the measurement can explain the variability. Factors associated with 
RWT and FS could be BMI, exercise, heart rate, and blood pressure.35 
 Various factors may affect tracking of cardiac structures. In adults, 
cardiac remodeling is varies between the sexes.73 However, even though a 
study in 231 adolescents found that boys have a larger LVM than girls, the 
degree of tracking was not influenced by sex.18 The results are comparable 
to our results. We also found that boys have larger cardiac structures, but 
no differences in the degree of tracking. In childhood and adolescence, 
most variation in cardiac size can be explained by lean mass and not by 
cardiovascular risk factors.22, 74 In our study, boys had a higher BSA and 
higher lean mass index than girls, which can explain the larger cardiac 
structures.75  
 To determine the most important age window for cardiac tracking, 
we used conditional analyses. With these analyses, we could determine the 
effect of a measure at a given age on the measure at 10 years, independent 
of the effect of the measures at the other ages. We did not find one age 
window to be consistently stronger correlated than the other age windows. 
Our results suggest that that the measures at 24 months seem to be a 
stronger predictor in infancy for the measures at the age of 10, than the 
measures at 1.5 months. This finding may reflect stability of cardiac 
structures after the first 2 years of life, or may reflect just a shorter time 
interval between the ages. However, we did not observe stronger 
correlations between 6 and 10 years. 
The observed moderate tracking is important from an etiological 
view point. It suggests that variation in cardiac structure partly originates 
in early life and might put individuals at risk for later cardiovascular 
TRACKING 
 32 
disease. However, based on this research, we cannot determine if tracking 
alone provides enough evidence to identify the individuals at risk in early 
life. More research and longer follow-up is needed to explain the variation 
in cardiac structure and to study whether this variation indeed leads to 
increased cardiovascular risk later in life, before predictive models can be 
created.  
 
Study limitations 
The main strength of this study is its population-based prospective study 
design starting from early fetal life. Also, we were able to perform 
echocardiography repeatedly in a large cohort of children over a time 
period of 10 years. Another strength is that we standardized the cardiac 
structural measures on BSA; this way we created SDS that were 
independent from body size at the time of measure. This ensured that we 
measured cardiac tracking, opposed to tracking of linear growth in 
childhood, since cardiac structures in childhood are mainly dependent on 
body size.22 This study was performed in a Dutch population, making it less 
generalizable to other ethnicities. A limitation of our study is that for each 
time point 15-25% of the children did not visit the research. Of the children 
who did visit, we could not obtain cardiac measures in 5-15% of the 
children. Missing values were because of the child being uncooperative at 
time of measure, or because of defective equipment or absent 
echocardiographer. However, we do not think these missing values lead to 
bias, because it is very unlikely that the correlation coefficients we found 
would be different in the children in whom we were not able to obtain 
cardiac measures. As mentioned previously, measurement error in 
repeated measures causes underestimation of the true tracking 
coefficients.72 Since measurement error is more likely in the younger 
children, who have smaller hearts and are less cooperative, this could have 
underestimated the tracking coefficients we found within infancy and from 
infancy to childhood. Also, measurement inaccuracies of the ventricular 
diameter and wall thickness could increase measurement error in the 
calculated measures, such as LVM, RWT and FS. Studies on tracking of 
cardiac structure with more precise methods, such as cardiac MRI or 
speckle-tracking echocardiography for cardiac function could be an 
interesting addition to this research field.76  
 
CONCLUSION 
Our study indicates that children who have a larger cardiac size measured 
by LVM, AOD and LAD, compared to their peers in infancy, are also more 
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likely to have a larger cardiac size in school-age. The strongest period for 
tracking across infancy to school-age seems to be between the ages of 24 
months and 10 years. Our results suggest moderate tracking of structural 
cardiac measures from early infancy until school-age, which become 
stronger at older ages, but not of FS or RWT. Moderate tracking of cardiac 
structures suggests that cardiac structures are at least partly determined in 
early life. Whether early cardiac structure and functional development 
predicts later life cardiac disease should be further studied. 
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SUPPLEMENTAL MATERIAL 
Table S2.1.1 Subject characteristics  
N, number; Wk, weeks; M, months; Y, years. Values are means (SD) or medians (95% range). 
P-value was estimated by using One-Way ANOVA test, Kruskal-Wallis test and Chi-square 
test.  
Characteristics Boys Girls P-value 
Characteristics at birth N=553 N=519  
Gestational age at birth, wk  40.3 (35.9-42.4) 40.3 (35.7-42.4) 0.54 
Premature, n (%) 29 (5.2) 21 (4.0) 0.35 
Birth weight, g  3550 (535) 3468 (538) 0.01 
Low birth weight, n (%) 20 (3.6) 20 (3.9) 0.84 
Small for gestational age, n (%) 36 (6.5) 34 (6.6) 0.98 
Large for gestational age, n (%) 59 (10.7) 71 (13.7) 0.13 
Characteristics at 1.5 months N=449 N=425  
Age at visit, m  1.5 (1.0-3.0) 1.5 (1.0-2.8) 0.60 
Weight at visit, g 5096 (746) 4777 (626) <0.01 
Length at visit, cm 57.5 (2.6) 56.4 (2.5) <0.01 
BSA at visit, m2 0.29 (0.03) 0.28 (0.02) <0.01 
Characteristics at 6 months N=449 N=426  
Age at visit, m  6.3 (5.5-8.1) 6.3 (5.5-8.4) 0.59 
Weight at visit, g 8200 (862) 7644 (815) <0.01 
Length at visit, cm 69.5 (2.5) 67.8 (2.5) <0.01 
BSA at visit, m2 0.40 (0.03) 0.39 (0.03) <0.01 
Characteristics at 24 months N=427 N=404  
Age at visit, m  25.1 (23.7-28.1) 25.1 (23.5-28.4) 0.43 
Weight at visit, kg 12.88 (1.39) 12.40 (1.33) <0.01 
Length at visit, cm 89.6 (3.3) 88.4 (3.2) <0.01 
BSA at visit, m2 0.57 (0.04) 0.56 (0.04) <0.01 
Characteristics at 6 years N=438 N=437  
Age at visit, y  5.9 (5.7-6.6) 5.9 (5.7-6.6) 0.42 
Weight at visit, kg 22.63 (3.03) 22.44 (3.40) 0.37 
Length at visit, cm 119.2 (5.1) 118.6 (5.3) 0.07 
BSA at visit, m2 0.86 (0.07) 0.86 (0.08) 0.24 
Characteristics at 10 years N=424 N=425  
Age at visit, y  9.8 (8.9-10.5) 9.8 (9.2-10.6) 0.04 
Weight at visit, kg 34.5 (5.7) 35.0 (6.5) 0.31 
Length at visit, cm 142.5 (6.2) 142.1 (6.6) 0.37 
BSA at visit, m2 1.16 (0.1) 1.17 (0.1) 0.45 
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Table S2.1.2 Distribution of cardiac measures in school-age for children for 
the different quartiles of the cardiac measure at 1.5 months 
 
Quartile of cardiac 
outcome at the age of 
1.5 months 
Quartile of cardiac outcome at the age of 10 years 
Quartile 1 Quartile 2 Quartile 3 Quartile 4 
Aortic root diameter     
Quartile 1 49 (35.8) 41 (29.9) 36 (26.3) 11 (8.0) 
Quartile 2 42 (32.1) 38 (29.0) 29 (22.1) 22 (16.8) 
Quartile 3 24 (17.5) 40 (29.2) 33 (24.1) 40 (29.2) 
Quartile 4 14 (9.9) 29 (20.6) 34 (24.1) 64 (45.4) 
Left atrial diameter     
Quartile 1 39 (30.2) 38 (29.5) 32 (24.8) 20 (15.5) 
Quartile 2 34 (24.8) 33 (24.1) 37 (27.0) 33 (24.1) 
Quartile 3 34 (23.0) 33 (22.3) 36 (24.3) 45 (30.4) 
Quartile 4 25 (18.7) 36 (26.9) 34 (25.4) 39 (29.1) 
Left ventricular mass     
Quartile 1 32 (28.8) 32 (28.8) 29 (26.1) 18 (16.2) 
Quartile 2 33 (25.2) 35 (26.7) 38 (29.0) 25 (19.1) 
Quartile 3 31 (25.8) 32 (26.7) 25 (20.8) 32 (26.7) 
Quartile 4 18 (14.3) 24 (19.0) 38 (30.2) 46 (36.5) 
Relative wall 
thickness 
    
Quartile 1 32 (26.0) 22 (17.9) 28 (22.8) 41 (33.3) 
Quartile 2 34 (27.6) 31 (25.2) 33 (26.8) 25 (20.3) 
Quartile 3 32 (23.5) 43 (31.6) 32 (23.5) 29 (21.3) 
Quartile 4 28 (20.9) 31 (23.1) 41 (30.6) 34 (25.4) 
Fractional 
shortening 
    
Quartile 1 52 (38.0) 48 (35.0) 28 (20.4) 9 (6.6) 
Quartile 2 42 (28.6) 44 (29.9) 36 (24.5) 25 (17.0) 
Quartile 3 32 (22.9) 32 (22.9) 36 (25.7) 40 (28.6) 
Quartile 4 11 (8.9) 17 (13.8) 30 (24.4) 65 (52.8) 
Values are numbers (%) and represent the distribution of children in quartiles of cardiac 
measures at the age of 10 for the children in the 4 quartiles of the measure at the age of 1.5 
months.  
  
TRACKING 
 36 
N= 1,072 
Singleton live birth children available for 
detailed cardiovascular follow up. 
 
Children participating in detailed follow 
up/successful echocardiograms: 
 -1.5 months   N=873/794 
 -6 months   N=875/830 
 -24 months   N=831/703 
 -6 years   N=875/818 
 -10 years  N=849/782 
 
N = 1,106 
Children available for detailed follow up in 
infancy  
N = 27 
Excluded due to non-singleton 
livebirth  
N = 1,079 
Singleton live birth children available for 
detailed follow up in infancy  
 
N = 7 
Excluded due to cardiac 
abnormalities 
Figure S2.1.1 Flow chart of participants included in 
the analysis  
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Figure S2.1.2 (continued) 
 
 
 
 
 
 
Bars represent the percentage of children with a cardiac measure in quartile groups, at the 
age of 10 years (x-axis). The first part represents the distribution of cardiac structure at the 
age of 10 years, for the children who were in the lowest quartile group at the age of 24 
months; while the second part represents the distribution of cardiac structure at 10 years, 
for the children who were in the highest quartile group at 24 months of age. For example, 
the bar on the left shows that of the children who were in the lowest quartile group of aortic 
root diameter at the age of 24 months, over 38% was still in that quartile group at the age 
of 10 years.  
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ABSTRACT 
Objective: Low birth weight is associated with cardiovascular disease. We 
examined the effects of fetal and infant growth patterns on cardiovascular 
outcomes in children. 
Methods: In a population-based prospective cohort study among 6,239 
children, we estimated fetal femur length and weight by 20 and 30 weeks 
ultrasound, and child length and weight at birth, 0.5, 1, 2 and 6 years. We 
measured blood pressure, carotid-femoral pulse wave velocity, aortic root 
diameter, left ventricular mass and fractional shortening at 6 years. We 
used regression analyses to identify longitudinal growth patterns 
associated with height standardized vascular outcomes and body surface 
area standardized cardiac outcomes.  
Results: Younger gestational age and lower birth weight were associated 
with higher blood pressure, smaller aortic root diameter and lower left 
ventricular mass in childhood (all p-values <0.05). Children with 
decelerated or normal fetal growth followed by accelerated infant growth 
had higher blood pressure, whereas those with decelerated growth during 
both fetal life and infancy had a relatively larger left ventricular mass. 
Longitudinal growth analyses showed that children with increased blood 
pressure tended to be smaller during third trimester of fetal life, but of 
normal size during infancy, than children with normal blood pressure. 
Children with increased aortic root diameter or left ventricular mass 
tended to be larger during fetal life, but of similar size during infancy. 
Conclusion: Specific fetal and infant growth patterns are associated with 
different cardiovascular outcomes in children. Further studies are needed 
to identify the underlying mechanisms and the long-term cardiovascular 
consequences. 
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INTRODUCTION 
Previous follow-up studies have shown associations of low birth weight 
with cardiovascular disease in later life.8, 9 More recent follow-up studies 
showed that specifically children with low birth weight followed by high 
rates of childhood weight gain have increased risks of cardiovascular 
disease.3 It has been hypothesized that a mismatch between a suboptimal 
fetal environment and affluent postnatal environment, characterized by 
fetal growth restriction followed by rapid childhood weight gain, leads to 
adverse cardiovascular adaptions, which subsequently predisposes 
individuals to cardiovascular disease.4  
Most studies use birth weight as a proxy measure for fetal growth. 
Studies with directly measured fetal growth are scarce.10, 77 Results from a 
prospective study suggested that increased fetal growth between 18 and at 
38 weeks of gestation was associated with lower systolic blood pressure in 
childhood.10 We have previously reported that smaller size in mid-
pregnancy and a larger infant size is related to a higher systolic blood 
pressure in infancy.77 Thus far, the specific early growth patterns associated 
with cardiovascular health and disease outcomes in later life are unknown. 
Detailed studies focused on the associations of specific fetal and infant 
growth patterns with cardiovascular adaptations in children might extend 
our knowledge on the critical periods in the earliest phase of life for 
cardiovascular disease development.3 
In a population-based prospective cohort study among 6,239 
children, we examined the associations of longitudinal fetal and infant 
growth patterns and critical periods with cardiovascular outcomes at 6 
years. Cardiovascular outcomes included height adjusted blood pressure 
and carotid-femoral pulse wave velocity and body surface area adjusted 
aortic root diameter, left ventricular mass and fractional shortening. All 
outcomes are known to track from childhood onwards and may predict 
disease and mortality.15, 17, 61, 78, 79 
METHODS 
Design and study population  
This study was embedded in the Generation R Study, a population-based, 
prospective cohort study from fetal life onwards in Rotterdam, The 
Netherlands.64, 80 Response rate at birth was 61% (2002 - 2006).64 Fetal and 
childhood growth were repeatedly assessed by ultrasounds and physical 
examinations. In total 8,305 children participated in these studies, of 
whom 6,239 (75%) attended the research center at 6 years for 
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cardiovascular measurements (flow chart given in Figure S2.2.1). Written 
informed consent was obtained from all parents of participants. The study 
has been approved by the local Medical Ethics Committee. 
 
Fetal, infant and childhood growth  
Fetal ultrasound examinations were carried out in each trimester of 
pregnancy.81 First trimester ultrasounds were mainly used for establishing 
gestational age.81 Second trimester (median 20.5 weeks, 95% range 18.6 – 
23.4) and third trimester (median 30.4 weeks, 95% range 28.4 – 33.1) fetal 
head circumference, abdominal circumference, and femur length were 
measured to the nearest millimeter using standardized ultrasound 
procedures.82 Estimated fetal weight was calculated using the Hadlock 
formula.83 Gestational age adjusted standard deviation scores (SDS) for all 
fetal growth characteristics were constructed on data from the total study 
group.81 These were based on reference growth curves and represent the 
equivalent of z-scores.82 In line with previous studies, we defined fetal 
growth deceleration and acceleration as a decrease or increase of >0.67 
standard deviation of weight from 20 weeks of gestational age to birth. The 
group between these two markers is considered as having normal growth.75 
At birth, information on infant sex, date of birth and weight was obtained 
from community midwife and hospital registries. We created gestational 
age- and sex-adjusted birth length and weight SDS within the total study 
population by using Growth Analyzer 3.5 (Dutch Growth Research 
Foundation, Rotterdam, the Netherlands) based on North-European 
reference standards.84, 85 We defined small size for gestational age at birth 
as being <5th sex specific percentile for weight and large size for gestational 
age at birth as being >95th sex specific percentile for weight. Preterm birth 
was defined as birth <37.0 weeks of gestation. 
 Infant length and weight were repeatedly measured at the 
Community Health Centers according to standardized procedures by well-
trained staff at the median ages of 6.2 months (95% range 5.2 – 8.3), 11.1 
months (95% range 10.1 - 15.5) and 24.8 months (95% range 23.4 – 28.1). 
Sex and age adjusted SDS for infant growth characteristics were obtained 
using Dutch reference growth curves.86 Similarly as for fetal growth, weight 
growth deceleration and acceleration were defined as a decrease or increase 
of >0.67 standard deviation (SD) of weight from birth to 24 months of 
age.75  
 At the median age of 6.2 years (95% range 5.6 – 7.9) years, we 
measured child height and weight without shoes and heavy clothing, and 
calculated body mass index.  
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Childhood cardiovascular outcomes 
At the median age of 6.2 years (95% range 5.6 – 7.9) years, we measured 
blood pressure at the right brachial artery, four times with one minute 
intervals, using the validated automatic sphygmanometer Datascope 
Accutor PlusTM (Paramus, NJ, USA).87We calculated the mean value by 
using the last three blood pressure measurement of each participant. 
Carotid-femoral pulse wave velocity was assessed using the automatic 
Complior SP device (Complior; Artech Medical, Pantin, France) with 
participants in the supine position.88 Carotid-femoral pulse wave velocity 
was calculated as the ratio of the distance travelled by the pulse wave and 
the time delay between the waveforms, as expressed in meters per second.89 
To cover a complete respiratory cycle, the mean of at least 10 consecutive 
pressure waveforms was used in the analyses. Carotid-femoral pulse wave 
velocity can be measured reliably, with good reproducibility, in large 
pediatric population-based cohorts.90 We performed M-mode 
echocardiographic measurements using methods recommended by the 
American Society of Echocardiography. Our sonographers are experienced 
and worked under supervision of a pediatric cardiologist, who also 
performed regular quality checks. We measured aortic root diameter, left 
ventricular diastolic diameter, left ventricular posterior wall thickness and 
interventricular septum thickness and calculated fractional shortening and 
left ventricular mass.65, 67 Intraobserver and interobserver intraclass 
correlation coefficients were calculated previously in 28 children with a 
median age 7.5 years, (interquartile range 3.0 - 11.0) and varied between 
0.91 to 0.99 and 0.78 to 0.96, respectively.66  
 
Covariates 
We obtained information about maternal age, pre-pregnancy weight, 
parity, educational level, household income, smoking status and folic acid 
use during pregnancy by questionnaires. Maternal height was measured 
without shoes and pre-pregnancy body mass index was calculated. 
Information about gestational hypertension and preeclampsia was 
obtained from midwife and hospital registries. The following criteria were 
used to identify women with gestational hypertension: systolic blood 
pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg after 20 
weeks of gestation in previously normotensive women. These criteria plus 
the presence of proteinuria (defined as two or more dipstick readings of 2+ 
or greater, one catheter sample reading of 1+ or greater, or a 24 h urine 
collection containing at least 300 mg of protein) were used to identify 
women with preeclampsia.91 Maternal blood pressure was measured at 
intake during pregnancy, with the validated Omron 907 automated digital 
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oscillometric sphygmanometer (OMRON Healthcare Europe B.V. 
Hoofddorp, the Netherlands).92, 93 Infant ethnicity was classified by the 
countries of birth of the parents and was categorized as European or non-
European. The largest non-European groups were the Turkish, Surinamese 
and Moroccan groups.64 Breastfeeding was assessed using questionnaires 
and categorized as 4 months exclusive breastfeeding; 4 months partial 
breastfeeding; and never breastfeeding.  
 
Statistical analysis 
First, we used linear regression models to assess the associations of birth 
characteristics, both continuously and in clinical categories, with 
cardiovascular outcomes (systolic blood pressure, diastolic blood pressure, 
carotid-femoral pulse wave velocity, aortic root diameter, left ventricular 
mass and fractional shortening). We tested for non-linearity, but no 
significant non-linear associations were present. Second, we used stratified 
linear regression models to assess whether the associations of fetal growth 
deceleration and acceleration, based on the difference in weight SD score 
between 20 weeks and birth, with cardiovascular outcomes were modified 
by infant growth acceleration or deceleration based on the difference in 
weight SD score between birth and 2 years. We calculated the population 
attributable risk percent (PAR%) for increased systolic blood pressure 
(upper 15%) for the fetal growth deceleration group and for the infant 
growth acceleration group (compared to the normal growth groups), by 
using this formula: PAR=(risk in population) – (risk in non-exposed) and 
PAR%=PAR/risk in population. Third, we performed conditional regression 
analyses to identify independent critical early life growth periods 
associated with cardiovascular outcomes. Conditional regression analyses 
take into account the correlations between early life growth measures at 
different ages.75 These analyses are described in detail in the Methods 
S2.2.1. Briefly, we constructed length, weight and body mass index gain 
variables, which are statistically independent from each other, using 
standardized residuals resulting from the linear regression model of length, 
weight and body mass index regressed on the prior corresponding growth 
measurements. This allows simultaneous inclusion of all growth measures 
in a regression model to assess the most critical periods of growth.71 Fourth, 
we compared fetal and infant growth patterns between children with and 
without high-risk cardiovascular outcomes. High-risk cardiovascular 
outcomes were defined as a high (highest 15%) blood pressure, carotid-
femoral pulse wave velocity, aorta root diameter or left ventricle mass or a 
low (lowest 15%) fractional shortening. For these analyses we used repeated 
measurement regression models, which take into account the correlation 
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between repeated growth measurements of the same participant.94 For all 
analyses, we constructed height adjusted standard deviation scores for the 
vascular outcomes (blood pressure, pulse wave velocity) and body surface 
area adjusted SDS for the cardiac outcomes (aortic root diameter, left 
ventricular mass) using Generalized Additive Models for Location, Size and 
Shape (GAMLSS) using R, version 3.2.0 (R Core Team, Vienna, Austria).95-
97 These models enable flexible modelling, taking into account the 
distribution of the response variable.70 All models were adjusted for 
relevant covariates (maternal age, pre-pregnancy body mass index, parity, 
educational level, smoking status and folic acid use during pregnancy, 
systolic and diastolic blood pressure at intake and gestational hypertensive 
disorders, child’s sex, ethnicity, breastfeeding, and current age), selected 
on the basis of their associations with the outcomes of interest based on 
previous studies or change in effect estimate >10%.98 We did not observe 
significant statistical interaction terms between fetal and infant growth 
measures and child sex or ethnicity in relation to cardiovascular outcomes. 
Missing covariates were imputed using the multiple imputations procedure 
to reduce potential bias associated with missing data, twenty-five datasets 
were created and analyzed together (Methods S2.2.1).99, 100 The repeated 
measurement analyses were performed using SAS version 9.3 (SAS Institute 
Inc., Cary, NC, USA), including the Proc Mixed module for unbalanced 
repeated measurements. All other analyses were performed using the 
Statistical Package for the Social Sciences version 21.0 for Windows (IBM 
Corp., Armonk, NY, USA).  
 
RESULTS 
Subject characteristics  
Maternal and child characteristics of study participants are shown in Table 
2.2.1 (Characteristics based on original, and not imputed data are shown in 
Table S2.2.1). The participating mothers had a median body mass index of 
23.0 kg/m2. Of the participating children, 50.2% was a boy and 63.9% had 
the European ethnicity. Non-response analyses show that children who did 
not participate in the cardiovascular follow-up studies at the age of 6 years, 
had lower gestational age at birth and lower birth weight and had mothers 
who were younger and lower educated, than children who did participate 
(Table S2.2.2). All fetal and infant growth measures are given in Table 
S2.2.3.  
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Table 2.2.1. Subject characteristics (N=6,239) 
 
Subject characteristics N  
Maternal characteristics   
Age, y 6239 31.1 (19.8 – 39.9) 
Height, cm 6239 167.6 (7.3) 
Weight, kg 6239 65.0 (49.9 – 95.1) 
Body mass index pre-pregnancy, kg/m2 6239 23.0 (18.2 – 33.6) 
Parity, n (%) 6239  
 0  3508 (56.2) 
 ≥1  2731 (43.8) 
Maternal education, n (%) 6239  
 Low/middle  3413 (54.7) 
 Higher  2826 (45.3) 
Folic acid intake during pregnancy, n (%) 6239  
 No use  1648 (26.4) 
 Start in the first 10 weeks  1974 (31.6) 
 Start periconceptional  2617 (41.9) 
Alcohol consumption during pregnancy, n (%) 6239  
 No  2865 (45.9) 
 Yes   3374 (54.1) 
Smoking during pregnancy, n(%) 6239  
 No  4630 (74.2) 
 Yes  1609 (25.8) 
Systolic blood pressure, mmHg 6239 115.6 (12.2) 
Diastolic blood pressure, mmHg 6239 68.1 (9.5) 
Gestational hypertensive disorders*, n (%) 6239 397 (6.4) 
Birth and infant characteristics   
Sex, boys, n (%) 6239  
 Boys  3132 (50.2) 
 Girls  3107 (49.8) 
Ethnicity, European, n(%) 6239  
 European  3988 (63.9) 
 Non-European  2251 (36.1) 
Gestational age at birth unit, weeks 6239 40.1 (35.9 – 42.3) 
Birth weight, grams 6239 3429 (551) 
Preterm birth <37 weeks at delivery (%) 6239 309 (5.0) 
Small for gestational age†, n (%) 6239 291 (4.7) 
Large for gestational age‡, n (%) 6239 310 (5.0) 
Breastfeeding, n (%) 6239  
 4 months exclusive  1456 (23.3) 
 4 months partial  4138 (66.3) 
 Never  645 (10.3) 
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Table 2.2.1 (continued) 
 
Child characteristics at 6 years   
Age, y 6239 6.0 (5.6 – 7.9)  
Height, cm 6239 119.5 (6.0) 
Weight, kg 6239 22.6 (17.6 – 34.2) 
Body mass index, kg/m2 6239 15.9 (13.6 – 21.3) 
Systolic blood pressure, mmHg 6196 102.8 (8.3) 
Diastolic blood pressure, mmHg 6196 60.8 (6.9) 
Carotid-femoral pulse wave velocity, m/s 5078 5.5 (0.9) 
Aortic root diameter, mm 5925 19.3 (1.8) 
Left ventricular mass, grams 5813 53.4 (11.6) 
Fractional shortening, % 5899 35.2 (4.5) 
Values are means (SD), medians (95% range) or numbers (%). The values represent the 
pooled results after multiple imputations (N=25). *Pre-eclampsia or pregnancy induced 
hypertension. †Sex specific gestational age adjusted birth weight <5th percentile in total 
cohort. ‡Sex specific gestational age adjusted birth weight >95th percentile in total cohort. 
Characteristics based on observed, not imputed, data are given in Table S2.2.1. 
  
Birth outcomes and childhood cardiovascular outcomes  
Table 2.2.2 shows that younger gestational age at birth was associated with 
a higher systolic blood pressure, smaller aortic root diameter and lower left 
ventricular mass in childhood (all p-values for trend <0.05). Similarly, a 
lower birth weight was associated with a higher systolic and diastolic blood 
pressure and with a smaller aortic root diameter and left ventricular mass 
in childhood (all p-values for trend <0.05). A lower gestational age adjusted 
birth weight was associated with a higher systolic and diastolic blood 
pressure and smaller aortic root diameter and left ventricular mass in 
childhood (all p-values for trend <0.05). We did not observe consistent 
associations of birth measurements and gestational age with childhood 
carotid-femoral pulse wave velocity or fractional shortening. Similar results 
were present in the models adjusted for age and gender of the child only 
(data not shown). P-values are shown in Table S2.2.4. 
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Fetal and infant growth measures and childhood cardiovascular 
outcomes  
Figure 2.2.1 shows that as compared to children with normal growth 
during fetal life and infancy, those with fetal weight growth deceleration 
followed by infant weight growth acceleration had a higher systolic and 
diastolic blood pressure (differences 0.12 SDS (95% Confidence Interval 
(CI) 0, 0.24) and 0.13 SDS (95% CI 0.01, 0.25), respectively), and smaller 
aortic root diameter (difference -0.15 SDS (95% CI -0.27, -0.03). Children 
with growth deceleration during both fetal life and infancy had the highest 
left ventricular mass. We observed the highest systolic blood pressure 
among children with normal fetal growth followed by accelerated growth. 
The PAR% for the fetal growth deceleration group (compared to normal 
growth) for increased systolic blood pressure was 3.7%, while the PAR% for 
infant growth acceleration on systolic blood pressure was 14.9%. Among 
children with normal fetal growth, those with infant growth acceleration 
had a smaller aortic root diameter (difference -0.15 SDS (95% CI -0.27, -
0.03) and higher fractional shortening (difference 0.15 SDS (95% CI 0.03, 
0.28). Fetal growth acceleration followed by infant growth deceleration 
was associated with lower systolic and diastolic blood pressure (differences 
-0.17 SDS (95% Confidence Interval (CI) -0.29, -0.05) and -0.16 SDS (95% 
CI -0.28, -0.04), respectively, compared to children with normal fetal and 
infant growth). Infant growth was not associated with carotid-femoral 
pulse wave velocity. Exact results are shown in Table S2.2.5. 
 To further identify critical periods for the different cardiovascular 
outcomes, we performed conditional regression analyses. Results are given 
in Figure S2.2.2 and suggest that not fetal size, but low weight at birth, and 
high weight and body mass index during infancy are associated with higher 
systolic blood pressure in childhood, conditional on respective weight and 
body mass index at earlier ages (Figure S2.2.2A-B). Length, but not weight, 
in late infancy, conditional on earlier measurements, was positively 
associated with carotid-femoral pulse wave velocity in childhood (Figure 
S2.2.2C). Weight in fetal life and at birth, but not at older ages was 
positively associated with aortic root diameter and left ventricular mass in 
childhood (Figure S2.2.2D-E). Fetal femur length at 30 weeks was 
inversely, and length at birth was positively associated with left ventricular 
mass in childhood (Figure S2.2.2E). Body mass index in late infancy was 
inversely associated with fractional shortening, conditional on respective 
weight and body mass index at earlier ages (Figure S2.2.2F).  
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Longitudinal growth patterns associated with high-risk childhood 
cardiovascular outcomes 
Figure 2.2.2 shows that as compared to children who had a normal blood 
pressure at 6 years, those who had an increased blood pressure tended to 
be smaller during third trimester of fetal life, but of similar size during 
infancy (p-values <0.05). We observed stronger effect estimates for systolic 
blood pressure than diastolic blood pressure. Children with increased 
carotid-femoral pulse wave velocity showed similar fetal growth patterns as 
children without increased carotid-femoral pulse wave velocity, but they 
had lower weights during infancy. As compared to children with a normal 
aortic root diameter and left ventricular mass, those with increased aortic 
root diameter and left ventricular mass, respectively, tended to be larger 
during fetal life, but of similar size during infancy (p-values <0.05). We 
observed a tendency for children with decreased fractional shortening to 
be taller and heavier during both fetal and infant life as compared to those 
with normal fractional shortening. 
 
Figure 2.2.2 Fetal and infant growth patterns of children with increased 
levels of cardiovascular risk factors (N = 6,239) 
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Figure 2.2.2 (continued) 
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Figure 2.2.2 (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
Values are based on repeated linear regression models. Regression coefficients (95% 
confidence interval) reflect the difference in (femur)length and weight standard deviation 
score from second trimester onwards for children with increased cardiovascular risk 
compared to children without this risk. Having increased risk is defined as having systolic 
and diastolic blood pressure, carotid-femoral pulse wave velocity, aortic root diameter or 
left ventricular mass ≥85th or having fractional shortening ≤15th centile. For blood pressure 
and carotid femoral pulse wave velocity, we used height adjusted standard deviation scores, 
whereas for aortic root diameter and left ventricular mass we used body surface area 
adjusted standard deviation scores. All models were adjusted for maternal age, pre-
pregnancy body mass index, parity, educational level, smoking status and folic acid use 
during pregnancy, systolic and diastolic blood pressure at intake and gestational 
hypertensive disorders, child’s sex, ethnicity, breastfeeding, and current age.  
 
DISCUSSION  
In this population-based, prospective cohort study, we identified fetal and 
infant growth patterns and critical periods associated with adverse 
cardiovascular outcomes in childhood. Younger gestational age at birth and 
lower weight at birth were both associated with higher blood pressure, 
smaller aortic root diameter and lower left ventricular mass. Also, children 
who had an increased blood pressure at 6 years tended to be smaller during 
late fetal life followed by higher growth rates during infancy. Children, who 
had an increased aortic root diameter or left ventricular mass at 6 years, 
had higher growth rates during both fetal life and infancy. 
 
Methodological considerations  
Main strengths of this study are its population-based prospective design 
starting in fetal life, and the large number of fetal and infant growth 
measurements and cardiovascular outcomes available. We investigated the 
influence of prospectively measured fetal and childhood growth patterns, 
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in addition to birth size, on cardiovascular outcomes using different 
statistical approaches. The repeated fetal and infant growth measurements 
provided the opportunity to assess the effects of both fetal and infant 
growth on cardiovascular outcomes, to identify critical periods during fetal 
life and infancy and to discover specific growth patterns associated with an 
adverse cardiovascular profile. Some limitations need to be discussed. 
Response rate at baseline in the Generation R Study cohort was 61%. Biased 
estimates in large cohort studies mainly arise from loss to follow-up, rather 
than from nonresponse at baseline.101 Of the children available for follow-
up, 75% participated in the cardiovascular follow-up measurements. This 
could lead to bias if the associations between early growth characteristics 
with cardiovascular outcomes differ between those included and those not 
included in the analyses. Lower gestational age at birth and lower birth 
weight were more prevalent among children who were not included in the 
study, as compared to those included. The effect of selective loss to follow-
up is difficult to estimate. Ethnicity is associated with fetal growth patterns 
and birth weight.102, 103 However, in the current study, we did not find 
significant interaction terms between ethnicity and fetal and infant growth 
measures in relation to cardiovascular outcomes. We have adjusted the 
analyses for ethnicity and our results do not suggest that the differences 
between ethnic groups influence the results. Although we used several 
cardiovascular outcome measurements, more detailed information can be 
collected by advanced cardiovascular Magnetic Resonance Imaging (MRI). 
Previous studies reported specific effects of preterm birth on cardiac shape 
and morphology, rather than on left ventricular mass.104 For the repeated 
measurement regression models, we dichotomized our outcomes into 
increased versus normal risk, using a 15% cut-off. However, results were not 
dependent on this cut-off, because we observed similar results when we 
used 10% or 25% as cut-off. Participants in this study have a median age of 
6.0 years. Whether the observed associations are clinically important later 
in life needs to be further studied. Although the potential confounding 
effect of factors related to the risk of cardiovascular disease is expected to 
be restricted in young children, and we did take many potential 
confounders into account, the influence of residual confounding should be 
considered, as in all observational studies.  
 
Interpretation of main findings 
Fetal and infant life seem to be critical periods for development of 
cardiovascular health in adulthood.4 It has been hypothesized that a 
mismatch between suboptimal fetal environment and affluent postnatal 
environment leads to adverse cardiovascular adaptations, which 
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subsequently predisposes individuals to cardiovascular disease.10 Previous 
studies have shown that children born with a small size at birth and 
childhood growth acceleration have a greater risk of cardiovascular disease 
in later life.3, 14 In the current study, we examined the associations of fetal 
and infant growth with cardiovascular outcomes and aimed to identify 
critical periods and longitudinal growth patterns associated with adverse 
cardiovascular profiles in childhood. 
The associations of low birth weight with blood pressure in later life 
are well established but the effect estimates seem to be small.105 Results 
from a systematic review suggest that especially children with a low birth 
weight followed by high childhood growth rates have an increased blood 
pressure.14 By using conditional regression analyses, another study showed 
that low birth weight and accelerated growth in infancy are associated with 
higher blood pressure, independent from each other.106 However, the 
effects of adiposity in childhood on blood pressure were much stronger that 
the effects of birth outcomes.106 Another study using adiposity growth 
trajectories on repeatedly measures blood pressure, shows that adiposity 
trajectories in childhood are associated with higher blood pressure, 
independent from birth weight.107 In line with these studies, we observed 
associations of lower gestational age, birth weight and gestational age 
adjusted birth weight with higher systolic and diastolic blood pressure in 
childhood. Furthermore, we observed that body mass index increase in 
infancy, independent from fetal growth or birth weight, was positively 
associated with blood pressure. Our results suggest that both lower fetal 
weight gain and high infant weight gain are associated higher blood 
pressure in childhood, with stronger effect estimates for infant weight gain.  
A suboptimal fetal development may lead to impaired elastin 
synthesis, and subsequently stiffer arteries and increased blood pressure.108 
A study amongst 337 adults aged 50 showed that lower birth weight was 
associated with higher femoro-popliteal-tibial pulse wave velocity, but not 
with the pulse wave velocity on the aorto-iliac segment.109 Another study 
in 86 children aged 8.2 years showed that children who were born preterm 
and small for gestational age had increased arterial stiffness.110 We did not 
observe consistent associations of gestational age, birth weight or 
gestational age adjusted birth weight with aortic-femoral pulse wave 
velocity. We could not identify critical periods of growth associated with 
arterial stiffness. Our results are in line with a study among 951 adults aged 
25 years, in which no relation was found between birth weight and pulse 
wave velocity.111 Further studies are needed to examine whether the 
associations of birth outcomes with pulse wave velocity become present at 
older ages.  
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Previous studies suggested that early life growth characteristics 
might influence cardiac structure in children and adults.11, 46 We observed 
that fetal growth rates were positively associated with aortic root diameter 
and left ventricular mass. In line with our findings, a study among 216 
children reported a positive association of birth weight with aortic root 
diameter.112 The Framingham Heart Study reported height and weight to be 
positively associated with aortic root diameter in adults aged 20 to 89 
(mean 48 years).113 In the same study, systolic blood pressure was inversely 
associated with aortic root diameter.113 This is in line with our results. We 
observed that both gestational age adjusted birth weight and fetal growth 
deceleration followed by growth acceleration were associated with higher 
systolic blood pressure and with smaller aortic root diameter.  
A study in 200 children aged 5 years showed that children with 
growth restriction in fetal life had a different cardiac shape, with increased 
transversal diameters and more globular cardiac ventricles.11 Another study 
among 102 young adults, who were born preterm, showed that left ventricle 
geometry was altered and ventricular mass was increased.104 We observed 
that birth weight was positively associated with body surface area 
standardized left ventricular mass. In childhood, muscle mass is an 
important determinant of left ventricular mass.22, 74 Lean mass is also 
positively associated with birth weight.114 It is possible that children with a 
higher birth weight have both higher lean mass and thus cardiac mass. 
Early cardiac growth is determined by myocardial cell hyperplasia, while 
later in life cardiac growth is determined by hypertrophy.7 Children with 
normal or decelerated fetal growth, followed by infant growth deceleration 
had the highest left ventricular mass, relative to current body size. This is 
in line with another study, which found low weight at the age of one year 
to be associated with left ventricular hypertrophy in adulthood.46 Further 
studies are needed to assess geometry of the cardiac structures of children 
with fetal growth restriction, and the possible associations with an adverse 
cardiovascular profile in adulthood. The observation that a lower 
gestational age and fetal growth deceleration followed by infant weight 
growth acceleration with higher blood pressure were not paired with left 
ventricular hypertrophy or aortic root diameter, might also be explained by 
the association of lean mass with left ventricular mass in children.74  
Although the observed effect estimates of fetal and infant growth 
on cardiovascular outcomes are small and without clinical relevance for 
individuals, the results from this study may be important on a population 
based level. The results are an important contribution to the field of 
developmental origins of cardiovascular disease. They suggest that both 
fetal and infant growth, and especially the combination of both, influence 
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cardiovascular development and might predispose individuals to 
cardiovascular disease in adulthood. The critical periods and growth 
patterns for vascular development may differ from those for cardiac 
development. Although previous studies indicated tracking of a range of 
structural and functional properties of the cardiovascular system from 
childhood to adulthood, the consequences of the modest effect estimates 
on the individual risk of cardiovascular disease in later life need to be 
further studied. 15, 36, 60 
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SUPPLEMENTAL MATERIAL 
Methods S2.2.1 Statistical analysis 
 
To take into account the correlation between fetal and infant growth 
characteristics, we used conditional regression analyses to examine the 
associations of these measurers with childhood outcomes.75 We 
constructed length, weight and body mass index gain variables, which are 
statistically independent from each other, using standardized residuals 
resulting from the linear regression model of length, weight and body mass 
index regressed on the prior corresponding growth measurements. This 
allows simultaneous inclusion of all growth measures in a regression 
model.75 
The percentages of missing covariate values within the population 
for analysis were lower than 15.0%, except for folic acid use (30.6%) 
maternal pre-pregnancy BMI (24.8%) and breastfeeding (21.7%). Data were 
imputed according to the Markov Chain Monte Carlo method, assuming 
no monotone missing pattern. Data were analyzed in each set separately, 
and pooled estimates from the 25 imputed datasets were used to report the 
effect estimates and their 95% confidence intervals (95% CI).100  
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Figure S2.2.1 Flow chart of participants included in the analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
N = 8,305 
Children available for follow up studies at 6 
years 
N = 208 
Excluded: twins  
 
N = 8,097 
Singleton live born children  
 
N = 93 
Excluded: missing data on birth weight or 
gestational age (N=93) 
N = 8,004 
Children with information about birth weight 
and gestational age 
N = 1738 
Excluded: not attending the research center 
(N = 1,545) and no cardiovascular 
measurements available (N= 193) at 6 years 
N = 6,266 
Children attending the research center with 
cardiovascular measurements available 
N = 27 
Excluded: cardiac abnormalities 
 
N = 6,239 
Singleton children with information about birth 
weight and gestational age and participation in 
the measurements for the present study 
 
Blood pressure: N = 6196 
Pulse wave velocity: N = 5078 
Cardiac measures: N = 5925 
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Figure S2.2.2 Associations of fetal and infant growth measures with 
childhood cardiovascular outcomes from conditional analyses (N = 6,239)  
A.  
 
 
 
 
 
 
 
 
 
 
 
 
B.  
 
 
 
 
 
 
 
 
 
 
 
 
C.  
 
 
 
 
 
 
 
  
 CHAPTER 2.2 
 
65 
Figure S2.2.2 (continued)  
D.  
 
 
 
 
 
 
 
 
 
 
E.  
 
 
 
 
 
 
 
 
 
 
F.  
 
 
 
 
 
 
 
 
 
 
Abbreviations: SDS, Standard deviation scores; CI, confidence interval. Values are 
regression coefficients (95% CI) from conditional analyses. Exact numbers corresponding 
to the regression coefficients are presented in Table S2.2.6. Length in fetal life represents 
estimated femur length. For blood pressure and carotid femoral pulse wave velocity, we used 
height adjusted standard deviation scores, whereas for aortic root diameter and left 
ventricular mass, we used body surface area adjusted standard deviation scores. The 
estimates represent differences in cardiovascular measures per standardized residual 
change of fetal and infant growth measures. Models are adjusted for maternal age, pre-
pregnancy body mass index, parity, educational level, smoking status and folic acid use 
during pregnancy, systolic and diastolic blood pressure at intake and gestational 
hypertensive disorders, child’s sex, ethnicity, breastfeeding, and current age. 
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Table S2.2.1 Subject characteristics based on original data (N = 6,239) 
 
Subject characteristics N Missing  
N (%)  
Maternal characteristics    
Age, y 6239 0 (0) 30.5 (5.2) 
Height, cm 5677 562 (9.0) 167.5 (7.4) 
Weight, kg 4700 1539 (24.7) 64.0 (49.0–98.0) 
Body mass index pre-pregnancy, kg/m2 4691 1548 (24.8) 22.7 (18.1–34.7) 
Parity, n (%) 6073 166 (2.7)  
 0   3425 (56.4) 
 ≥1   2648 (43.6) 
Maternal education, n (%) 5709 530 (8.5)  
 Low/middle   3042 (53.3) 
 Higher   2667 (46.7) 
Folic acid intake during pregnancy, n 
(%) 
4330 1909 (30.6)  
 No use   1090 (25.2) 
 Start in the first 10 weeks   1380 (31.9) 
 Start periconceptional   1860 (43.0) 
Alcohol consumption during pregnancy, 
n (%) 
4992 1247 (20.0)  
 No   2287 (45.8) 
 Yes    2705 (54.2) 
Smoking during pregnancy, n(%) 5053 1186 (19.0)  
 No   3738 (74.0) 
 Yes   1315 (26.0) 
Systolic blood pressure, mmHg 5643 596 (9.6) 115.6 (12.2) 
Diastolic blood pressure, mmHg 5643 596 (9.6) 68.1 (9.5) 
Gestational hypertensive disordersa, n 
(%) 
5530 709 (11.4) 335 (6.1) 
Birth and infant characteristics    
Sex, boys, n(%) 6239 0 (0)  
 Boys   3132 (50.2) 
 Girls   3107 (49.8) 
Ethnicity, European, n(%) 6087 152 (2.4)  
 European   3914 (64.3) 
 Non-European   2173 (35.7) 
Gestational age at birth unit, weeks 6239 0 (0) 40.1 (35.9 –42.3) 
Birth weight, grams 6239 0 (0) 3429 (551) 
Preterm birth <37 weeks at delivery (%) 6239 0 (0) 309 (5.0) 
Small for gestational ageb, n (%) 6239 0 (0) 291 (4.7) 
Large for gestational agec, n (%) 6239 0 (0) 310 (5.0) 
Breastfeeding, n (%) 3940 2299 (36.8)  
 4 months exclusive   1003 (16.1) 
 4 months partial   2564 (41.1) 
 Never   373 (6.0) 
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Table S2.2.1 (continued) 
 
Child characteristics at 6 years    
Age, y 6239 0 (0) 6.0 (5.6–7.9)  
Height, cm 6239 0 (0) 119.5 (6.0) 
Weight, kg 6239 0 (0) 22.6 (17.6–34.2) 
Body mass index, kg/m2 6239 0 (0) 15.9 (13.6–21.3) 
Systolic blood pressure, mmHg 6196 43 (0.7) 102.8 (8.3) 
Diastolic blood pressure, mmHg 6196 43 (0.7) 60.8 (6.9) 
Carotid-femoral pulse wave velocity, m/s 5078 1161 (18.6) 5.5 (0.9) 
Aortic root diameter, mm 5925 314 (5.0) 19.3 (1.8) 
Left ventricular mass, grams 5813 426 (6.8) 53.4 (11.6) 
Fractional shortening, % 5899 340 (5.4) 35.2 (4.5) 
Values are means (SD), medians (95% range) or numbers (%). Values represent the results 
based on the original, non-imputed data. a Pre-eclampsia or pregnancy induced 
hypertension. bSex specific gestational age adjusted birth weight <5th percentile in total 
cohort. cSex specific gestational age adjusted birth weight >95th percentile in total cohort. 
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Table S2.2.2 Non-response analysis for childhood follow-up data at 6 years 
(N=8,305) 
 
Subject characteristics 
Follow-up at 6 
years 
N=6,239 
Lost to follow-
up at 6 years 
N=2,066 
P-
value 
Maternal characteristics    
Age, y 30.5 (5.2) 29.5 (5.4) <0.01 
Height, cm 167.5 (7.4) 167.3 (7.4) 0.20 
Weight, kg 64.0 (49.0-98.0) 64.0 (48.0-98.9) 0.33 
Body mass index pre-pregnancy, 
kg/m2 
22.7 (18.1-34.7) 22.6 (17.8-35.0) 0.28 
Primiparity, n (%) 3425 (56.4) 1022 (52.4) 0.00 
Maternal education, higher, n (%) 2667 (46.7) 708 (40.3) <0.01 
Folic acid intake during pregnancy, 
never, n (%) 
1090 (25.2) 416 (31.3) <0.01 
Alcohol consumption during 
pregnancy, never, n (%) 
2287 (45.8) 862 (54.7) <0.01 
Smoking during pregnancy, never, 
n(%) 
3738 (74.0) 1134 (70.8) 0.01 
Systolic blood pressure, mmHg 115.6 (12.2) 115.2 (12.4) 0.28 
Diastolic blood pressure, mmHg 68.1 (9.5) 67.5 (9.7) 0.03 
Gestational hypertensive disordersa, n 
(%) 
335 (6.1) 110 (6.3) 0.69 
Birth and infant characteristics    
Sex, boys, n(%) 3132 (50.2) 1057 (51.2) 0.44 
Ethnicity, European, n(%) 3914 (64.3) 1195 (63.4) 0.47 
Gestational age at birth unit, weeks 40.1 (35.9-42.3) 39.9 (33.7-42.3) <0.01 
Birth weight, grams 3429 (551) 3307 (643) <0.01 
Preterm birth <37 weeks at delivery 
(%) 
309 (5.0) 215 (10.8) <0.01 
Small for gestational ageb, n (%) 291 (4.7) 119 (6.1) 0.01 
Large for gestational agec, n (%) 310 (5.0) 100 (5.1) 0.81 
Breastfeeding, n (%)   <0.01 
 4 months exclusive 1003 (25.5) 210 (20.6)  
 4 months partial 2564 (65.1) 675 (66.1)  
 Never 373 (9.5) 136 (13.3)  
Values are means (SD), medians (95% range) or numbers (%). Values represent the results 
based on the original, non-imputed data. a Pre-eclampsia or pregnancy induced 
hypertension. bSex specific gestational age adjusted birth weight <5th percentile in total 
cohort. cSex specific gestational age adjusted birth weight >95th percentile in total cohort. 
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ABSTRACT 
Objective: To evaluate the impact of infant growth on childhood health, 
we examined the associations of detailed longitudinal infant weight 
velocity patterns with childhood cardiovascular and metabolic outcomes. 
Study Design: In a population-based prospective cohort study among 
4,649 children, we used repeated growth measurements between 0 and 3 
years to derive peak weight velocity (PWV), age at adiposity peak (AGEAP) 
and body mass index at adiposity peak (BMIAP). At the age of 6 years, we 
measured blood pressure, left ventricular mass, and cholesterol, 
triglycerides and insulin concentrations and define children with clustering 
of risk factors. We assessed the associations using two multivariable linear 
regression models. 
Results: A 1-standard deviation score (SDS) higher infant PWV was 
associated with higher diastolic blood pressure (0.05 SDS (95% Confidence 
Interval (CI) 0.02, 0.09)), and lower left ventricular mass (-0.05 SDS (95% 
CI -0.09, -0.01), independently of body size. A 1-SDS higher BMIAP was 
associated with higher systolic (0.12 (95% CI 0.09, 0.16) and diastolic blood 
pressure (0.05 (95% CI 0.01, 0.08)), but these associations were explained 
by childhood BMI. We did not observe associations of PWV, BMIAP and 
AGEAP with cholesterol and insulin concentrations. Higher PWV and 
AGEAP were associated with higher risk of clustering of cardiovascular risk 
factors in childhood (p-values<0.05). 
Conclusion: Infant weight velocity patterns are associated with 
cardiovascular outcomes. Further studies are needed to explore the 
associations with metabolic outcomes and long-term consequences. 
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INTRODUCTION 
Rapid growth in early life is associated with an increased cardiovascular risk 
profile later in life.3 Previous studies suggest that subjects with higher 
cardiovascular disease (CVD) risk were small at birth, but had accelerated 
childhood growth.2, 115, 116 Especially rapid weight gain in the first 3 months 
of life is associated with risk factors of CVD in early adulthood.13, 117 
Similarly, excessive weight gain in infancy is associated with increased 
blood pressure in early adulthood.44 We have previously observed that 
specific fetal and infant weight gain were associated with various 
cardiovascular properties at 6 years.118 
 Early growth velocity patterns can be studied in more detail by 
deriving specific growth measures from longitudinal data. Repeatedly 
measured anthropometric data enable construction of infant weight 
growth indices, such as infant peak weight velocity (PWV), body mass 
index at adiposity peak (BMIAP) and age at adiposity peak (AGEAP).119, 120 
We have previously reported that these measures are strongly related to 
childhood adiposity. Higher infant PWV and BMIAP were associated with 
higher childhood BMI, body fat percentage, android/gynoid fat mass ratio 
and pre-peritoneal abdominal fat area.45, 119 An increasing number of studies 
suggest that growth velocity patterns during early infancy are associated 
with cardiovascular risk later in life, but studies on the association between 
more detailed growth indices and cardiovascular and metabolic factors are 
lacking.121, 122 We hypothesized that infant growth velocity patterns are 
associated with cardiovascular risk in school-aged children.123 
 We examined in a population-based prospective cohort study 
among 4,649 children followed from fetal life onwards, the associations of 
infant PWV, BMIAP and AGEAP with childhood cardiovascular and 
metabolic outcomes, including blood pressure, left ventricular mass, and 
total-, HDL-, and LDL-cholesterol, triglycerides, and insulin 
concentrations and clustering of cardiovascular risk factors. 
METHODS 
Study design 
This study was embedded in the Generation R Study, a population-based 
prospective cohort study from early pregnancy onwards in Rotterdam, the 
Netherlands.64, 80 Of all eligible children in the study area, 61% participated 
in the study at birth.64 The study protocol was approved by the local 
Medical Ethical Committee of the Erasmus MC (MEC-2007-413). Written 
informed consent was obtained from all mothers. 
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 Infant growth measures were available in 6,523 children 
participating in the preschool phase of the study. We excluded 1,797 
children who did not have at least 3 infant growth measurements, which 
were necessary for infant growth modeling. Of the remaining 4,726 
children, 4,681 participated in the follow-up studies at the age of 6 years. 
Cardiovascular and metabolic outcomes were measured in 4,649 children 
(Figure S2.3.1). 
 
Longitudinal infant growth velocity patterns 
Gestational age and sex adjusted standard deviation scores for birth weight 
and length were calculated using North-European growth charts.84 
Childhood length and weight were measured according to standardized 
procedures at birth, at the ages of 1, 2, 3, 4, 6, 11, 14, 18, 24 and 36 months. 
The median number of postnatal growth measurements was 5 (full range: 
3-11).64 Age- and sex-adjusted SDS for all growth characteristics were 
obtained with Dutch reference growth charts.86 As previously described, 
these growth measures were used to construct longitudinal weight and 
body mass index growth patterns, and derive infant PWV, AGEAP and 
BMIAP.119, 120 Briefly, infant PWV was derived using the Reed1 model for 
boys and girls separately.124 The model was fitted by sex on all weight 
measurements taken at 0-3 years of age, including birth weight. The first 
derivative of the fitted distance curve was taken to obtain the weight 
velocity curve. To obtain the infant PWV, the maximum of this curve was 
taken. This value reflects the maximum rate of growth in infancy. For infant 
BMIAP, a cubic mixed effects model was fitted on log(BMI) from 14 days to 
1.5 years, using sex as a covariate. Modeling of BMI growth was performed 
from the age of 14 days onwards, because children may lose up to 10% of 
their body weight in the first 2 weeks of life. When fitting the model, age 
was centralized to 0.75 years. In addition to fixed effects, we included 
random effects for the constant and the slope in the model. Subsequently, 
BMI was derived for each individual at the point where the curve reaches 
its maximum, which gives BMIAP and AGEAP. 
 
Childhood cardiovascular and metabolic properties 
Children visited our research center for follow up measurements at the 
median age of 6 years (95% range 5.6 – 7.3). We measured blood pressure 
at the right brachial artery, four times with one minute intervals, using the 
validated automatic sphygmonanometer Datascope Accutor 
PlusTM(Paramus, NJ, USA).87 We calculated the mean value by using the 
last three blood pressure measurement of each participant. M-mode 
echocardiographic measurements were performed and left ventricular 
 CHAPTER 2.3 
 79 
mass was computed using the formula derived by Devereux.65, 67 
Intraobserver and interobserver intraclass correlation coefficients were 
calculated previously and varied between 0.91 to 0.99 and 0.78 to 0.96, 
respectively.66 Thirty-minutes fasting blood samples were collected to 
measure total-, HDL-, and LDL-cholesterol, triglycerides, and insulin 
concentrations, using Cobas 8000 analyser (Roche, Almere, the 
Netherlands). Quality control samples demonstrated intra and inter assay 
coefficients of variation ranging from 0.77-1.39%, and 0.87-2.40%, 
respectively. 
We defined children with clustering of cardiovascular risk factors, 
using the previously described definition of childhood metabolic syndrome 
phenotype, which means having three or more of the following 
components: android fat mass % =>75th percentile; systolic or diastolic 
blood pressure =>75th percentile; HDL-cholesterol <=25th percentile or 
triglycerides =>75th percentile; and insulin level =>75th percentile.94 
Percentiles were derived from the study population. We used android fat 
mass as percentage of total body fat mass, which was used as proxy for waist 
circumference, because waist circumference was not available. Total body 
fat mass and android fat mass were measured using a Dual-energy X-ray 
absorptiometry (DXA) scanner (iDXA, GE-Lunar, 2008, Madison, WI, 
USA) and analyzed with the enCORE software v.12.6.125 
 
Covariates 
Maternal age, and pre-pregnancy BMI were assessed at enrollment in the 
study. Information on maternal educational level, smoking, alcohol 
consumption, and folic acid supplement use during pregnancy was 
obtained by questionnaires.64 Information on gestational hypertensive 
disorders was obtained from midwife and hospital registries.126 Child´s 
ethnicity (European, Non-European) was classified by the countries of birth 
of the parents. At the age of 6 years, we measured height and weight and 
calculated BMI. We obtained sex- and age-specific SDS based on Dutch 
reference growth curves.86 
 
Statistical analyses 
First, we compared characteristics between boys and girls using One-Way 
ANOVA, Kruskal-Wallice and Chi-square tests. Also, we explored 
correlations between early growth measures and cardiovascular properties 
using Pearson correlation coefficients. Second, we assessed the associations 
of infant PWV, AGEAP and BMIAP with childhood cardiovascular and 
metabolic outcomes using two multivariable linear regression models, 
respectively. The basic model was adjusted for child age and sex, while the 
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confounder model was additionally adjusted for covariates selected on their 
associations with the outcome of interest based on previous studies or a 
change in effect estimate of >10%. For blood pressure and metabolic 
outcomes, we additionally created a third model controlling for current 
childhood BMI. Finally, we used logistic regression models to examine the 
associations of infancy PWV, AGEAP and BMIAP with the risk of clustering 
of cardiovascular risk factors. We did not adjust these analyses for multiple 
testing, because of the strong correlation between the different exposures 
and outcomes. Metabolic risk factors that were not normally distributed 
were log-transformed or root-transformed. We constructed standard 
deviation scores (SDS)(SDS=(observed value-mean/SD)) of determinants 
and metabolic outcomes. We constructed height adjusted SDS for the 
blood pressure and body surface area adjusted SDS for the left ventricular 
mass using Generalized Additive Models for Location, Size and Shape 
(GAMLSS) using R, version 3.2.0 (R Core Team, Vienna, Austria).95-97, 127 We 
tested the interaction of PWV, AGEAP and BMIAP with sex, ethnicity and 
gestational age and weight at birth, in relation to cardiovascular variables. 
Because interaction between AGEAP and sex on systolic and diastolic blood 
pressure was significant, we performed the regression analyses stratified by 
sex. To reduce the possibility of potential bias associated with missing data, 
missing values in covariates were imputed using the multiple imputations 
procedure with five imputations and these datasets were analyzed 
together.99 Statistical analyses were performed using SPSS version 21.0 
(IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp). 
 
RESULTS 
Subject characteristics 
Table 2.3.1 shows the subject characteristics according to sex. Girls had 
lower infant PWV and BMIAP (all p values <0.01) than boys. At the age of 
6 years, boys had higher height, weight and left ventricular mass, whereas 
girls had higher blood pressure, android fat mass percentages, total-
cholesterol and triglycerides concentrations and higher percentage of 
clustering of cardiovascular risk factors (all p-values <0.05). Subject 
characteristics before imputation are shown online in Table S2.3.1, while 
Table S2.3.2 and Table S2.3.3 show Pearson correlation coefficients 
between infant PWV, AGEAP and BMIAP and childhood cardiovascular 
and metabolic properties, respectively. 
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Infant growth velocity patterns and cardiovascular outcomes 
Table 2.3.2 shows that a 1-SDS increase of infant PWV was associated with 
higher diastolic blood pressure (0.06 SDS (95% Confidence Interval (CI) 
0.02, 0.09)), and lower left ventricular mass (-0.05 SDS (95% CI -0.09, -
0.01), independently of current body size. The positive association of PWV 
with systolic blood pressure was explained by current childhood BMI. A 1-
SDS higher infant BMIAP was associated with higher systolic (0.12 (95% CI 
0.09, 0.16), and diastolic blood pressure (0.05 (95% CI 0.01, 0.08), but 
these associations were explained by current childhood BMI. The 
associations of infant PWV and BMIAP with childhood blood pressure 
tended to be stronger in girls. Infant AGEAP was not associated with 
cardiovascular outcomes. Table S2.3.4 shows results from the basic models 
adjusted for child’s age and sex only. 
 
Infant growth velocity patterns and metabolic outcomes 
Table 2.3.3 shows in the models adjusted for current BMI that a 1-SDS 
higher AGEAP was associated with lower triglycerides concentrations (-
0.05 SDS (95% CI -0.10, -0.01)), and this association tended to be stronger 
in boys. Infant PWV and BMIAP were not associated with any of the 
metabolic outcomes. None of the infant growth patterns were associated 
with childhood LDL and HDL cholesterol concentrations or with LDL/total 
cholesterol ratio (results are not shown). We did not observe any 
association of infant growth velocity patterns with metabolic properties in 
the basic models adjusted for child’s age and sex (Table S2.3.5). 
 
Infant growth velocity patterns and risk of clustering of 
cardiovascular risk factors 
Table 2.3.4 shows that, after adjusting for covariates, higher infant PWV 
and AGEAP were associated with higher risk of clustering of cardiovascular 
risk factors (Odds Ratio (OR) 1.13 (95% CI 1.01, 1.26) and OR 1.11 (95% CI 
1.00, 1.22), respectively). BMIAP was with borderline significance 
associated with the risk of clustering of cardiovascular risk factors (OR 1.11 
(95% CI 1.00, 1.22)). 
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Table 2.3.1 Subject characteristics (N = 4,649) 
Subject 
characteristics 
Total (N=4,649) Boys (N=2,323) Girls (N=2,326) P 
value 
Maternal 
characteristics 
    
Age, y 31.0 (4.9) 31.1 (4.9) 31.0 (4.8) 0.31 
Body mass before 
pregnancy, kg/m2 
22.6 (18.1, 34.2) 22.7 (18.0, 33.9) 22. 6 (18.1, 34.6) 0.51 
Maternal education, n 
(%) 
   0.70 
 Low/middle 2275 (48.9) 1130 (48.6) 1145 (49.2)  
 Higher 2380 (51.1) 1197 (51.4) 1183 (50.8)  
Folic acid intake 
during pregnancy, n 
(%) 
   0.18 
 No use 1056 (22.7) 548 (23.5) 508 (21.8)  
 Start in the 
first 10 weeks 
1453 (31.2) 739 (31.8) 714 (30.7)  
 Start 
periconceptional 
2146 (46.1) 1040 (44.7) 1107 (47.6)  
Alcohol consumption 
during pregnancy, n 
   0.51 
 No 1983 (42.6) 980 (42.1) 1004 (43.1)  
 Yes  2672 (57.4) 1347 (57.9) 1324 (56.9)  
Smoking during 
pregnancy, n(%) 
   0.22 
 No 3555 (76.4) 1768 (76.0) 1787 (76.8)  
 Yes 1100 (23.6) 559 (24.01) 541 (23.2)  
Systolic blood 
pressure, mmHg 
115.3 (12.0) 115.7 (12.04) 115.8 (11.9) 0.80 
Diastolic blood 
pressure, mmHg 
68.2 (9.4) 68.1 (9.3) 68.3 (9.5) 0.61 
Gestational 
hypertensive 
disordersa 
282 (6.1) 127 (5.5) 155 (6.7) 0.13 
Birth and infant 
characteristics 
    
Ethnicity, n (%)    0.49 
 European 3518 (75.7) 1751 (75.4) 1769 (76.1)  
 Non-
European 
1131 (24.3) 572 (24.6) 557 (23.9)  
Gestational age at 
birth unit, weeks 
40.1 (36.0, 42.3) 40.1 (36.0, 42.3) 40.1 (36.0, 42.1) 0.23 
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Table 2.3.1 (continued) 
Birth weight, grams 3459 (535) 3523 (545) 3390 (516) <0.01 
Preterm birth <37 
weeks at delivery, n 
(%) 
193 (4.1) 98 (4.2) 95 (4.1) 0.88 
Peak weight velocity  
(kg/year) 
12.2 (2.1) 13.2 (2.0) 11.3 (1.77) <0.01 
Age at adiposity peak 
(months) 
8.4 (7.8, 9.6) 8.4 (7.8,9.6) 8.6 (7.8,9.6) 0.99 
Body mass index at 
adiposity peak (kg/m2) 
17.6 (16.1, 19.2) 17.8 (16.3, 19.4) 17.3 (15.9,19.0) <0.01 
Child characteristics 
at 6 years 
    
Age, y 6.0 (5.6, 7.3) 6.0 (5.6, 7.4) 6.0 (5.6, 7.2) 0.29 
Height, cm 118.9 (0.1) 119.3 (5.6) 118.4 (5.6) <0.01 
Weight, kg 22.2 (17.4, 32.4) 22.6 (17.6, 32.2) 22.0 (17.2, 32.4) 0.01 
Body mass index, 
kg/m2 
15.8 (13.6, 20.7) 15.8 (13.7, 20.6) 15.8 (13.5, 20.8) 0.70 
Android fat mass (%) 3.7 (0.9) 3.6 (0.8) 4.0 (1.0) <0.01 
Systolic blood 
pressure, mmHg 
102.5 (8.2) 101.9 (7.7) 103.0 (8.5) <0.01 
Diastolic blood 
pressure, mmHg 
60.6 (6.8) 59.9 (6.6) 61.2 (6.8) <0.01 
Left ventricular mass, 
grams 
52.8 (11.2) 55.2 (11.4) 50.4 (10.3) <0.01 
Total cholesterol, 
mmol/l 
4.2 (0.6) 4.1 (0.6) 4.3 (0.6) <0.01 
Triglycerides, mmol/l 1.0 (0.4, 2.4) 1.0 (0.4, 2.3) 1.1 (10.4, 2.5) <0.01 
Insulin, U/l 114.0 (17.8, 398.3) 114.7 (16.2, 385.5) 112.6 (19.1, 422.2) 0.05 
Clustering of risk 
factors, N (%) 
743 (24.8) 355 (22.9) 388 (27) 0.01 
Values are means (SD), medians (95% range). Values represent the results based on imputed 
data. Characteristics based on original data are shown in Table S2.3.1.  
a Pre-eclampsia or pregnancy induced hypertension.
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Table 2.3.2 Associations of infant growth velocity measures with childhood 
cardiovascular outcomes (N=4,649) 
 
Abbreviations: N: number, SDS: standard deviation scores, BMI: body mass index, PWV: peak weight 
velocity, AGEAP: age at adiposity peak, BMIAP: body mass index at adiposity peak, NA not applicable. 
Values are linear regression coefficients (95% CI) based on multiple linear regression models and reflect 
the change in outcome per SDS increase in each infant growth characteristics. Confounder model is 
adjusted for maternal factors: pre-pregnancy body mass index, educational level, smoking during 
pregnancy, use of alcohol during pregnancy, folic acid supplement use during pregnancy, systolic and 
diastolic blood pressure at intake and gestational hypertensive disorders, and child factors: age, sex 
(total group), ethnicity, birth weight and gestational age at birth. BMI model for systolic and diastolic 
blood pressure was additionally adjusted for childhood BMI. For blood pressure we used height 
adjusted standard deviation scores, whereas for left ventricular mass, we used body surface area 
adjusted standard deviation scores. P<0.05 for interaction between AGEAP and sex on systolic and 
diastolic blood pressure.  
* P value <0.05, ** P value <0.01. 
 
  
SDS difference in childhood cardiovascular outcomes (95% Confidence Interval) 
 Systolic blood 
pressure 
Diastolic blood 
pressure 
Left ventricular 
mass 
Total group    
PWV (1 SDS = 2.1 kg/year) 0.09 (0.05, 0.12)** 0.06 (0.02, 0.09)** -0.05 (-0.09,-0.01)** 
BMI model - PWV  0.01 (-0.02, 0.05) 0.05 (0.01, 0.09)* NA 
AGEAP (1 SDS = 0.5 months) 0.02 (-0.02, 0.05) 0.00 (-0.03, 0.03) 0.01 (-0.02, 0.05) 
BMI model - AGEAP  0.00 (-0.03, 0.03) 0.00 (-0.03, 0.03) NA 
BMIAP (1 SDS = 0.8 kg/m2) 0.12 (0.09, 0.16)** 0.05 (0.01, 0.08)* -0.02 (-0.06, 0.01) 
BMI model – BMIAP  0.04 (0.00, 0.08) 0.04 (0.00, 0.08) NA 
Boys    
PWV (1 SDS = 2.0 kg/year) 0.07 (0.03, 0.12)** 0.04 (-0.01, 0.09) -0.05 (-0.10, -0.00)* 
BMI model - PWV  0.00 (-0.05, 0.05) 0.02 (-0.03, 0.07) NA 
AGEAP (1 SDS = 0.5 months) -0.03 (-0.07, 0.02) -0.03 (-0.08, 0.01) 0.03 (-0.01, 0.08) 
BMI model - AGEAP  -0.04 (-0.09, 0.00) -0.04 (-0.08, 0.01) NA 
BMIAP (1 SDS = 0.8 kg/m2) 0.14 (0.09, 0.19)** 0.03 (-0.02, 0.08) -0.03 (-0.08, 0.03) 
BMI model – BMIAP  0.05 (0.00, 0.11) 0.00 (-0.06, 0.06) NA 
Girls    
PWV (1 SDS = 1.8 kg/year) 0.10 (0.04, 0.16)** 0.08 (0.02, 0.14)** -0.05 (-0.10, 0.01) 
BMI model - PWV  0.03 (-0.04, 0.09) 0.09 (0.02, 0.15)** NA 
AGEAP (1 SDS = 0.5 months) 0.06 (0.01, 0.11)* 0.04 (-0.01, 0.09) -0.01 (-0.06, 0.04) 
BMI model -  AGEAP  0.04 (-0.01, 0.09) 0.04 (-0.01, 0.09) NA 
BMIAP (1 SDS = 0.8 kg/m2) 0.11 (0.05, 0.16)** 0.06 (0.01,0.12)* -0.02 (-0.07, 0.03) 
BMI model – BMIAP 0.03 (-0.03, 0.09) 0.07 (0.01, 0.13)* NA 
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Table 2.3.3 Associations of infant growth velocity patterns with childhood 
metabolic outcomes (N=3,136) 
 
SDS difference in childhood cardiovascular outcomes (95% Confidence Interval) 
 Total cholesterol Triglycerides Insulin 
Total group    
PWV (1 SDS = 2.1 
kg/year) 
0.03 (-0.02, 0.07) -0.00 (-0.05, 0.04) 0.04 (-0.01, 0.08) 
BMI model - PWV  -0.00 (-0.05, 0.05) -0.03 (-0.07, 0.02) -0.03 (-0.08, 0.02) 
AGEAP (1 SDS = 0.5 
months) 
-0.03 (-0.07, 0.01) -0.05 (-0.09, -0.01)* -0.00 (-0.04, 0.04) 
BMI model - AGEAP  -0.04 (-0.08, 0.00) -0.05 (-0.10, -0.01)** -0.02 (-0.06, 0.02) 
BMIAP (1 SDS = 0.8 
kg/m2) 
0.02 (-0.02, 0.07) 0.02 (-0.03, 0.06) 0.04 (-0.01, 0.08) 
BMI model - BMIAP  -0.02 (-0.07, 0.03) -0.01 (-0.06, 0.04) -0.05 (-0.10, -0.00) 
Boys    
PWV (1 SDS = 2.0 
kg/year) 
0.04 (-0.02, 0.09) 0.00 (-0.05, 0.07) 0.01 (-0.04, 0.07) 
BMI model - PWV  0.01 (-0.06, 0.07) -0.02 (-0.08, 0.05) -0.03  (-0.09, 0.03) 
AGEAP (1 SDS = 0.5 
months) 
-0.02 (-0.08, 0.03) -0.06 (-0.11, -0.00) 0.00 (-0.05, 0.06) 
BMI model - AGEAP  -0.03 (-0.08, 0.02) -0.07 (-0.12, -0.01)* -0.01 (-0.06, 0.05) 
BMIAP (1 SDS = 0.8 
kg/m2) 
0.02 (-0.04, 0.08) 0.01 (-0.05, 0.07) 0.02 (-0.05, 0.08) 
BMI model - BMIAP  -0.03 (-0.09, 0.05) -0.03 (-0.10, 0.05) -0.05 (-0.12, 0.02) 
Girls    
PWV (1 SDS = 1.8 
kg/year) 
0.02 (-0.06, 0.09) -0.02 (-0.09, 0.05) 0.07 (0.00, 0.15) 
BMI model - PWV  -0.02 (-0.10, 0.06) -0.05 (-0.07, -0.02) -0.03 (0.11, 0.05) 
AGEAP (1 SDS = 0.5 
months) 
-0.04 (-0.10, 0.02) -0.04 (-0.10, 0.02) -0.01 (-0.08, 0.05) 
BMI model - AGEAP  -0.05 (-0.11, 0.02) -0.04 (-0.10, 0.04) -0.04 (-0.10, 0.03) 
BMIAP (1 SDS = 0.8 
kg/m2) 
0.02 (-0.04, 0.09) 0.02 (-0.04, 0.09) 0.06 (-0.01, 0.13) 
BMI model - BMIAP  -0.01 (-0.09, 0.07) 0.01 (-0.06, 0.08) -0.06 (-0.13, 0.02) 
Abbreviations: N: number, SDS: standard deviation scores, BMI: body mass index, PWV: peak weight 
velocity, AGEAP: age at adiposity peak, BMIAP: body mass index at adiposity peak. Values are linear 
regression coefficients (95% CI) based on multiple linear regression models and reflect the change in 
outcome per SDS increase in each infant growth characteristics. Model adjusted for maternal factors: 
pre-pregnancy body mass index, educational level, smoking during pregnancy, use of alcohol during 
pregnancy, folic acid supplement use during pregnancy, systolic and diastolic blood pressure at intake 
and gestational hypertensive disorders, and child factors: age, sex, ethnicity, birth weight and 
gestational age at birth. All models were additionally adjusted for childhood BMI. P<0.05 for interaction 
between AGEAP and sex on systolic and diastolic blood pressure.  
* P value <0.05, ** P value <0.01. 
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Table 2.3.4 Associations of infant growth velocity patterns with clustering 
of cardiovascular risk factor (N=2,990) 
 
 Odds Ratio for clustering for 
cardiovascular risk factors (95% CI) 
PWV (1 SDS = 2.1 kg/year) 1.13 (1.01 – 1.26)* 
AGEAP (1 SDS = 0.5 months) 1.11 (1.00 - 1.22)* 
BMIAP (1 SDS = 0.8 kg/m2) 1.11 (1.00-1.24) 
Abbreviations: N: number, SDS: standard deviation scores, BMI: body mass index PWV: 
peak weight velocity, AGEAP: age at adiposity peak, BMIAP: body mass index at adiposity 
peak.  Models are adjusted for maternal factors: pre-pregnancy body mass index, educational 
level, income, smoking during pregnancy, use of alcohol during pregnancy, folic acid 
supplement use during pregnancy, systolic and diastolic blood pressure at intake and 
gestational hypertensive disorders, and child factors: age, sex, ethnicity, birth weight and 
gestational age; * P value <0.05;  
 
DISCUSSION 
We observed in a large population-based prospective cohort study that 
early infant growth velocity patterns are associated with certain 
cardiovascular outcomes, but not consistently with metabolic outcomes. 
The observed associations of infant growth patterns with childhood blood 
pressure tended to be stronger in girls than in boys. Higher infant growth 
velocity patterns were also associated with an increased risk of clustering 
of cardiovascular risk factors. 
 
Methodological considerations 
The main strength of our study is the population-based prospective cohort 
design, including a large number of subjects whom we studied from early 
fetal life onwards. The repeated infant growth measures enabled us to study 
the effects of infant growth velocity patterns on the cardiovascular and 
metabolic properties. However, some limitations need to be discussed. Of 
the total group of singleton live born children with information on growth, 
follow-up measurements were available in 71%. Loss to follow-up would 
lead to selection bias if the associations of early infant growth measures 
with childhood cardiovascular and metabolic measures would be different 
between those included and those not included in the final analyses.101 A 
limitation is that blood lipids and insulin concentrations were measured 
in blood samples that were collected in 30 minutes-fasting states. 
According to studies in adults, fasting time has little influence on 
cholesterol levels, but concentrations of triglyceride and insulin vary 
more substantially with differences in fasting time.128, 129 The 
measurement error for triglycerides and insulin levels in our study 
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population could have led to non-differential misclassification, and this 
may have resulted in an underestimation of our effect estimates for 
associations with triglycerides and insulin levels. Finally, although we 
performed adjustments for a large number of potential maternal and 
childhood confounders, residual confounding still might have occurred, as 
in any observational study. 
 
Interpretation of main findings 
A pattern of rapid growth in early life is associated with a higher risk of 
CVD in later life.3 A study among 2,285 Japanese adolescents aged 13 to 14 
years shows that rapid weight gain during early childhood predicts high 
blood pressure and unfavorable lipid concentrations.123 Moreover, data 
from five birth cohort studies showed that faster relative weight gain during 
early infant life was associated with an increased risk of elevated blood 
pressure in adulthood.130 In line with these studies, we showed that early 
infant growth patterns are associated with cardiovascular variables in 
childhood. However, we did not find an association with metabolic 
variables. 
 Most previous studies used change in weight or length between two 
time points as indicator of growth. More detailed infant growth patterns 
can be derived from the longitudinally collected anthropometric measures, 
such as PWV, BMIAP and AGEAP. Previously, a study in Germany among 
1127 children up to the age of 10 years, reported that higher PWV in infancy 
is associated with an increase in systolic and diastolic blood pressure after 
adjustment for confounders, including BMI.131 However, another cohort 
study among 2822 children in the Netherlands showed that the association 
of BMIAP with blood pressure at the age of 6 years was mediated by current 
BMI.132 In the same study, it has been shown that timing of BMI peak 
seemed not to be associated as strongly as magnitude of BMI peak with 
blood pressure.132 In line with these studies, we observed an association of 
infant PWV and BMIAP with childhood blood pressure, which could be 
explained by current BMI. The association of infant PWV and BMIAP and 
diastolic blood pressure in our study was independent from current BMI in 
girls. Also, in the present study, infant AGEAP was not associated with 
childhood blood pressure. 
Fetal and early life growth patterns may also influence cardiac 
structures in children and adults.11, 46 A previous study examined the effect 
of early infant weight on left ventricular mass among 290 men born in East 
Hertfordshire, England. They reported that low weight at 1 year was 
associated with higher left ventricular mass in adulthood.46 In line with this 
study, we observed that higher PWV leads to lower left ventricular mass, 
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relative to current body size. Recent study suggests that fat mass is a minor 
predictor of left ventricular mass, while lean body mass is a much stronger 
predictor.22 Therefore, the association between higher PWV and lower left 
ventricular mass might be explained by a different body composition of 
children with and without increased PWV, relative to current body surface 
area (BSA). 
 Several studies have been performed focused on the associations of 
infant weight gain with metabolic outcomes. A study among 1,999 subjects 
showed that a slower increase in BMI during the first 6 months after birth 
was associated with an atherogenic lipid profile in adult life.133 An 
additional study among 396 men aged 58 years reported that the 
combination of being born small followed by a rapid weight gain was 
associated with the occurrence of risk factors included in the metabolic 
syndrome, and that growth patterns during infancy and childhood 
correlate with insulin levels later in life.134 In our study, we only observed 
an inverse association of infant AGEAP with triglycerides concentrations 
after adjusting for current BMI. This observation was not consistent with 
other results and may be a chance finding. Also, our observation may be 
explained by the strong positive association of BMI with triglycerides. 
Results from a study among 128 subjects suggest that rapid weight gain 
during infancy predicted clustering of metabolic risk factors at age 17 
years.135. Consistently with these results, our results showed higher risk of 
clustering of cardiovascular risk factors in children with higher PWV and 
AGEAP. Thus, the increased risk for clustering seemed to be mainly driven 
by the increased blood pressure and adiposity, and not by the metabolic 
risk factors. 
Although the observed effect estimates infant growth on 
cardiovascular and metabolic outcomes are small and without clinical 
relevance for individuals, the results from this study may be important on 
a population based level. These results are especially important from an 
etiological perspective and give an important contribution to the field of 
developmental origins of cardiovascular disease. They suggest that infant 
growth influence cardiovascular development and might predispose 
individuals to cardiovascular disease in adulthood. We have shown that 
infant weight gain patterns may most importantly affect blood pressure and 
adiposity in childhood. Future research should focus on whether these 
changes in early childhood are associated with cardiovascular morbidity 
and mortality at later ages. 
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SUPPLEMENTAL MATERIAL 
Table S2.3.1 Subject characteristics based on original data (N = 4,649) 
 
Subject characteristics Total (N=4,649) Boys (N=2,323) Girls (N=2,326) P 
value 
Maternal characteristics     
Age, y 31.0 (4.9) 31.1 (4.9) 31.0 (4.8) 0.31 
Body mass before 
pregnancy, kg/m2 
22.6 (18.1, 34.3) 22.5 (18.0, 34.0) 22.7 (18.3, 35.0) 0.24 
Maternal education, n (%)    0.41 
 Low/middle 2076 (47.7) 1023 (47.1) 1053 (48.3)  
 Higher 2275 (52.3) 1150 (52.9) 1125 (51.7)  
Folic acid intake during 
pregnancy, n (%) 
   0.36 
 No use 680 (20.7) 347 (21.3) 333 (20.1)  
 Start in the first 
 10 weeks 
1033 (31.5) 523 (32.1) 510 (30.8)  
 Start 
periconceptional 
1571 (47.8) 759 (46.6) 812 (49.1)  
Alcohol consumption 
during pregnancy, n (%) 
   0.39 
 No 1567 (41.7) 764 (41.0) 803 (42.4)  
 Yes  2188 (58.3) 1099 (59.0) 1089 (57.6)  
Smoking during pregnancy, 
n(%) 
   0.16 
 No 3129 (76.3) 1555 (76.1) 1574 (76.4)  
 Yes 974 (23.7) 489 (23.9) 485 (23.6)  
Systolic blood pressure, 
mmHg 
115.7 (12.0) 115.7 (12.04) 115.8 (11.9) 0.80 
Diastolic blood pressure, 
mmHg 
68.2 (9.4) 68.1 (9.3) 68.3 (9.5) 0.61 
Gestational hypertensive 
disordersa 
243 (5.8) 107 (5.1) 136 (6.5) 0.06 
Birth and infant 
characteristics 
    
Ethnicity, European, n    0.50 
 European 3482 1730 1752  
 Non-European 1110 565 545  
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Table S2.3.1 (continued) 
 
Gestational age at birth 
unit, weeks 
40.1 (36.0, 42.3) 40.1 (36.0, 42.3) 40.1 (36.0, 42.1) 0.27 
Birth weight, grams 3457.2 (536.0) 3523.7 (545.1) 3390.6 (516.5) <0.01 
Preterm birth <37 weeks at 
delivery, n (%) 
193 (4.2) 98 (4.2) 95 (4.1) 0.88 
Peak weight velocity 
(kg/year) 
12.2 (2.1) 13.2 (2.0) 11.3 (1.77) <0.01 
Age at adiposity peak 
(months) 
8.4 (7.8, 9.6) 8.4 (7.8–9.6) 8.6 (7.8–9.6) 0.99 
Body mass index at 
adiposity peak (kg/m2) 
17.6 (16.1, 19.2) 17.8 (16.3, 19.4) 17.3 (15.9, 19.0) <0.01 
Child characteristics at 6 
years 
    
Age, y 6.0 (5.6, 7.3) 6.0 (5.6, 7.4) 6.0 (5.6, 7.2) 0.29 
Height, cm 118.9 (0.1) 119.3 (5.6) 118.4 (5.6) <0.01 
Weight, kg 22.2 (17.4, 32.4) 22.6 (17.6, 32.2) 22.0 (17.2, 32.4) 0.01 
Body mass index, kg/m2 15.8 (13.6, 20.7) 15.8 (13.7, 20.6) 15.8 (13.5, 20.8) 0.70 
Android fat mass (%) 3.7 (0.9) 3.6 (0.8) 4.0 (1.0) <0.01 
Systolic blood pressure, 
mmHg 
102.5 (8.2) 101.9 (7.7) 103.0 (8.5) <0.01 
Diastolic blood pressure, 
mmHg 
60.6 (6.8) 59.9 (6.6) 61.2 (6.8) <0.01 
Left ventricular mass, grams 52.8 (11.2) 55.2 (11.4) 50.4 (10.3) <0.01 
Total cholesterol, mmol/l 4.2 (0.6) 4.1 (0.6) 4.3 (0.6) <0.01 
Triglycerides, mmol/l 1.0 (0.4, 2.3) 0.9 (0.4, 2.3) 1.0 (0.4, 2.5) <0.01 
Insulin, U/l 114.0 (17.8, 
398.3) 
114.7 (16.2, 
385.5) 
112.6 (19.1, 
422.2) 
0.05 
Clustering of cardiovascular 
risk factors, % 
 743 (24.8) 355 (22.9) 388 (27) 0.01 
Values are means (SD) or medians (95% range). Values represent the results based on the 
original, non-imputed data. a Pre-eclampsia or pregnancy induced hypertension.
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Table S2.3.2 Correlation coefficients between early growth and childhood 
cardiovascular properties (N=4,649) 
 
 Infant growth measures (SDS) Childhood cardiovascular 
measures (SDS) 
 PWV 
(kg/year) 
AGEAP 
(months) 
BMIAP 
(kg/m2)) 
Systolic 
blood 
pressure 
Diastolic 
blood 
pressure 
Left 
ventricular 
mass 
PWV (kg/year) 1 - - - - - 
AGEAP 
(months) -0.02 1 - - - - 
BMIAP 
(kg/m2) 0.69** -0.21** 1 - - - 
Systolic blood 
pressure 0.05** 0.02 0.06** 1 - - 
Diastolic blood 
pressure 0.03 0.01 -0.01 0.62** 1 - 
Left 
ventricular 
mass 
0.04** 0.00 0.06** -0.05** -0.06** 1 
Abbreviations; N: number, SDS: standard deviation score, PWV: peak weight velocity, 
AGEAP: age at adiposity peak, BMIAP: body mass index at adiposity peak. Values are 
Pearson’s correlation coefficients. For blood pressure we used height adjusted standard 
deviation scores, whereas for left ventricular mass we used body surface area adjusted 
standard deviation scores. 
*P value <0.05, ** P value <0.01. 
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Table S2.3.3 Correlation coefficients between early growth and childhood 
metabolic properties(N=3,136) 
 
 Infant growth 
measures (SDS) Childhood metabolic measures (SDS) 
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Total-
cholesterol 0.05** -0.02 -0.02 1 - - - - 
HDL- 
cholesterol 0.02 0.02 -0.02 0.30** 1 - - - 
LDL- 
cholesterol -0.04* -0.04* 0.00 0.85** -0.06** 1 - - 
Triglycerides -0.03 -0.01 -0.02 0.18** -0.39** 0.14** 1 - 
Insulin 0.01 0.00 0.01 -0.02 -0.08** -0.04* 0.22** 1 
Abbreviations: N: number, SDS: standard deviation scores, BMI: body mass index, PWV: 
peak weight velocity, AGEAP: age at adiposity peak, BMIAP: body mass index at adiposity 
peak. Values are Pearson’s correlation coefficients.We constructed standard deviation 
scores (SDS)(SDS=(observed value-mean/SD)) of growth measures and metabolic 
outcomes. 
* P value <0.05, ** P value <0.01 
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Table S2.3.4 Associations of infant growth measures with childhood 
cardiovascular properties; basic model (N=4,649) 
 
Abbreviations: N: number, SDS: standard deviation scores, PWV: peak weight velocity, 
AGEAP: age at adiposity peak, BMIAP: body mass index at adiposity peak. Values are linear 
regression coefficients (95% CI) based on multiple linear regression models and reflect the 
change in outcome per SDS increase in each infant growth characteristics. Models adjusted 
for child’s age and sex only.For blood pressure we used height adjusted standard deviation 
scores, whereas left ventricular mass, we used body surface area adjusted standard deviation 
scores. P<0.05 for interaction between AGEAP and sex on systolic and diastolic blood 
pressure. 
* P value <0.05, ** P value <0.01 
  
 SDS difference in childhood cardiovascular outcomes (95% 
Confidence Interval) 
 Systolic blood pressure 
Diastolic blood 
pressure Left ventricular mass 
Total group    
PWV (1 SDS = 2.1 
kg/year) 0.1 (0.07, 0.13)** 0.08 (0.05, 0.10)** -0.07 (-0.10, -0.03)** 
AGEAP (1 SDS = 
0.5 months) 0.02 (-0.01, 0.05) 0.01 (-0.02, 0.04) 0.00 (-0.02, 0.03) 
BMIAP (1 SDS = 
0.8 kg/m2) 0.08 (0.05, 0.11)** 0.02 (-0.02, 0.05) -0.01 (-0.04, 0.02) 
Boys    
PWV (1 SDS = 2.0 
kg/year) 0.08 (0.04, 0.12)** 0.06 (0.02, 0.10)** -0.05 (-0.10, -0.01)* 
AGEAP (1 SDS = 
0.5 months) -0.02 (-0.06, 0.02) -0.03 (-0.07, 0.01) 0.02 (-0.02, 0.06) 
BMIAP (1 SDS = 
0.8 kg/m2) 0.10 (0.06, 0.14)** 0.01 (-0.03, 0.05) 0.00 (-0.04, 0.04) 
Girls    
PWV (1 SDS = 1.8 
kg/year) 0.12 (0.07, 0.17)** 0.10 (0.05, 0.15)** -0.08 (-0.13, -0.03)** 
AGEAP (1 SDS = 
0.5 months) 0.08 (0.03, 0.12) 0.05 (0.01, 0.09)* -0.01 (-0.06, 0.03) 
BMIAP (1 SDS = 
0.8 kg/m2) 0.07 (0.02, 0.11)** 0.02 (-0.02, 0.06) -0.02 (-0.06, 0.03) 
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Table S2.3.5 Associations of infant growth measures with childhood 
metabolic properties; basic model(N=3,136). 
SDS difference in childhood metabolic outcomes (95% 
Confidence Interval) 
Total cholesterol Triglycerides Insulin 
Total group 
PWV (1 SDS = 
2.1 kg/year) 0.03 (-0.02, 0.07) 0.00 (-0.05, 0.04) 0.04 (-0.01, 0.08) 
AGEAP (1 SDS = 
0.5 months) -0.03 (-0.07, 0.01) -0.05 (-0.09, 0.01) 0.00 (-0.04, 0.04) 
BMIAP (1 SDS = 
0.8 kg/m2) 0.02 (-0.02, 0.07) 0.02 (-0.03, 0.06) 0.04 (-0.01, 0.08) 
Boys 
PWV (1 SDS = 
2.0 kg/year) 0.04 (-0.02, 0.09) 0.01 (-0.05, 0.07) 0.01  (-0.04, 0.07) 
AGEAP (1 SDS = 
0.5 months) -0.02 (-0.08, 0.03) -0.06 (-0.12, 0.00) 0.00 (-0.05, 0.06) 
BMIAP (1 SDS = 
0.8 kg/m2) 0.02 (-0.04, 0.08) 0.01 (-0.05, 0.07) 0.02 (-0.05, 0.07) 
Girls 
PWV (1 SDS = 
1.8 kg/year) 0.02 (-0.06, 0.09) -0.02 (-0.09, 0.05) 0.07 (0.00, 0.15) 
AGEAP (1 SDS = 
0.5 months) -0.04 (-0.10, 0.02) -0.04 (-0.10, 0.02) -0.01 (-0.08, 0.05)
BMIAP (1 SDS = 
0.8 kg/m2) 0.02 (-0.04, 0.09) 0.02 (-0.04, 0.09) 0.06 (0.00, 0.13) 
Abbreviations: N: number, SDS: standard deviation scores, PWV: peak weight velocity, 
AGEAP: age at adiposity peak, BMIAP: body mass index at adiposity peak. Values are linear 
regression coefficients (95% CI) based on multiple linear regression models and reflect the 
change in outcome per SDS increase in each infant growth characteristics. Model adjusted 
for maternal factors: pre-pregnancy body mass index, educational level, income, smoking 
during pregnancy, use of alcohol during pregnancy, folic acid supplement use during 
pregnancy, systolic and diastolic blood pressure at intake and gestational hypertensive 
disorders, and child factors: age, sex, ethnicity, birth weight and gestational age at birth.  
All p-values > 0.05.
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Figure S2.3.1 Flow chart of participants included in the analysis. 
N = 8,305 
Children available for follow up studies at 6 years 
N = 1, 782 
Excluded: twin birth and children with no written consent for 
participation in preschool investigation 
N = 6,523 
Singleton live born children participating in the preschool 
period with information on growth 
N = 1,797 
Excluded: fewer than three postnatal growth measurements 
N = 4,726 
Singleton live born children participating in the preschool 
period with information on growth 
N = 45 
Excluded: no cardiovascular measurements available at the 
age of 6 years 
N = 4,681 
Singleton children with information on growth and 
participation in follow-up measurements at the age of 6 years 
N = 32 
Excluded: cardiac abnormalities 
N = 4,649 
Singleton children with information on growth and 
participation in follow-up measurements at the age of 6 years 
Blood pressure: N = 4,527 
Left ventricular mass: N = 4,346 
Total cholesterol: N = 3,132 
HDL cholesterol: N = 3,136 
LDL cholesterol: N = 3,130 
Triglycerides: N = 3,130 
Insulin: N = 3,111 
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ABSTRACT 
Objectives Early-life is critical for cardiac development. We examined the 
associations of longitudinal fetal and childhood growth patterns with 
childhood right and left ventricular structures measured by cardiac MRI.  
Methods In a population-based prospective cohort study among 2,827 
children, we measured growth at 20 and 30 weeks of pregnancy, at birth, 
0.5, 1, 2, 6 and 10 years. At 10 years, we measured right ventricular end-
diastolic volume (RVEDV), left ventricular end-diastolic volume (LVEDV), 
left ventricular mass (LVM) and left ventricular mass-to-volume ratio 
(LMVR) by cardiac MRI. 
Results Small size for gestational age at birth was associated with smaller 
RVEDV and LVEDV, relative to current body surface area (BSA), but with 
larger LMVR (p<0.05). Children in the upper 25% of RVEDV, LVEDV and 
LVM at age 10 years, were larger at birth and became taller and leaner in 
childhood (p<0.05). In contrast, children in the lower 25% of RVEDV, 
LVEDV and LVM were smaller at birth and became shorter and heavier in 
childhood (p<0.05). Both fetal and childhood growth were independently 
of each other associated with childhood RVEDV, LVEDV and LVM.  
Conclusion Children who are larger at birth, and grow taller and leaner in 
childhood have larger hearts, relative to BSA. Small size at birth children, 
who grow shorter and heavier in childhood have relatively smaller hearts 
with larger LMVR. Both fetal and childhood growth are important for 
development of cardiac dimensions.  
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INTRODUCTION 
Fetal exposure to an adverse environment leads to cardiovascular 
adaptations, which predispose individuals to disease in later life.3, 4 
Evidence suggests that early-life growth patterns directly affect cardiac 
structure and function.11, 46, 136 Follow-up studies have shown that 
individuals with a lower weight in infancy have a higher left ventricular 
mass (LVM) in adulthood, an independent risk factor for mortality.46 
Recent studies have shown that children with fetal growth restriction have 
more globular, shorter ventricles, and cardiac dysfunction.11 Similar 
changes were observed in preterm born young adults.104 A major limitation 
of previous studies is that no information is available on right ventricular 
measures, while the right ventricle is dominant in fetal life.137 Cardiac 
Magnetic Resonance Imaging (cMRI) is a more precise method to assess 
cardiac measures than echocardiography and enables imaging of both left 
and right ventricular dimensions.29 A previous cMRI study in adolescents 
showed that preterm birth was associated with changes in cardiac 
geometry, which were more pronounced in the right than in the left 
ventricle.31 Although these previous studies strongly suggest that early-life 
is important for programming of cardiac structure, function and disease in 
later life, it remains unknown which period in fetal life or infancy is critical.  
We examined in a population-based prospective cohort study 
among 2,827 children the associations of fetal and infant growth with 
cardiac measures assessed by cMRI in children aged 10 years. Cardiac 
measures included right ventricular end-diastolic volume (RVEDV), right 
ventricular ejection fraction (RVEF), left ventricular end-diastolic volume 
(LVEDV), left ventricular ejection fraction (LVEF), left ventricular mass 
(LVM) and left ventricular mass-to-volume ratio (LMVR). We 
hypothesized that both gestational age at birth, and fetal and childhood 
growth across their full spectrum are associated with right and left cardiac 
adaptations, independent of current body size. Analyses were focused on 
longitudinal growth patterns and identification of critical growth periods.  
 
METHODS 
Design and study population 
This study was embedded in the Generation R Study, a population-based, 
prospective cohort study from fetal life onwards in Rotterdam, The 
Netherlands.138 Response rate at birth was 61% (2002 - 2006).138 Fetal and 
childhood growth were repeatedly assessed by ultrasounds and physical 
examinations until the age of 10 years. Good quality cardiac MRI was 
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obtained in 2,827 children (Figure S2.4.1). Written informed consent was 
obtained from all parents of participants. The study has been approved by 
the local Medical Ethics Committee.   
 
Fetal and childhood growth measurements 
As previously described, fetal ultrasound examinations were carried out in 
each trimester of pregnancy.81 Second trimester (median 20.5 weeks, 95% 
range 18.6 – 23.4) and third trimester (median 30.4 weeks, 95% range 28.4 
– 33.1) fetal head circumference, abdominal circumference, and femur 
length as proxy for fetal length were measured to the nearest millimeter 
using standardized ultrasound procedures.82 Estimated fetal weight was 
calculated using the Hadlock formula.83 Gestational age adjusted standard 
deviation scores (SDS) for all fetal growth characteristics were constructed 
based on reference growth curves.81, 82 At birth, information on infant sex, 
date of birth and weight was obtained from community midwife and 
hospital registries. We created gestational age- and sex-adjusted birth 
length and weight SDS by using Growth Analyzer 3.5 (Dutch Growth 
Research Foundation, Rotterdam, the Netherlands) based on North-
European reference standards.84 We defined small or large size for 
gestational age as being <10th  or >90th sex specific percentile for weight. 
Preterm birth was defined as birth <37.0 weeks of gestation. 
 Infant length and weight were measured at the Community Health 
Centers using standardized procedures at the median ages of 6.2 months 
(95% range 5.2 – 8.3), 11.1 months (95% range 10.1 - 15.5) and 24.8 months 
(95% range 23.4 – 28.1). Sex and age adjusted SDS were obtained using 
Dutch reference growth curves.86  
At the median ages of 5.9 years (95% range 5.7- 7.3) and 9.9 years 
(95% range 9.5– 11.8), we measured child height and weight without shoes 
and heavy clothing, and calculated body mass index (BMI) and body 
surface area (BSA) using the Haycock formula.69 
 
Cardiac Magnetic Resonance Imaging  
We performed cMRI using a wide-bore GE Discovery MR 750 3T scanner 
(General Electric, Milwaukee, MI, USA), as described in more detail in 
Methods S2.4.1. Briefly, we acquired localizer images, followed by ECG 
gated breath-held scans lasting less than 10 seconds per breath-hold. A 
short-axis SSFP cine stack was then obtained with basal slice alignment and 
covering the ventricles with contiguous 8-mm thick slices over several end-
expiration breath-holds. The scans were stored on a digital archive for post-
processing. 
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Off-line image analyses for right and left ventricular measures on 
the short-axis cine stack was performed by Precision Image Analysis 
(Kirkland, WA, USA) using Medis QMASS software (Medis, Leiden, the 
Netherlands). The guidelines of the Society for Cardiovascular Magnetic 
Resonance were followed to semi-automatically contour right and left 
ventricular short-axis endocardial and left ventricular epicardial borders.139 
Papillary muscle was included in the ventricular cavity. Cardiac 
measurements included RVEDV, RVEF, LVEDV, LVEF, and LVM. We 
calculated LMVR as LVM/LVEDV. 
 
Covariates 
Information about education, household income, height and parity was 
collected by questionnaires and medical charts. Infant ethnicity was 
classified by the countries of birth of the parents and was categorized as 
Dutch or non-Dutch.138 Largest non-Dutch ethnicities are: European, 
Turkish, Moroccan, Surinamese, Cape Verdian and Dutch Antilles. Child 
systolic and diastolic blood pressure were measured on the right brachial 
artery, using the validated automatic sphygmomanometer Accutorr Plus 
(Datascope Corporation, Fairfield, New Jersey). Child blood pressure and 
anthropometric measurements preceded the cMRI visit by 1.1 months (95% 
range 0-2.8 months).  
 
Statistical analysis 
We constructed BSA adjusted SDS for the cardiac measures using 
Generalized Additive Models for Location, Size and Shape (GAMLSS) in R, 
version 3.2.0 (R Core Team, Vienna, Austria). This enables flexible 
modelling, taking into account the distribution of the outcome variable.70 
Since LMVR is a ratio we did not create a BSA adjusted SDS, but 
standardized this measure as (observed value-mean)/SD. Similarly, we 
created SDS for all growth measures to enable comparison of effect 
estimates. First, we used linear regression models to assess the associations 
of birth characteristics (gestational age, weight and gestational age 
adjusted size at birth), both continuously and in clinical categories, with 
cardiac measures (RVEDV, RVEF, LVEDV, LVEF, LVM, LMVR). Second, we 
compared longitudinal fetal and childhood growth patterns between 
different quartiles of the cardiac measures. For these analyses, we used 
repeated measurement regression models, which take into account the 
correlation between repeated growth measurements of the same 
participant.94 Finally, we performed conditional regression analyses to 
identify independent critical growth periods associated with cardiac 
measures. Conditional regression analyses take into account the 
EARLY AND CHILDHOOD GROWTH 
 102 
correlations between growth measures at different ages. This allows 
simultaneous inclusion of all growth measures in a regression model to 
assess the most critical periods of growth.71 All models were adjusted for 
relevant covariates, selected on the basis of their associations with the 
outcomes of interest based on previous studies and change in effect 
estimate >10%. Maternal BMI, blood pressure, smoking during pregnancy 
or gestational hypertensive disorders did not change the effect estimates 
and were therefore not included in the final models. We did not observe 
significant statistical interaction terms with child sex or ethnicity. Missing 
data of covariates and anthropometric measures for conditional analyses 
were imputed using multiple imputations in five created datasets, and 
analyzed together.99 We performed repeated analyses using SAS software 
version 9.4 for Windows (SAS Institute Inc., Cary, NC, USA), all other 
analyses were performed using Statistical Package for the Social Sciences 
version 21.0 for Windows (IBM Corp., Armonk, NY, USA).  
 
RESULTS 
Study participant characteristics 
Maternal and child characteristics are shown in Table S2.4.1. Non-response 
analysis is shown in Table S2.4.2. Correlation coefficients between growth 
and cardiac measures are given in Table S2.4.3. 
 
Birth outcomes and cardiac measures at school-age 
Table 2.4.1 shows that preterm birth was associated with higher LVEF in 
childhood than term birth (difference 0.25 SDS (95% Confidence Interval 
(CI) 0.07, 0.43)), but not with other cardiac measures. A 1-SDS higher birth 
weight was associated with higher RVEDV (0.09 SDS (95% CI 0.06, 0.13)) 
and LVEDV (0.10 SDS (95% CI 0.06, 0.13)), relative to current body size. 
Birth weight adjusted for gestational age was also associated with lower 
LMVR (-0.06 SDS (95% CI -0.10, -0.02)). Table S2.4.4 shows that 
additional adjusting for lean body mass percentage did not change the 
main results.
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Table 2.4.1 Birth characteristics and ventricular outcomes at the age of 10 
years (N = 2,827) 
 Difference in cardiac measures standard deviation scores (95% 
Confidence Interval) 
Birth 
characteristics N 
Right ventricular 
end-diastolic 
volume 
Right ventricular 
ejection fraction 
Left ventricular 
end-diastolic 
volume 
Gestational age     
<37.0 weeks 126 -0.08 (-0.24, 0.07) 0.04 (-0.14, 0.22) -0.16 (-0.31, 0.00) 
37.0-41.9 weeks 2500 Reference Reference Reference 
≥42 weeks 201 -0.01 (-0.14, 0.12) -0.05 (-0.19, 0.10) -0.08 (-0.20, 0.05) 
Trend  2827 -0.01 (-0.04, 0.03) 0.00 (-0.04, 0.03) 0.01 (-0.03, 0.04) 
     
Birth weight     
<2000 g 28 -0.01 (-0.33, 0.32) 0.00 (-0.37, 0.37) -0.16 (-0.49, 0.16) 
2000-2499 g 88 -0.06 (-0.25, 0.13) 0.11 (-0.11, 0.33) -0.08 (-0.27, 0.11) 
2500-2999 g 401 -0.02 (-0.12, 0.08) -0.08 (-0.20, 0.04) -0.09 (-0.19, 0.01) 
3000-3499 g 959 Reference Reference Reference 
3500-3999 g 922 0.13 (0.05, 0.21)** 0.02 (-0.08, 0.11) 0.12 (0.04, 0.20)** 
4000-4499g 351 0.20 (0.09, 0.31)** -0.10 (-0.23, 0.02) 0.17 (0.06, 0.28)** 
≥4500 grams 75 0.44 (0.24, 0.65)** -0.02 (-0.26, 0.22) 0.31 (0.11, 0.52)** 
Trend  2827 0.09 (0.06, 0.13)** -0.03 (-0.07, 0.01) 0.10 (0.06, 0.13)** 
     
Birth weight for 
gestational age     
Small  255 -0.14 (-0.26, -
0.03)** 
0.00 (-0.13, 0.13) -0.18 (-0.29, -0.06)** 
Normal  2274 Reference Reference Reference 
Large  298 0.22 (0.11, 0.32)** -0.02 (-0.15, 0.09) 0.18 (0.07, 0.28)** 
Trend  2827 0.11 (0.08, 0.14)** -0.03 (-0.07, 0.11) 0.11 (0.08, 0.14)** 
Birth 
characteristics N 
Left ventricular 
ejection fraction 
Left ventricular 
mass 
Left ventricular 
mass-to-volume 
ratio 
Gestational age     
<37.0 weeks 126 0.25 (0.07, 0.43)** -0.08 (-0.24, 0.08) 0.05 (-0.13, 0.23) 
37.0-41.9 weeks 2500 Reference Reference Reference 
≥42 weeks 201 0.00 (-0.15, 0.14) 0.00 (-0.13, 0.12) 0.06 (-0.09, 0.20) 
Trend  2827 -0.05 (-0.09, -0.01)* 0.01 (-0.02, 0.04) 0.01 (-0.03, 0.05) 
     
Birth weight     
<2000 g 28 0.41 (0.03, 0.78)* -0.33 (-0.66, -0.00)* -0.25 (-0.62, 0.12) 
2000-2499 g 88 0.16 (-0.06, 0.38) 0.06 (-0.13, 0.25) 0.12 (-0.10, 0.34) 
2500-2999 g 401 -0.04 (-0.16, 0.08) 0.03 (-0.08, 0.13) 0.10 (-0.02, 0.22) 
3000-3499 g 959 Reference Reference Reference 
3500-3999 g 922 0.00 (-0.10, 0.09) 0.00 (-0.08, 0.08) -0.09 (-0.18, 0.00) 
4000-4499 g 351 -0.10 (-0.22, 0.03) 0.10 (-0.01, 0.21) 0.00 (-0.13, 0.12) 
≥4500 grams 75 0.16 (-0.08, 0.40) 0.13 (-0.08, 0.34) -0.09 (-0.33, 0.14) 
Trend  2827 -0.05 (-0.09, -0.01)* 0.02 (-0.01, 0.06) -0.05 (-0.08, 0.01) 
     
Birth weight for 
gestational age   
  
Small  255 -0.03 (-0.16, 0.10) 0.04 (-0.08, 0.15) 0.16 (0.03, 0.29)* 
Normal  2274 Reference Reference Reference 
Large  298 0.01 (-0.11, 0.14) 0.12 (0.01, 0.22)* 0.01 (-0.12, 0.13) 
Trend  2827 -0.02 (-0.06, 0.02) 0.02 (-0.01, 0.05) -0.06 (-0.10, -0.02)** 
Values are regression coefficients (95% confidence interval) and reflect the change in 
standard deviation (SDS) of each cardiac measure for each birth weight or gestational age 
group, compared to the reference group. Trend estimates represent the effect estimates for 
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the continuous associations per SDS change in birth characteristic. We used body surface 
adjusted standard deviation scores, except for left ventricular mass-to-volume ratio. Models 
are adjusted for maternal height, parity, educational level, income level, child’s sex, 
ethnicity, current age, and time difference between BSA measurement and MRI.  
*P < 0.05;** P< 0.01. Models additionally adjusted for childhood lean body mass percentage 
are shown in Table S2.4.4.  
 
Longitudinal fetal and infant growth patterns and cardiac measures 
at school-age 
Figure 2.4.1 shows the results of the longitudinal growth analyses. As 
compared to children in the 25-75% range of RVEDV and LVEDV, those in 
the upper 25% had higher fetal length and weight growth, whereas those 
in the lower 25% had lower fetal length and weight. In childhood the 
children in the upper 25% for RVEDV and LVEDV had normal height and 
slightly lower weight growth, whereas children in the lower 25% had lower 
childhood height growth and higher weight gain (Figure 2.4.1A-B). 
Children in the highest quartile of LVM had higher height and lower weight 
gain in childhood (Figure 2.4.1C). Children in the highest LMVR had 
higher weight gain (Figure 2.4.1D). No differences in fetal and infant 
growth patterns were observed for RVEF and LVEF (Figure 2.4.1E-F). 
 
Figure 2.4.1 Fetal and childhood growth patterns and cardiac structure 
and function measures (N = 2,827) 
 
Figure 2.4.1A  
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Figure 2.4.1B  
 
 
Figure 2.4.1C  
 
 
Figure 2.4.1D 
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Figure 2.4.1E 
 
 
Figure 2.4.1F 
 
Figures show results of repeated measurement regression models. Each point shows the 
difference in length or weight (± 95% confidence interval), from children in the lowest or 
highest 25% of the cardiac measure, compared to the children in the middle 25-75%. A 
parallel line indicates growth rates comparable to the reference group, while an increase or 
decrease of the slope indicates lower or higher growth rates. 
Abbreviations: SDS standard deviation score; RVEDV right ventricular end-diastolic 
volume; RVEF right ventricular ejection fraction; LVEDV left ventricular end-diastolic 
volume; LVEF left ventricular ejection fraction; LVM left ventricular mass; LMVR left 
ventricular mass-to-volume ratio. 
 
Early life critical periods and cardiac measures at school-age 
Figure 2.4.2A-B shows that fetal length and weight growth from 20 weeks 
gestational age until birth were positively associated with RVEDV and 
LVEDV, independent from growth in other periods, or from current 
childhood body size (p-values <0.05). The highest effect estimate was 
observed for height gain from 24 months to 6 years. Higher weight and BMI 
gain from 6 to 10 years were associated with lower RVEDV and LVEDV. 
Height gain between 24 months and 6 years was associated with higher 
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LVM, relative to current body size, while higher weight and BMI gain 
between 6 and 10 years were associated with lower LVM at the age of 10 
years (Figure 2.4.2C). Weight gain between 24 months and 6 years was 
associated with higher LMVR, while weight gain in late pregnancy was 
associated with lower LMVR (Figure 2.4.2D). We did not observe 
independent associations of fetal or infant growth with RVEF or LVEF at 
school-age (Figure 2.4.2E-F).  
 
Figure 2.4.2 Associations of fetal and childhood growth measures with 
childhood cardiac measures from conditional analyses (N=2,827) 
 
Figure 2.4.2A  
 
Figure 2.4.2B  
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Figure 2.4.2C 
 
Figure 2.4.2D  
 
Figure 2.4.2E  
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Figure 2.4.2F  
 
Conditional growth models for length, weight, and BMI to cardiac structure at 10 years. Each 
point shows the strength of association (±95% CI) for the period of growth from the 
preceding point and represents a difference from normal population growth over that 
period. 
 
DISCUSSION 
In this population-based prospective cohort study, we observed that higher 
birth weight for gestational age was associated with higher RVEDV and 
LVEDV, and with lower LMVR. Longitudinal growth analyses suggest that 
children who are larger at birth, and grow to be taller and leaner in 
childhood have larger hearts, relative to their body size, whereas children 
who are smaller at birth and who are shorter and heavier in childhood have 
smaller hearts with a larger LMVR. Both fetal and childhood growth seem 
to be independently related to cardiac dimensions in childhood.  
 
Interpretation of main findings 
Adults who were born preterm or with low birth weight are at increased 
cardiovascular risk later in life, especially when followed by increased 
childhood weight gain.3 In an adverse fetal environment, fetal blood flow 
and cardiac adaptations may lead to better short-term survival.4 However,  
previous studies suggest that a mismatch reflected by a restricted fetal 
environment  followed by an affluent postnatal environment, leads to an 
increased risk of cardiovascular disease.5 Animal and human studies show 
that fetal growth restriction affects the maturation and sarcomere structure 
of cardiomyocytes, and causes changes in fetal hemodynamics leading to 
cardiac pressure and volume overload.19-21 These changes might affect 
cardiac structure and shape around the time of birth, and the development 
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of the heart in later life.19, 21 During childhood, the heart grows in 
accordance with the hemodynamic demands of a growing body.136 A study 
in adolescents observed that both birthweight and current body size were 
independently from each other associated with LVM, but infant growth was 
not.136 In the current study, we examined the associations of fetal, infant 
and childhood growth with right and left cardiac structure and function, 
independent of current body size and aimed to identify critical periods of 
growth. 
Previous studies in young adults have shown that those who were 
born preterm had higher right ventricular mass and LVM, but lower 
RVEDV and LVEDV than term born adults.31, 104 The changes were greater 
in the right ventricle.31 In our study, we did not find associations of 
gestational age with cardiac structure. In our study, preterm birth averaged 
at 34.4 weeks gestational age, compared to 30.3 weeks in the previous 
studies.31, 104 Effects of preterm birth on cardiac structure in later life might 
only be present in extreme prematurity or changes might become 
detectable after childhood when the heart has been exposed to more and 
longer periods of physical stress. Next to preterm birth, fetal growth 
restriction may affect cardiac development. 21 A study in 11-year old children 
with fetal growth restriction showed shorter and more global ventricles 
than in children with normal fetal growth.21 The Young Finns Study in 784 
young adults showed a slightly larger left ventricular diameter in the adults 
who were born small for gestational age, but no differences in LVEDV, 
RVEDV or LVM.43 We observed smaller ventricular volumes and mass in 
children who were born small for gestational age. Direct comparison with 
the two previous studies is difficult since they used echocardiography. Also, 
the indexing methods to account for current body size were different.21, 43 
Altogether, preterm birth and weight at birth might influence cardiac size 
and cardiac shape in later life. These changes in cardiac size and shape 
could also relate to subclinical cardiac dysfunction and ultimately to 
cardiac disease risk in later life.21  
 We have previously observed that higher weight in fetal life, but not 
infant weight were independently associated with higher LVM at the age of 
6 years.118 One study in 418 adolescents observed that both birth weight and 
current size were associated with LVM, independently from each other.136 
We observed that children with larger ventricular volumes and mass are 
taller and heavier from fetal life onwards until childhood. Also, we observed 
that children with relatively smaller ventricular volumes had lower height 
gain and higher weight gain than children with normal sized hearts in 
childhood, relative to current body size. Children with higher LMVR had 
higher weight gain in childhood than children with lower LMVR. This is in 
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line with previous studies, that show cardiac remodeling in obese 
children.56 The higher LMVR we observed could be the first sign of 
concentric remodeling, known to be associated with cardiac disease in 
adulthood.26  
We used conditional regression analyses to identify critical periods 
of growth. Both fetal and childhood growth, but not infant growth were 
associated with cardiac dimensions. Our findings suggest that fetal and 
childhood growth patterns  influence cardiac structure at school-age. We 
previously observed moderate tracking of cardiac measures between 
infancy and childhood, which became stronger later in childhood.140 This 
tracking also continues until late adolescence and possibly into 
adulthood.18 However, it is unclear how the observed cardiac adaptations 
in childhood relate to adult cardiac disease. In adults, cardiac remodeling 
resulting in left ventricular hypertrophy is associated with cardiac disease.26 
Obesity in childhood is associated with LVH in later adulthood.35 However, 
the larger cardiac dimensions we observed in taller and leaner children 
might not be a sign of pathological adaptation, but of physiological 
adaptation. This adaptive remodeling can also be observed in 
preadolescent athletes.141 We observed that a growth pattern with higher 
childhood weight gain was associated not only with lower RVEDV, LVEDV 
and LVM, but also with higher LMVR. This might be a first sign of adverse 
cardiac remodeling, leading to increased cardiac risk later in life. Further 
research is necessary to examine childhood right and left cardiac growth 
and remodeling and relate these to cardiac disease.  
 
Methodological considerations 
Main strengths of this study are its population-based prospective design, 
and the large number of fetal and child growth measurements and cardiac 
imaging available. The population is representative for the general Dutch 
population, but one should be careful when generalizing our results to 
other countries or ethnicities. Repeated measurements allowed us to 
examine growth patterns and to identify critical periods of growth. By using 
cMRI, we were able to study the right ventricle.29 Some limitations need to 
be discussed. Of all children, 72% attended the MRI center and 69% of 
those had good quality cMRI. This loss to follow up could lead to bias if the 
associations of growth with cardiac measures differ between those included 
and not included in the analyses (Table S2.4.2). However, we deem this 
unlikely. We used a 3T MRI because this was available and used in our other 
population-based studies. Use of this scanner could have affected image 
quality and maybe led to missing data because of artifacts in some scans, 
we consider it unlikely that this has affected the associations between 
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growth and cardiac measures.142 We standardized our measures on BSA to 
account for current body size. However, height and weight were measured 
1.1 months before MRI. The calculated BSA might underestimate the actual 
BSA at time of cMRI. We adjusted all our analyses for the time difference, 
but this measurement error could lead to attenuation of the effect estimates 
we observed. We did not observe statistical interaction between growth 
measures and sex. The BSA standardized measures possibly already took 
into account differences in body size between boys and girls. It is also 
possible that although boys and girls have different cardiac measures, the 
associations between growth and cardiac measures do not differ. Despite 
the fact that we adjusted for a significant number of confounders, residual 
confounding might be of concern, as in any observational study. In 
childhood, cardiac mass and size is mainly determined by lean body mass, 
and not by blood pressure.22 This is in line with our observations, the 
results did not change after adding childhood blood pressure to our models 
(results not shown). We do not have detailed information on exercise and 
fitness levels, which might also influence body composition and cardiac 
measures.  
 
CONCLUSION 
Size for gestational age is related with right and left cardiac measures in 
mid-childhood. Relative to current body size, children who are larger at 
birth, and grow to be taller and leaner in childhood have larger hearts, 
whereas children who are smaller at birth and who are shorter and heavier 
in childhood have smaller hearts, but a larger LMVR. Both fetal and 
childhood growth are critical for development of cardiac dimensions. How 
these differences in cardiac structure in childhood relate to adult 
cardiovascular disease needs to be further investigated.   
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SUPPLEMENTAL MATERIAL 
Methods S2.4.1 Cardiac Magnetic Resonance Imaging 
We performed cardiac magnetic resonance imaging (cMRI) using a wide-bore GE 
Discovery MR 750 3T scanner (General Electric, Milwaukee, MI, USA). Children 
were first introduced with the scanning environment through the use of a 
simulated scanning session. Approximately 60 minutes were reserved for scanning 
of the brain, lungs, heart, abdomen and hips. Scanning time allocated to the 
cardiac imaging was 12 minutes. We used multi-phase ungated free-breathing 
steady-state-free-precession (SSFP) real-time scans to acquire localizer images in 
all necessary orientations. From these, 2-chamber and 4-chamber views were 
acquired with ECG gated breath-held scans lasting less than 10 seconds per breath-
hold. A short-axis SSFP cine stack was then obtained with basal slice alignment 
and covering the ventricles and part of the atria with contiguous 8-mm thick slices 
over several breath-holds. All breath-held cMRI sequences were retrospectively 
ECG gated with the help of a precordial 4-lead ECG using the vectocardiogram 
gating option of the patient monitoring unit and acquired at end-expiration. The 
imaging parameters for the short axis acquisitions were as follow: field of view of 
280 x 280 mm2, scan matrix of 128 x 128; 16 views per segment, repetition time 3.7 
ms, echo time 1.7 ms, flip angle 45°. The 2-chamber, 4-chamber and the short axis 
SSFP scans were stored on a digital archive for post-processing.  
Off-line image analyses for right and left ventricular measures on the 
short-axis cine stack was performed by Precision Image Analysis (Kirkland, WA, 
USA) under supervision of an experienced radiologist, using Medis QMASS 
software (Medis, Leiden, the Netherlands). Right and left ventricular short-axis 
endocardial and left ventricular epicardial borders were semi-automatically 
contoured at end-diastole and end-systole to allow automated calculation of right 
and left ventricular volume and left ventricular mass (LVM), following the 
guidelines of the Society for Cardiovascular Magnetic Resonance (SCMR).139 
Papillary muscle was included in the ventricular cavity. LVM was calculated as 
(diastolic epicardial volume-diastolic endocardial volume)×1.05. Since the scan 
spatial resolution was not adequate to contour right ventricular epicardial borders, 
no right ventricular mass could be calculated. Cardiac measurements included 
right ventricular end-diastolic volume (RVEDV), right ventricular ejection fraction 
(RVEF), left ventricular end-diastolic volume (LVEDV), left ventricular ejection 
fraction (LVEF), and LVM. Coefficients of variation were calculated in a random 
subset of 25 scans. Intra-observer variability was between 2.5% and 7.2%, while 
interobserver was between 3.5% and 8.7%. Intra-observer variability for each 
measurement were as follows: RVEDV 3.9%; RVEF 5.1%; LVEDV 2.5%; LVEF 4.3% 
and LVM 7.2%. Inter-observer variability was: RVEDV 5.0%; RVEF 5.3%; LVEDV 
3.5%; LVEF 5.9% and LVM 8.7%. 
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Figure S2.4.1 Flow chart of participants included in the analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
N = 4,135 
Singleton live born children attending the MRI 
center  
 
N = 37 
Excluded: missing data on birth weight or 
gestational age  
N = 4,098 
Children with information about birth weight 
and gestational age 
 
 N = 734 
Excluded: No cardiac MRI was performed, 
due to logistic or participant constraints 
N = 3,364 
Children participating in cardiac MRI 
 
N = 515 
Excluded: Poor quality cardiac MRI 
N = 2,849 
Children with good quality cardiac MRI 
 
N = 22 
Excluded: Cardiac abnormality in medical 
history 
 
N = 2,827 
Singleton children with information about birth 
weight and gestational age and participation in 
the measurements for the present study 
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Table S2.4.1 Subject characteristics (N=2,827) 
 
Subject characteristics N Values Imputed valuesa 
Maternal characteristics    
Age, y 2827 31.6 (20.6-40.2) 31.5 (20.6-40.2) 
Height, cm 2540 167.9 (7.4) 167.9 (7.2) 
Weight, kg 2081 64.0 (49.0-99.0) 65.0 (49.9-94.0) 
Body mass index pre-pregnancy, kg/m2 2079 22.5 (18.0-34.6) 22.9(18.1-33.0) 
Parity, nulliparous, n (%) 2742 1588 (57.9) 1628(57.6) 
Maternal education, higher, n (%) 2620 1349 (53.2) 1454 (51.4) 
Household monthly income, <€1600 
netto, n (%) 2827 1103 (39.0) 1103 (39.0) 
Systolic blood pressure at intake, mmHg 2526 116 (12) 116 (12) 
Diastolic blood pressure at intake, mmHg 2526 68 (10) 68 (10) 
Birth and infant characteristics    
Sex, boys, n (%) 2827 1369 (48.4) 1369 (48.4) 
Ethnicity, Dutch, n (%) 2771 1693 (59.9) 1711 (60.5) 
Gestational age at birth unit, weeks 2827 40.1 (36.0-42.3) 40.1 (36.0-42.3) 
Preterm birth <37 weeks at delivery (%) 2827 126 (4.5) 126 (4.5) 
Birth weight, grams 2827 3447 (555) 3447 (555) 
Child characteristics at 10 years    
Age at MRI, y 2827 9.9 (9.5-11.8) 9.9 (9.5-11.8) 
Height, cm 2827 141.6 (6.6) 141.6 (6.6) 
Weight, kg 2827 33.8 (25.4-53.0) 33.8 (25.4-53.0) 
Body mass index, kg/m2 2827 16.9 (14.0-24.3) 16.9 (14.0-24.3) 
Body surface area, m2 2827 1.15 (0.95-1.50) 1.15 (0.95-1.50) 
Lean body mass, % 2808 70.1 (54.6-80.1) 70.1 (54.6-80.1) 
Right ventricular end-diastolic volume, 
ml 2825 98.5 (65.8-144.3) NA 
Right ventricular ejection fraction, % 2825 58.2 (4.9) NA 
Left ventricular end-diastolic volume, ml 2825 98.7 (69.9-138.6) NA 
Left ventricular ejection fraction, % 2826 58.4 (4.6) NA 
Left ventricular mass, g 2825 47.5 (32.9-72.9) NA 
Left ventricular mass-to-volume ratio 2823 0.48 (0.37-0.68) NA 
Values are means (SD), medians (95% range) or numbers (%), based on original, non-
imputed data.  
NA: not applicable; a Values are based on imputed data with N=2827. Cardiac measures were 
not imputed.
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Table S2.4.2 Non-response analysis 
 
Subject characteristics 
Children without 
cardiac MRI 
N=1,308 
Children with 
cardiac MRI 
N=2,827 
P-
Value 
Maternal characteristics    
Age, y 31.2 (20.1-39.8) 31.6 (20.6-40.2) 0.04 
Height, cm 167.3 (7.4) 167.9 (7.4) 0.02 
Weight, kg 64.0 (49.0-100.0) 64.0 (49.0-99.0) 0.83 
Body mass index pre-pregnancy, kg/m2 22.7 (18.1-35.0) 22.5 (18.0-34.6) 0.40 
Parity, nulliparous, n (%) 714 (57.3) 1588 (57.9) 0.71 
Maternal education, higher, n (%) 533 (45.7) 1394 (53.2) <0.01 
Household income, <€1600 netto, n (%) 603 (46.1) 1103 (39.0) <0.01 
Systolic blood pressure at intake, mmHg 116 (12) 116 (12) 0.87 
Diastolic blood pressure at intake, 
mmHg 68 (9) 68 (10) 0.79 
Birth and infant characteristics    
Sex, boys, n (%) 699 (53.4) 1369 (48.4) <0.01 
Ethnicity, Dutch, n (%) 695 (54.5) 1693 (61.1) <0.01 
Gestational age at birth unit, weeks 40.1 (35.6-42.3) 40.1 (36.0-42.3) 0.70 
Birth weight, grams 3416 (545) 3447 (555) 0.09 
Preterm birth <37 weeks at delivery (%) 64 (5.0) 126 (4.5) 0.67 
Child characteristics at 10 years    
Age at MRI, y 9.89 (9.5-12.2) 9.95 (9.5-11.8) <0.01 
Height, cm 141.5 (6.9) 141.6 (6.6) 0.66 
Weight, kg 34.2 (25.2-55.6) 33.8 (25.4-53.0) 0.27 
Body mass index, kg/m2 17.1 (14.1-25.3) 16.9 (14.0-24.3) 0.06 
Body surface area, m2 1.16 (0.95-1.53) 1.15 (0.95-1.50) 0.36 
Lean body mass, % 70.1 (53.9-79.7) 70.1 (54.6-80.1) 0.37 
Values are means (SD), medians (95% range) or numbers (%), based on original, non-
imputed data. P-values from ANOVA, Mann-Whitney U or chi-square tests.  
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Table S2.4.3 Correlation coefficients between growth parameters and 
cardiac outcomes 
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Length       
20 weeks 0.01 0.00 0.03 -0.02 0.01 -0.02 
30 weeks 0.02 -0.02 0.03 -0.04 0.00 -0.02 
Birth 0.08** 0.01 0.08** 0.02 0.03 -0.02 
6 months 0.11** -0.02 0.11** -0.02 0.07** 0.00 
12 months 0.06** 0.03 0.08** -0.01 0.04 0.01 
24 months 0.09** 0.01 0.10** -0.02 0.06** 0.01 
6 years 0.10** 0.00 0.11** -0.03 0.08** 0.03 
10 years 0.14** -0.02 0.15** -0.03 0.10** 0.02 
Weight       
20 weeks 0.04* 0.00 0.06** -0.02 0.03 -0.02 
30 weeks 0.11** -0.02 0.12** -0.02 0.06** -0.04 
Birth 0.14** -0.04 0.13** -0.03 0.04* -0.06** 
6 months 0.02 -0.03 0.02 -0.02 0.02 0.04 
12 months 0.04 0.01 0.06* 0.00 0.03 0.02 
24 months 0.06* -0.01 0.06** -0.03 0.03 0.03 
6 years 0.03 -0.01 0.04 -0.02 0.04 0.08** 
10 years 0.01 -0.01 0.01 0.00 0.01 0.09** 
BMI       
6 months -0.05* -0.02 -0.05 0.00 -0.02 0.05* 
12 months 0.01 -0.01 0.01 0.01 0.00 0.02 
24 months 0.01 -0.02 0.00 -0.01 0.00 0.03 
6 years -0.04* -0.01 -0.03 0.00 -0.01 0.09** 
10 years -0.07** 0.01 -0.08** 0.02 -0.05** 0.10** 
Values are Pearson correlation coefficients. Growth variables are standardized on sex and 
age. Cardiac outcomes are standardized on body surface area.  
*P-value <0.05; **P-value <0.01.  
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ABSTRACT 
Background: An adverse fetal environment leads to fetal hemodynamic 
adaptations with cardiac flow alterations that may subsequently affect 
cardiac development. We examined the associations of third trimester 
placental and fetal cardiac hemodynamics with cardiac outcomes in school-
age children. 
Methods and Results: We performed a population-based prospective 
cohort study among 547 mothers and their children. At a gestational age of 
30.4 (95% range 28.4, 32.7) weeks, we measured umbilical and cerebral 
artery resistance, cardiac output and tricuspid and mitral E/A waves with 
Doppler. At the median age of 10.0 years (95% range 9.4, 11.7) we measured 
cardiac outcomes with cardiac Magnetic Resonance Imaging (cMRI). 
Cardiac outcomes included right ventricular end-diastolic volume 
(RVEDV) and ejection fraction (RVEF), left ventricular end diastolic 
volume (LVEDV) and ejection fraction (LVEF), left ventricular mass (LVM), 
and left ventricular mass-to-volume ratio (LMVR) as LVM/LVEDV. Higher 
third-trimester umbilical artery resistance was associated with higher 
childhood RVEF (p-value<0.05), but not with other cardiac outcomes. The 
third-trimester umbilical / cerebral artery pulsatility index ratio was not 
associated with childhood cardiac outcomes. Higher third-trimester fetal 
left cardiac output was associated with lower childhood LVEF and higher 
LMVR (p-value<0.05). Third-trimester fetal right cardiac output was not 
associated with childhood cardiac outcomes. A higher third-trimester fetal 
tricuspid valve E/A ratio was associated with higher childhood RVEF (p-
value<0.05).  
Conclusions: Our findings suggest that fetal cardiac blood flow 
redistribution may have long term effects on cardiac structure and 
function. These results should be considered as hypothesis generating and 
need further replication.  
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INTRODUCTION  
Cardiovascular disease is at least partially established in the earliest phase 
of life.5 Changes in fetal hemodynamics may be a mechanism linking an 
adverse fetal environment with cardiovascular adaptations and subsequent 
risk of cardiovascular disease in later life.11 An adverse fetal environment 
leads to fetal blood flow redistribution in favor of the upper parts of the 
body at expense of the trunk, a phenomenon known as “brain sparing”.143 
This fetal blood flow redistribution also leads to intra-cardiac flow changes 
with cardiac output switched in favor of the left ventricle, which provides 
blood for the brain circulation.144 A rise in the placental vascular resistance 
and peripheral arterial vasoconstriction in the trunk causes increased right 
ventricular afterload, and a drop in right cardiac output.145 The rise in 
ventricular afterload leads to reduced peak systolic velocities in the aorta 
and pulmonary artery.146 These changes in intra-cardiac blood flow 
patterns may affect right and left ventricular structure and function in later 
life through alterations in shear stress and wall tension, and through the 
effects on cardiomyocyte maturation and apoptosis.146 Previously, we 
reported that lower third-trimester fetal growth was associated with 
specific fetal hemodynamic changes, such as reduction of cardiac output, 
stroke volume, and pulmonary artery and cardiac compliance.147 The long-
term consequences of these fetal flow adaptations are not known. A 
previous study among 200 children reported that fetal growth restriction 
is associated with cardiac shape and stroke volume alterations in children 
aged 5 years.11 In line with these findings, we previously observed that fetal 
cardiac hemodynamics, mainly uterine artery resistance (UA PI) and left 
cardiac output in the third trimester, were associated with cardiac 
dimensions in the first six years.60, 148  
 Therefore, we examined in a population-based prospective cohort 
study among 547 children the associations of placenta and fetal cardiac 
blood flow patterns with childhood right and left cardiac outcomes, 
assessed by cardiac Magnetic Resonance Imaging (cMRI).  
 
METHODS 
Study design  
This study was embedded in the Generation R Study, a population-based 
prospective cohort study from fetal life onwards in Rotterdam, the 
Netherlands.58 Details of this study have been described previously.58 
Detailed assessments of fetal growth and blood flow patterns were 
conducted in a subgroup of 1,216 Dutch mothers and their children.58 
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Third-trimester fetal hemodynamics were available in 1,179 singletons live 
born children, of whom 547 visited the Generation R MRI research center 
at the age of 10 years and did not have cardiac abnormalities (Figure 
S2.5.1). Written permission was received from parents. The study has been 
approved by the local Medical Ethics Committee. 
 
Third trimester fetal growth and hemodynamics characteristics 
In the third trimester, we measured head circumference, abdominal 
circumference and femur length and estimated fetal weight using the 
formula by Hadlock et al.83 Fetal hemodynamics were assessed by pulsed-
wave Doppler at a median gestational age of 30.2 weeks (range 28.8 to 32.3 
weeks), as described previously.147, 148 For each measurement, three 
consecutive uniform waveforms were recorded and the mean was used for 
analyses. Feto-placental vascular resistance was evaluated with recorded 
flow-velocity waveforms from the umbilical artery. An increase in umbilical 
artery pulsatility index (UA PI) indicates increased umbilical artery 
resistance.147 UA PI was determined in a free-floating loop of the umbilical 
cord. Color Doppler visualization was used to obtain flow-velocity 
waveforms of the proximal part of the cerebral arteries. An increased ratio 
between the UA PI and the middle cerebral artery (MCA) PI is an indicator 
of brain sparing. This umbilical artery-cerebral artery ratio (U/C ratio) is 
calculated as UA PI/ MCA PI.146, 148  
Cardiac flow-velocity waveforms at the level of the mitral and 
tricuspid valves were recorded from the apical four-chamber view of the 
fetal heart. Peak velocities of the E wave and the A wave were recorded. The 
E/A ratio is an index for ventricular diastolic function and expresses both 
cardiac compliance and preload conditions.147 A higher E/A ration reflects 
less stiff and more compliant ventricles. Cardiac outflow flow-velocity 
waveforms from the aorta and pulmonary artery were recorded from the 
five-chamber view and the short-axis view of the fetal heart just above the 
semi-lunar valves. Peak systolic velocities in the aorta and pulmonary 
artery, time-velocity integral, fetal heart rate and the inner diameters 
during systole were recorded. Left and right cardiac output were calculated 
in milliliters per minute by multiplying the vessel area of the aorta or 
pulmonary artery by the time-velocity integral by fetal heart rate.  
 
Cardiac Magnetic Resonance Imaging 
MRI scanning was performed on a wide-bore GE Discovery MR 750 3T 
scanner (General Electric, Milwaukee, MI, USA). The scanning 
environment was introduced to the children in a 30-minute simulated 
scanning session. Total brain and body scanning session lasted 
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approximately 1-hour, of which 12 minutes was reserved for the cardiac 
imaging. Briefly, we acquired localizer images, followed by ECG gated 
breath-held scans lasting less than 10 seconds per breath-hold (Methods 
S2.4.1). A short-axis SSFP cine stack was then obtained with basal slice 
alignment and covering the ventricles and part of the atria with contiguous 
8-mm thick slices over several end expiration breath-holds. The scans were 
stored on a digital archive for post-processing. Off-line image analyses for 
right and left ventricular measures on the short-axis cine stack was 
performed by Precision Image Analysis (Kirkland, WA, USA) under 
supervision of an experienced radiologist, using Medis QMASS software 
(Medis, Leiden, the Netherlands). The guidelines of the Society for 
Cardiovascular Magnetic Resonance (SCMR) were followed to semi-
automatically contour right and left ventricular short-axis endocardial and 
left ventricular epicardial borders.139 Papillary muscle was included in the 
ventricular cavity. Cardiac measurements included right ventricular end-
diastolic volume (RVEDV), right ventricular ejection fraction (RVEF), left 
ventricular end diastolic volume (LVEDV), left ventricular ejection fraction 
(LVEF), and left ventricular mass (LVM). We calculated left ventricular 
mass-to-volume ratio (LMVR) as LVM/LVEDV. 
 
Covariates 
We obtained information about gestational age at birth, birth weight and 
sex from midwife and hospital records. Information about maternal age, 
pre-pregnancy body mass index, folic acid use and smoking during 
pregnancy, maternal education, and infant breastfeeding was collected by 
questionnaires and medical charts. At the age of 10 years, child height and 
weight were measured without shoes and heavy clothing, and body mass 
index (BMI) and body surface area (BSA) were calculated. BSA was 
computed using the Haycock formula (BSA (m2)=0.024265 x weight 
(kg)0.5378 x height (cm)0.3964).69 Systolic and diastolic blood pressures were 
measured on the right brachial artery, using the validated automatic 
sphygmomanometer Accutorr Plus (Datascope Corporation, Fairfield, New 
Jersey). These measurements preceded the cMRI by a median of 1.1 months 
(95% range 0 - 24.8 months).  
 
Statistical analyses 
First, we assessed the differences in subject characteristics between boys 
and girls using ANOVA for continuous variables, Kruskal-Wallis tests for 
non-parametric variables, and chi-square tests for categorical variables. 
Similarly, we compared subject characteristics for children with and 
without successful cardiac MRI in a non-response analysis. Second, we 
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explored the Pearson correlation coefficients between fetal hemodynamics 
in third trimester and all childhood cardiac outcomes. Main hemodynamic 
exposure measures included fetal blood flow redistribution measures (UA 
PI, U/C ratio), right cardiac measures (right cardiac output, pulmonary 
artery PSV, tricuspid valve E/A ratio) and left cardiac measures (left cardiac 
output, aorta ascendens PSV and mitral valve E/A ratio). Childhood cardiac 
outcomes include RVEDV, RVEF, LVEDV, LVEF, LVM and LMVR. Third, 
we used linear regression models to analyze the associations of third 
trimester fetal hemodynamics and cardiac outcomes at the age of 10 years. 
Models were adjusted for child sex, gestational age at 3rd trimester 
measurement, current age and time difference between measurement of 
BSA and cardiac MRI. Covariates (estimated third trimester fetal weight, 
maternal age, folic acid intake and smoking status during pregnancy, 
maternal education level, breast feeding, and childhood blood pressure) 
were selected on the basis of their associations with the outcomes of 
interest based on previous study results, but they were not included in the 
models, because they did not cause a change in effect estimate >10%. We 
did not observe sex-specific interaction with fetal hemodynamics in 
relation to the cardiac outcomes of interest. Therefore, we did not stratify 
our analysis on sex. We constructed BSA adjusted standard deviation scores 
(SDS) for the cardiac outcomes using Generalized Additive Models for 
Location, Size and Shape (GAMLSS) using R, version 3.2.0 (R Core Team, 
Vienna, Austria).95-97 These models enable flexible modelling, taking into 
account the distribution of the response variable.70 The SDS of the cardiac 
outcomes are based on the full cohort of all children who had successful 
cardiac MRI (N=3,018), not only on the sub selection in the current study. 
Since LMVR is not usually standardized on BSA, we created standard 
deviation scores as (observed value-mean)/SD. We also created these SDS 
for all determinants, to enable comparison of effect estimates. In order to 
reduce potential bias due to missing data, we performed multiple 
imputations (N=5) of missing covariates. We did not adjust for multiple 
testing, since the different determinants or outcomes are strongly 
correlated and adjusting for multiple testing might be too strict. For our 
analyses we used the Statistical Package of Social Sciences version 21.0 
(SPSS Inc, Chicago, IL, USA). 
RESULTS 
Subject characteristics 
Subject characteristics are presented in Table 2.5.1. At the age of 10 years 
RVEDV, LVEDV, and LVM were higher in boys than in girls, whereas RVEF 
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and LVEF were slightly higher in girls (Table 2.5.2). These measures were 
also different between boys and girls when standardized on BSA (Table 
S2.5.1). The correlations of placental and fetal cardiac hemodynamics with 
childhood cardiac outcomes (standardized on BSA) are shown in Table 
S2.5.2. The correlation between UA PI and RVEF is visualized in Figure 
S2.5.2. A non-response analysis is shown in Table S2.5.3. Children with 
successful cardiac MRI had mothers who were older, had higher intake of 
periconceptional folic acid, smoked less frequently during pregnancy and 
were more often higher educated. There were no differences in fetal 
hemodynamics and childhood anthropometric measures between children 
with and without follow up studies.    
 
Table 2.5.1 Subject characteristics (N=547) 
Subject characteristics Boys (n=266) Girls (n=281) P value 
Maternal characteristics    
Age, years 31.8 (3.8) 32.3 (3.8) 0.18 
Prepregnancy BMI, kg/m2 22.6(18.3, 32.9) 23.0(18.8, 34.3) 0.18 
Folic acid intake during pregnancy, 
start periconceptional, n (%) 
180 (67.7) 189 (67.2) 0.87 
Never smoked during pregnancy, n 
(%) 
222 (80.7) 227 (78.5) 0.20 
High education level, n (%) 214 (77.8) 213 (73.7) 0.27 
Third trimester fetal measurements    
Gestational age at measurement, 
weeks 
30.5 (28.6, 32.8) 30.4 (28.3, 32.7) 0.22 
Estimated fetal weight, grams 1636 (1194, 2236) 1601 (1172, 2232) 0.49 
Vascular resistance parameters    
Umbilical artery PI 0.95 (0.15) 0.98 (0.17) 0.05 
Umbilical/middle cerebral artery 
ratio 
0.50 (0.11) 0.50 (0.11) 0.51 
Fetal cardiac hemodynamics    
Right cardiac output, ml/min 822 (244) 833 (226) 0.62 
Pulmonary artery PSV, cm/s 72.5 (9.4) 74.1 (9.5) 0.05 
Tricuspid valve E/A ratio 0.77 (0.08) 0.78 (0.09) 0.08 
Left cardiac output, ml/min 614 (179) 598 (162) 0.28 
Aorta ascendens PSV, cm/s 91.0 (12.3) 91.3 (12.3) 0.74 
Mitral valve E/A ratio 0.78 (0.1) 0.79 (0.1) 0.16 
Birth characteristics    
Gestational age at birth, weeks 40.4 (37.0, 42.6) 40.1 (37.0, 42.1) <0.01 
Birth weight, grams 3620 (450) 3469 (512) <0.01 
Breastfeeding, never, n (%) 24 (9.0) 26 (9.2) 0.88 
Childhood characteristics    
Age at follow up, years 10.0 (9.4, 11.8) 10.0 (9.4, 11.7) 0.41 
Height, cm 142.4 (6.4) 142.0 (6.2) 0.53 
Weight, kg 33.8(25.8, 50.3) 34.0 (25.1, 47.4) 0.34 
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Table 2.5.1 (continued) 
 
Body mass index, kg/m2 16.6 (13.8, 23.0) 17.0 (13.8, 22.5) 0.11 
Body surface area, m2 1.15 (0.96, 1.46) 1.16 (0.95, 1.42) 0.43 
Systolic blood pressure, mmHg 102 (7) 104 (7.7) <0.01 
Diastolic blood pressure, mmHg 57 (6) 58 (6) <0.01 
 
Table 2.5.2 Childhood cardiac outcomes (N=547) 
 
 Boys Girls P-
value 
Right cardiac outcomes    
Right ventricular end diastolic volume, ml 105.6 (18.7) 95.8 (17.1) <0.01 
Right ventricular ejection fraction, % 58.0 (4.9) 60.0 (5.0) <0.01 
Left cardiac outcomes    
Left ventricular end diastolic volume, ml 104.8 (16.5) 96.7 (14.9) <0.01 
Left ventricular ejection fraction, % 58.3 (4.6) 59.3 (4.5) 0.01 
Left ventricular mass, grams 50.6 (9.9) 46.5 (10.0) <0.01 
Left ventricular mass-to-volume ratio, 
grams/ml 0.49 (0.08) 0.48 (0.08) 0.60 
Values represent means (SD). Differences in subject characteristics between groups were 
evaluated using one-way-ANOVA-tests. Cardiac outcomes standardized on body surface 
area are shown in Table S2.5.1 
 
Fetal hemodynamics and left and right cardiac outcomes 
Table 2.5.3 shows that a 1-SDS increase in third trimester UA PI was 
associated with higher childhood RVEF (0.11 SDS (95% CI 0.02, 0.20)). UA 
PI was not associated with any of the other cardiac outcomes. The U/C ratio 
was not associated with childhood cardiac outcomes.  
Table 2.5.4 shows that right cardiac output and pulmonary artery 
PSV were not associated with childhood right ventricular outcomes. 
However, a 1-SDS higher fetal tricuspid valve E/A ratio, reflecting a less stiff 
and more compliant ventricle, was associated with higher childhood RVEF 
(0.09 (95% CI 0.00, 0.17)).  
Table 2.5.5 shows that a higher fetal left cardiac output was 
associated with lower childhood LVEF (-0.15 (95% CI -0.24, -0.05)) and 
higher LMVR (0.11 (95% CI 0.01, 0.20)). Aorta ascendens PSV and mitral 
valve E/A wave were not associated with childhood left ventricular 
outcomes.  
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Table 2.5.3 Associations of fetal blood flow redistribution with childhood 
right and left cardiac outcomes (N=547) 
 
 Childhood cardiac outcomes (SDS) 
Fetal blood flow redistribution 
exposures (SDS) 
Umbilical artery 
PI  
Umbilical/ 
cerebral ratio  
Right ventricular end-diastolic 
volume 
-0.05 (-0.13, 0.02) -0.06 (-0.13, 0.02) 
Right ventricular ejection fraction 0.11 (0.02, 0.20)* 0.08 (-0.02, 0.17) 
Left ventricular end-diastolic 
volume 
-0.03 (-0.10, 0.04) -0.05 (-0.13, 0.02) 
Left ventricular ejection fraction 0.06 (-0.03, 0.15) 0.09 (-0.00, 0.18) 
Left ventricular mass -0.04 (-0.12, 0.04) -0.01 (-0.09, 0.07) 
Left ventricular mass-to-volume 
ratio 
-0.01 (-0.09, 0.08) 0.04 (-0.06, 0.13) 
Abbreviations: SDS standard deviation score; PI pulsatility index.  
Values are regression coefficients (95% confidence interval) from linear regression models 
that reflect differences of childhood right and left ventricular outcomes in SDS per SDS 
change in fetal blood flow redistribution exposures. Cardiac measures at 10 years are 
standardized on body surface area (except left ventricular mass-to-volume ratio).  Model is 
adjusted for gestational age at 3rd trimester measurement, child sex, current age, and time 
difference between measurement of BSA and MRI. *p<0.05 
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DISCUSSION 
In this prospective cohort study, we observed that a higher UA PI, reflecting 
increased arterial resistance, was associated with higher childhood RVEF. 
A lower fetal tricuspid valve E/A ratio, indicating a stiffer and less 
compliant ventricle, was associated with a lower childhood RVEF. Higher 
fetal left cardiac output was associated with lower childhood LVEF and 
higher childhood LMVR.  
 
Interpretation of main findings 
Changes in fetal hemodynamics in response to an adverse fetal 
environment may lead to cardiovascular adaptations and subsequent risk 
of cardiovascular disease in later life.11 We previously reported that among 
1,215 fetuses decreased fetal growth was associated with a higher afterload 
and lower vascular compliance, even before the apparent stage of fetal 
growth restriction.147 These adaptations might lead to cardiac changes in 
structure and function in later life. Also, in the same cohort it was reported 
that a higher UA PI was associated with lower aortic root diameter at 2 
years and with lower LVM at 6 years.60, 148 Increased fetal left cardiac output 
was associated with larger LVM and atrial diameter at 2 years and with 
larger aortic root diameter at 6 years.60, 148 Another study among 200 
children aged 3-6 years, observed that small for gestational age children 
have a more globular heart, impaired relaxation and increased blood 
pressure and intima-media thickness.149 Thus, previous studies suggest that 
fetal growth is associated with fetal blood flow alterations and that these 
changes might be associated with left cardiac structural and functional 
outcomes in childhood. Another study in preterm born young adults 
showed that changes in right ventricular structure and function were more 
pronounced in the right ventricle than in the left.31 Thus far, no studies on 
the long term effects of fetal hemodynamics have been performed in 
children aged older than 6 years. Also, no information is available on 
structural developmental adaptations of the right ventricle.  
In the current study, we did not find associations of fetal UA PI with 
LVM at the age of 10 years. Possibly, the previously observed association of 
UA PI with LVM at 6 years is transient and disappears at older age. In the 
current study, we did observe an association of UA PI with childhood 
cardiac function. Previous research in children with fetal growth restriction 
showed reduced longitudinal motion and impaired relaxation, but no 
difference in ejection fraction.21 We observed that a higher UA PI was 
associated with higher RVEF. These findings may suggest that a higher 
umbilical artery resistance, reflecting a higher fetal right ventricular 
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afterload, is associated with higher childhood RVEF. A study in growth 
restricted fetuses observed an increased venous return in the superior vena 
cava, as a result of increased cerebral flow in brainsparing.150 This might 
also affect right ventricular function. However, we did not observe 
associations of U/C ratio or right cardiac output with childhood RVEF. 
Further studies are needed to replicate these findings. We also 
hypothesized that since a higher U/C ratio, reflecting brain sparing, is 
associated with lower cardiac output in fetal life, it would also be associated 
with reduced childhood right and left ejection fraction.143 However, in the 
current study we did not observe any associations of U/C ratio with 
childhood cardiac structure or function, independent of current BSA.  
Reduced fetal growth across the full range is associated with lower 
fetal right and left cardiac output, aorta ascendens and pulmonary artery 
PSV and possibly with lower E/A ratio’s.12, 143, 146, 147 To the best of our 
knowledge, there are no other studies on the associations of fetal cardiac 
output with childhood cardiac outcomes. We observed that higher fetal left 
cardiac output was associated with lower childhood LVEF and higher 
LMVR, but not with LVEDV or LVM. We also observed that lower fetal 
tricuspid valve E/A ratio was associated with lower RVEF. A lower E/A ratio 
indicates a less compliant ventricle and therefore worse diastolic function. 
Interestingly, in our study the lower diastolic function in fetal life was 
associated with lower childhood ejection fraction, an indicator of systolic 
function. Unfortunately, we did not have childhood diastolic cardiac filling 
measures. We did not observe associations of mitral valve E/A ratio with 
left cardiac structure or function at the age of 10 years. 
Most of the associations we observed could fit the hypothesis that 
changes in fetal hemodynamics could be associated with cardiac structure 
and function in later life, putting the individual at risk for cardiovascular 
disease. The observed associations could reflect chance findings. We did 
not take into account multiple testing because our different exposures and 
outcomes are strongly correlated, and adjusting for multiple testing might 
be too strict. Also, we studied women with relatively healthy pregnancies. 
It might be possible that in more compromised pregnancies fetal 
hemodynamic adaptations influence later cardiac structure and function 
more strongly.  
 
Methodological considerations  
The main strength of this study is the prospective design from early fetal 
life onwards, in a large cohort of children. To our knowledge, this is the 
first study examining the effects of fetal hemodynamics on cardiac 
outcomes, measured by cMRI in childhood. MRI is a more precise and 
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accurate tool than ultrasound and CT to study cardiac structure.29, 151 For 
the current sub group study, follow up was available in 46 %. Missing 
cardiac MRI scans were mostly because of later start of these measurements 
during the follow up visits, poor quality cardiac MRI scans were often 
caused by logistical or participant constraints. This loss to follow up could 
lead to bias if the associations of fetal hemodynamics with cardiac measures 
differ between those included and not included in the analyses. However, 
we deem this unlikely since non-response analysis showed no differences 
in fetal hemodynamics or childhood anthropometrics (Table S2.5.3). We 
have standardized our outcomes on BSA, to take into account current body 
size. The majority of the children visited the MRI within two months after 
anthropometrics were taken. A small proportion of children was invited to 
the MRI at a later age. For these children, the BSA we calculated might 
underestimate current body size, leading to increased z-scores for the 
cardiac outcomes. We adjusted all our analyses for the time difference 
between the BSA measurement and the MRI visit, but this measurement 
error could still lead to an attenuation of the effect estimates we observed. 
Despite the fact that we tested and adjusted for confounders, residual 
confounding might be of concern, as in any other observational study.  
CONCLUSION 
We observed associations of increased placental resistance and fetal 
hemodynamics with childhood cardiac structure and function. Our 
findings suggest that cardiac fetal blood flow redistribution may have long 
term effects on cardiac structure and function. These results should be 
considered as hypothesis generating and need further replication.  
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SUPPLEMENTAL MATERIAL 
Figure S2.5.1 Flow chart of the study population 
Subgroup of Dutch mothers with 
singleton live born children, 
N=1,216 
Children with data on fetal 
hemodynamics,  
N=1,179 
Children with successful cardiac 
MRI measurements,  
N= 553 
Excluded: missing fetal 
hemodynamic measurements, 
N=37 
 
Excluded: Missing or poor 
quality cardiac MRI 
measurements, N= 626 
Excluded: Cardiac abnormality 
in medical history 
N= 6 
 
Singleton children with data on 
fetal hemodynamics, childhood 
cardiac outcomes and no cardiac 
abnormalities 
N= 547 
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Figure S2.5.2 Correlation scatter plot of right ventricular ejection fraction 
by umbilical artery PI  
 
Abbreviations: SDS Standard Deviation Score; PI pulsatility index.  
 
Table S2.5.1 Childhood cardiac outcomes standardized on body surface 
area (N=547) 
 
 Boys Girls P-value 
Right cardiac outcomes    
Right ventricular end diastolic volume, SDS 0.37 (0.91) -0.26 (0.89) <0.01 
Right ventricular ejection fraction, SDS -0.05 (0.99) 0.36 (1.01) <0.01 
Left cardiac outcomes    
Left ventricular end diastolic volume, SDS 0.35 (0.89) -0.26 (0.86) <0.01 
Left ventricular ejection fraction, SDS -0.02 (1.01) 0.19 (0.98) 0.14 
Left ventricular mass, SDS 0.24 (0.91) -0.33 (1.04) <0.01 
Left ventricular mass-to-volume ratio, SDS 0.02 (0.96) -0.02 (1.04) 0.60 
Abbreviations: SDS Standard Deviation Score; SD standard deviation; Values represent 
mean SDS (SD). Differences in subject characteristics between groups were evaluated using 
one-way-ANOVA-tests. Since left ventricular mass-to-volume ratio is not usually 
standardized on body surface area, we created standard deviation scores as (observed value-
mean)/SD. 
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Table S2.5.3 Non-response analysis (N=1,179 ) 
 
 Children without 
cardiac MRI 
(n=632) 
Children with 
cardiac MRI 
(n=547) 
P 
value 
Maternal characteristics    
Age, years 31.1 (4.4) 32.1 (3.7) <0.01 
Prepregnancy BMI, kg/m2 22.3 (18.4, 34.4) 22.6 (18.6, 34.6) 0.52 
Folic acid intake during pregnancy, 
start periconceptional, n (%) 
298 (57) 300 (67) <0.01 
Never smoked during pregnancy, n 
(%) 
417 (72) 392 (79) 0.02 
High education level, n (%) 390 (66) 388 (76) <0.01 
Third trimester fetal measurements    
Gestational age at measurement, 
weeks 
30.3 (28.5, 32.6) 30.4 (28.4, 32.7) 0.12 
Estimated fetal weight, grams 1601 (1155, 2235) 1618 (1181, 2229) 0.42 
Vascular resistance parameters    
Umbilical artery PI 0.98 (0.17) 0.96 (0.16) 0.10 
Umbilical/middle cerebral artery 
ratio 
0.51 (0.12) 0.50 (0.11) 0.24 
Fetal cardiac hemodynamics    
Right cardiac output, ml/min 850 (259) 825 (234) 0.11 
Pulmonary artery PSV, cm/s 73.9 (9.4) 73.4 (9.5) 0.39 
Tricuspid valve E/A ratio 0.77 (0.08) 0.78 (0.09) 0.74 
Left cardiac output, ml/min 608 (179) 606 (170) 0.84 
Aorta ascendens PSV, cm/s 91.4 (12.4) 91.1 (12.3) 0.64 
Mitral valve E/A ratio 0.78 (0.10) 0.78 (0.10) 0.46 
Birth characteristics    
Gestational age at birth, weeks 40.1 (34.9, 42.4) 40.3 (37.0, 42.4) 0.07 
Birth weight, grams 3485 (573) 3544 (491) 0.06 
Breastfeeding, never, n (%) 69 (12) 45 (8) 0.04 
Childhood characteristics    
Age at follow up, years 10.0 (9.2, 11.7) 10.0 (9.4, 11.7) 0.41 
Height, cm 142.7 (6.5) 142.2 (6.3) 0.23 
Weight, kg 33.6 (26.2, 50.1) 34.0 (25.3, 48.7) 0.77 
Body mass index, kg/m2 16.6 (14.0, 22.5) 16.8 (13.8, 22.6) 0.20 
Body surface area, m2 1.15 (0.98, 1.45) 1.15 (0.96, 1.44) 0.99 
Systolic blood pressure, mmHg 103.2 (7.9) 102.9 (7.5) 0.60 
Diastolic blood pressure, mmHg 58.3 (6.3) 57.9 (6.3) 0.33 
Abbreviations: n; number; SD standard deviation; BPM beats per minute; PI pulsatility 
index; PSV peak systolic velocity. Values represent means (SD), medians (95% range) or 
numbers of subjects (valid %) and are based on original data. Differences in subject 
characteristics between groups were evaluated using one-way-ANOVA-tests or Kruskal-
Wallis tests for continuous variables and Chi-square tests for proportions. 
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ABSTRACT 
Background Maternal obesity may affect cardiovascular outcomes in the 
offspring. We examined the associations of maternal prepregnancy body 
mass index and gestational weight gain with childhood cardiac outcomes 
and explored whether these associations were explained by parental 
characteristics, infant characteristics, or childhood body mass index.  
Methods In a population-based prospective cohort study among 4,852 
parents and their children, we obtained maternal weight before pregnancy 
and in early-, mid- and late-pregnancy. At age 6 years, we measured aortic 
root diameter (cm) and left ventricular dimensions. We calculated left 
ventricular mass (g), left ventricular mass index (g/m2.7), relative wall 
thickness ((2*left ventricular posterior wall thickness)/left ventricular 
diameter), fractional shorting (%), eccentric left ventricular hypertrophy 
and concentric remodeling.  
Results A one standard deviation score (SDS) higher maternal 
prepregnancy body mass index was associated with higher left ventricular 
mass (0.10 SDS (95% Confidence Interval (CI) 0.08, 0.13)), left ventricular 
mass index (0.06 SDS (95% CI 0.03, 0.09)) and aortic root diameter (0.09 
SDS (95% CI 0.06, 0.12)), but not with relative wall thickness or fractional 
shortening. A one SDS higher maternal prepregnancy body mass index was 
associated with an increased risk of eccentric left ventricular hypertrophy 
(odds ratio 1.21 (95% CI 1.03, 1.41)), but not of concentric remodeling. When 
analyzing the effects of maternal weight in different periods 
simultaneously, only maternal prepregnancy weight and early pregnancy 
weight were associated with left ventricular mass, left ventricular mass 
index and aortic root diameter (p-values<0.05), independent of weight in 
other pregnancy periods. All observed associations were independent of 
parental and infant characteristics, but attenuated to non-significance after 
adjustment for childhood body mass index.  
Conclusion Maternal prepregnancy body mass index and weight gain in 
early pregnancy are both associated with offspring cardiac structure in 
childhood, but these associations seem to be fully explained by childhood 
body mass index.  
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INTRODUCTION 
Left ventricular hypertrophy and concentricity are associated with 
cardiovascular events.28 Left ventricular mass tracks from childhood to 
adulthood, suggesting that the risk of cardiac diseases is at least partly 
established in early life.18 During fetal life, the heart grows due to 
hyperplasia of cardiomyocytes, whereas after birth heart growth is mainly 
due to hypertrophic growth.7 Factors in early life, such as maternal 
smoking, preterm birth and low birth weight are associated with left 
ventricular structure and function in childhood.43, 104, 152. Therefore, fetal life 
may be a critical period for heart development. This programming may put 
an individual at risk for adverse health outcomes.153 Maternal obesity and 
excessive gestational weight gain are the most prevalent adverse fetal life 
exposures in Western countries and are associated with a number of 
cardiovascular risk factors in the offspring.154 48 Maternal obesity is 
associated with an increased risk of congenital heart disease in the 
offspring.155, 156 Animals studies in mice have shown that male offspring of 
obese dams develop cardiac hypertrophy and cardiac dysfunction, 
independent of change in offspring body weight or diet.157 The underlying 
mechanism is suggested to be the mitogenic action of increased insulin on 
cardiomyocytes.158 Human studies show that maternal obesity during 
pregnancy is associated with increased inter-ventricular septum thickness 
in the fetus.159 Maternal weight gain in pregnancy is also positively 
associated with left ventricular mass in infant offspring.160 Not much is 
known about the cardiac outcomes at later age in children from mothers 
with obesity or excessive weight gain.48  
Therefore, in a population-based prospective cohort study among 
4,868 children and their parents, we examined the associations of maternal 
and paternal prepregnancy body mass index (BMI) and maternal weight 
gain in different periods of pregnancy with childhood cardiac structure and 
function. We also explored whether these associations are explained by 
parental characteristics, infant characteristics, or childhood BMI. We 
compared the effects of maternal BMI and paternal BMI, to help distinguish 
between the effect of in utero-programming of maternal obesity on cardiac 
development and the effect of other factors such as shared family-based, 
lifestyle-related or genetic factors.     
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METHODS 
Design and study population 
This study was embedded in the Generation R Study, a population-based, 
prospective cohort study from fetal life onwards in Rotterdam, the 
Netherlands.64 Details of this study have been described previously.64 In 
total 7,200 mothers had information about prepregnancy BMI available. 
We only included the 6,947 of these who had singleton live births. Missing 
information on maternal prepregnancy BMI was mainly due to later 
enrollment in the study or non-participation in the first questionnaire. A 
total of 2,079 children did not participate in cardiac follow-up studies at 
the age of 6 years. We further excluded 16 children with cardiac 
abnormalities. The population for analysis included 4,852 children and 
their parents (flow chart Figure 3.1.1). Table S3.1.1 shows that mothers 
without offspring follow-up data were more likely to be lower educated, 
whereas the children without follow-up data were more often from non-
European descent, and had lower birth weight. Missing follow-up data is 
mainly due to no consent for follow up studies at the age of 6 years. Written 
informed consent was obtained from all parents of participants. The study 
has been approved by the local Medical Ethics Committee. 
 
Figure 3.1.1 Flow chart of participants included in the analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parental anthropometrics 
N= 4,852 
Singleton live birth children of mothers with pre 
pregnancy body mass index available, who 
participated in follow-up studies at the age of 6. 
 
Left ventricular mass N=4,495 
Left ventricular mass index N=4,495 
Relative wall thickness N=4,562 
Aortic root diameter N=4,577 
Fractional shortening N=4,559 
 
N = 7,200  
Mothers enrolled during pregnancy, with information 
about pre pregnancy body mass index available  
N = 253 
Excluded due to non-
singleton livebirth   
 N = 6,947 
Mothers enrolled during pregnancy, with information 
about pre pregnancy body mass index and singleton 
live birth  
 
N = 2,095 
Excluded due to no 
participation in follow-
up studies (n=2,079) or 
cardiac abnormalities 
(n=16) 
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As described previously, maternal and paternal height (cm) and weight (kg) 
were measured at enrollment, BMI was calculated (kg/m2).161 Information 
about maternal weight before pregnancy was obtained by questionnaire. 
Prepregnancy BMI was categorized in 4 categories: underweight (<18.5 
kg/m2); normal weight (18.5-24.9 kg/m2); overweight (25-29.9 kg/m2); and 
obese (≥30 kg/m2). Maternal weight was assessed in early (median 13.4 
weeks (95% range 9.9-18.9), mid (median 29.9 weeks (95% range 20.5-31.4) 
and late (median 39.0 (95% range 32.8-42.0) pregnancy. These periods 
were defined based on data collection in our cohort and time of self-
reported maximum weight.162 Gestational weight gain until a gestational 
age of 30 weeks (median 30.2 (95% range 28.5-32.9)) was measured and 
available for 4,710 women. Information about maximum weight during 
pregnancy was assessed by questionnaire two months after delivery in a 
subgroup of 2,638 mothers.162 Maximum weight from questionnaire two 
months after delivery and weight measured at 30 weeks were strongly 
correlated (r = 0.96 (p <0.011)).  
 
Childhood cardiac outcomes 
All children were invited to participate in detailed follow up measurements 
at the age of 6 years.163 We performed M-mode echocardiographic 
measurements using methods recommended by the American Society of 
Echocardiography. We measured aortic root diameter (AOD), left 
ventricular end-diastolic diameter (LVDD), left ventricular posterior wall 
thickness (LVPWT) and interventricular septum thickness (IVS). 
Intraobserver and interobserver intraclass correlation coefficients were 
calculated previously in 28 children with a median age of 7.5 years, 
(interquartile range 3.0 - 11.0) and varied between 0.91 to 0.99 and 0.78 to 
0.96, respectively.66 We calculated fractional shortening (FS) and left 
ventricular mass (LVM), using the formula derived by Devereux et al.65, 67 
To account for differing body sizes, we additionally calculated left 
ventricular mass index (LVMI) as left ventricular mass /height2.7. (ref. 164) 
To assess left ventricular concentricity, we calculated relative wall 
thickness (RWT) as (2*LVPWT)/LVDD, which was subsequently indexed 
to age (RWT-0.0062*(age in years-10)).165, 166 The presence of left 
ventricular hypertrophy (LVH) was defined as increased LVMi, based on 
the 95% cut off by Khoury et al. (corresponding values: 44.6 g/m2.7 for boys 
and 43.5g/m2.7 for girls aged 6-8).164 Concentricity was defined as increased 
RWT values (cut off >0.390 in both boys and girls).166 Since the predictive 
value of LVH and concentricity for cardiovascular outcomes in adults are 
higher when these are combined, we defined three different geometric 
patterns: 1) normal geometry (no LVH and no concentricity); 2) eccentric 
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LVH (LVH present, but no concentricity), and concentric remodeling (no 
LVH, but concentricity present).28 
  
Covariates  
We obtained information about maternal age, education level, folic acid 
use, alcohol consumption and paternal age and education level from 
questionnaires.64 First-trimester total calorie intake was obtained by food 
frequency questionnaire.167 Child’s ethnicity was classified by the countries 
of birth of the parents.58 At birth, information on infant sex, date of birth 
and weight was obtained from community midwife and hospital registries. 
We created gestational age- and sex- adjusted birth weight standard 
deviation score (SDS) by using Growth Analyzer 3.5 (Dutch Growth 
Research Foundation, Rotterdam, the Netherlands) based on North-
European reference standards.84 Breast-feeding was assessed using 
questionnaires. Infant weight was measured at community health centers 
according to standardized procedures at 24 months. Infant growth was 
defined as the difference in weight SDS between birth and two years of age. 
At the age of 6 years, we measured height and weight without shoes and 
heavy clothing and calculated BMI in our dedicated research center. We 
obtained sex- and age-specific SDS based on Dutch reference growth 
curves.86 Maternal total weight gain was defined as the difference in weight 
between weight measured at 30 weeks gestational age and self-reported 
weight before pregnancy.  
 
Statistical analyses 
First, differences in subject characteristics between maternal prepregnancy 
BMI categories were examined with 1-way ANOVA tests and χ2 tests. We 
examined the associations of maternal and paternal prepregnancy BMI 
singularly and simultaneously with childhood cardiac outcomes (LVM, 
LVMi, RWT, AOD, FS) in 3 linear regression models: (1) a basic model 
including child’s age and sex; (2) a confounder model additionally 
including covariates selected on the basis of their associations with the 
outcomes of interest based on previous study results or a change in effect 
estimate >10%; and (3) three mediator models, which additionally included 
either maternal weight gain, infant characteristics (birth weight, 
gestational age at birth and infant growth), or childhood BMI. Third, we 
examined the associations of maternal and paternal prepregnancy BMI 
with eccentric LVH or concentric remodeling using logistic regression 
models with the same adjustments. Finally, we performed conditional 
regression analyses to identify independent associations of maternal weight 
gain in different periods with cardiac outcomes (LVM, LVMi, RWT, AOD, 
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FS).71 Conditional analyses take into account the correlations between 
maternal prepregnancy weight and weight gain in different periods.162 We 
constructed maternal weight gain variables for each period, which are 
statistically independent from each other, by using standardized residuals 
obtained from regression of maternal weight at a specific time point on 
prior maternal weight measurements.71, 162 For all analyses, we constructed 
standard deviation scores (SDS) values ((observed value – mean)/SD) of 
determinants and outcomes to enable comparison of effect estimates. We 
did not construct SDS curves based on body surface area (BSA), because we 
aimed to explore the effect of current body size in the mediator models. We 
examined potential statistical interactions between maternal and paternal 
BMI and child’s sex and with birth weight for these associations, but no 
interaction was present. Missing data of covariates and maternal 
gestational weight (for conditional analyses only) were imputed using 
multiple imputations, five datasets were created and analyzed together.99 
All analyses were performed using the Statistical Package for the Social 
Sciences version 21.0 for Windows (IBM Corp., Armonk, NY, USA). 
RESULTS 
Subject characteristics 
Table 3.1.1 shows the subject characteristics according to maternal BMI 
category. Children of mothers with overweight and obesity had a higher 
birth weight, were less often breastfed, and had a higher BMI, LVM and 
AOD, compared to children from mothers with normal weight.  
Parental body mass index and childhood cardiac outcomes 
Table 3.1.2 shows that in the confounder models a one SDS higher 
maternal BMI was associated with a 0.10 SDS (95% Confidence Interval (CI) 
0.08, 0.13) increase in LVM. Maternal BMI was also positively associated 
with LVMi (0.06 SDS increase (95% CI 0.03, 0.09)) and AOD (0.09 SDS 
increase (95% CI 0.06, 0.12)). The different mediator models showed that 
the associations of prepregnancy BMI with cardiac outcomes were not 
explained by gestational weight gain, but attenuated slightly after 
adjustment for infant characteristics. When we adjusted the associations of 
maternal BMI with LVM, LVMi and AOD for childhood BMI SDS, all effect 
estimates attenuated and lost significance. Maternal BMI was not 
associated with RWT or FS. Paternal BMI was associated with increase in 
LVM, LVMi and AOD, but not with RWT or FS. Effect estimates were 
comparable with those of maternal BMI (Table S3.1.2). Similarly as for 
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maternal BMI, the associations of paternal BMI with LVM, LVMi and AOD 
attenuated and lost significance after adjustment for childhood BMI SDS. 
 Table 3.1.3 shows that a one SDS higher maternal BMI was 
associated with increased odds for eccentric LVH (Odds Ratio (OR) 1.21 
(95% CI 1.03, 1.41)), but not concentric remodeling (OR 0.95 (95% CI 0.85, 
1.06). The associations were not explained by gestational weight gain, 
attenuated only slightly after adjustment for infant characteristics, but 
attenuated and lost significance after adjustment for childhood BMI SDS. 
The effect estimates of paternal BMI with these cardiac outcomes were 
comparable to those for maternal BMI (Table S3.1.3).  
 
Gestational weight gain in different periods of pregnancy 
Figure 3.1.2 shows the independent associations of maternal prepregnancy 
weight and gestational weight gain in early-, mid- and late-pregnancy with 
cardiac outcomes from conditional analyses. Maternal prepregnancy 
weight was associated with LVM, LVMi and AOD but not with RWT or FS 
(all p-values <0.05). Also, gestational weight gain in early pregnancy, 
independent from prepregnancy weight or weight gain in mid- or late-
pregnancy was associated with LVM, LVMi, AOD and FS (all p-values 
<0.05). Weight gain in late pregnancy was also associated with LVM, but 
not with LVMi. We did not observe associations of gestational weight gain 
in mid- or late-pregnancy with other cardiac outcomes. Associations of 
prepregnancy weight and gestational weight gain in early pregnancy were 
explained by childhood BMI SDS, except the association of weight gain in 
early pregnancy with FS, which remained the same. Results from the 
normal linear regression models focused on the associations of weight gain 
in different periods of pregnancy and childhood cardiac outcomes are 
shown in Table S3.1.4. Weight gain in early pregnancy was associated with 
LVM, LVMi, AOD and FS, but not with RWT. The associations were largely 
explained by childhood BMI SDS.  
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Figure 3.1.2 Associations of maternal prepregnancy weight and weight gain 
in each period of pregnancy with childhood cardiac outcomes (N=4,852) 
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Figure 3.1.2 (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are standardized regression coefficients (95% CI) obtained from conditional 
analyses. The estimates represent differences in cardiac outcomes per standardized residual 
change of maternal weight gain. Maternal prepregnancy weight is considered as start point. 
Basic models are adjusted for child age and gender, and for maternal height. Full models are 
additionally adjusted for age mother, educational level, alcohol use during pregnancy, folic 
acid use during pregnancy, total calorie intake during pregnancy, breastfeeding, ethnicity 
child, gestational age at birth, birth weight, infant growth and childhood sex- and age-
specific BMI SDS.  
Abbreviations: SDS standard deviation score; CI confidence interval; BMI body mass index.  
 
DISCUSSION 
We observed that higher maternal prepregnancy BMI and weight gain in 
early pregnancy are associated with increased offspring LVM, LVMi and 
AOD in childhood, but not with RWT or FS. Higher maternal BMI also 
increased the odds for eccentric LVH. Similarly, paternal BMI was 
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associated with LVM, LVMi, AOD and eccentric LVH. All observed 
associations were fully explained by childhood BMI SDS.  
 
Methodological considerations 
Main strengths of this study are its population-based prospective design 
starting from pregnancy onwards, the multiple maternal weight 
measurements throughout pregnancy and the large number of detailed 
cardiac measurements. Follow up data were available in 68% of our study 
population. We did not observe differences in BMI of the parents who did 
and did not participate. However, children who did not participate in 
follow-up had lower birth weight. The non-response could lead to biased 
effect estimates if associations of parental BMI with cardiac measurements 
would be different between children included and not included in our 
analyses. This cannot be excluded, but seems unlikely. Not all gestational 
weight measurements were available in all women, due to later enrolment 
in the study, non-participation in follow up or questionnaires. In order to 
avoid bias related to complete-case analysis and to maintain statistical 
power, we used multiple imputations for missing information of maternal 
weight measurements in the conditional analyses.99 Information on 
maternal prepregnancy weight and maximum weight in pregnancy was 
self-reported. Self-reported weight tends to be underestimated, especially 
in case of higher maternal weight. This might lead to under- or 
overestimation of effect estimates of prepregnancy BMI and gestational 
weight gain in early pregnancy with cardiac outcomes, respectively. Finally, 
we adjusted for a large number of confounders, but residual confounding 
might still be an issue by factors such as childhood diet or exercise. 
 
Interpretation of main findings 
Maternal obesity is strongly associated with offspring obesity, and an 
adverse cardiovascular and metabolic profile.161, 168, 169 These associations 
may reflect a shared genetic predisposition, shared environmental and 
lifestyle related factors or direct intra-uterine mechanisms. The fetal or 
developmental overnutrition hypothesis proposes that maternal obesity 
leads to high maternal plasma concentrations of glucose, free fatty acids 
and amino acids crossing the placenta. These might cause permanent 
changes in appetite control, neuroendocrine functioning and energy 
metabolism of the developing fetus and thus lead to offspring obesity and 
an adverse cardiovascular profile.47, 170 In a previous study, we have found 
that parental BMI was not only associated with offspring BMI in childhood, 
but also with adiposity, blood pressure, lipid levels and insulin.161 
Associations for maternal BMI were stronger than with paternal BMI, 
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suggesting direct intra-uterine effects, besides the shared environmental, 
lifestyle and genetic effects. Not much is known about the cardiac effects 
of maternal overnutrition in humans. Studies in mice suggest that there is 
an association of maternal obesity with offspring cardiac hypertrophy.157, 158 
These associations could be caused by hyperinsulinemia in the fetus, 
leading to increased mitogenic action of insulin on myocytes.158 Offspring 
of obese mice showed increased myocyte width, increased expression of 
molecular markers of myocyte hypertrophy and reactivation of fetal genes 
associated with cardiac hypertrophy and function.157, 158 These associations 
were found independent from offspring body size.  
 In the current study, we found that maternal obesity is associated 
with offspring LVM, LVMi and AOD, but these associations were fully 
explained by current childhood BMI. A previous study in 76 obese and 
normal weight pregnant women in Norway showed that maternal obesity 
during pregnancy was associated with offspring thicker inter-ventricular 
septum in late pregnancy, and with smaller inner width of both ventricles.171 
Similar effects have been observed in women with gestational diabetes. 
However, the observed cardiac hypertrophy of offspring normalized in the 
first months of life.172 From previous studies we have learned that maternal 
prepregnancy BMI is associated with childhood BMI and adiposity, whereas 
childhood BMI is associated with childhood cardiac outcomes. 47, 161, 173-176 
Thus maternal obesity might lead to childhood adiposity, which in turn 
leads to cardiac hypertrophy. It is possible that more detailed cardiac 
measurements are necessary to show subclinical altered cardiac function 
and geometry independent of body size, such as strain imaging.177 
Next to maternal prepregnancy BMI, also gestational weight gain in 
early- and mid-pregnancy to be associated with LVM, LVMi and AOD. 
These associations were independent from prepregnancy weight or weight 
gain in the other pregnancy periods. The associations were fully mediated 
by offspring BMI. Maternal weight gain in early pregnancy mainly consists 
of increased fat deposition, whereas in mid- and late-pregnancy the weight 
gain reflects extracellular fluid expansion and growth of uterus, placenta 
and fetus.178 A previous study among 5,154 mother offspring pairs in the UK 
showed that gestational weight gain in early pregnancy was associated with 
offspring adiposity. In this latter study gestational weight gain between 14-
36 weeks was associated with offspring adiposity only among women who 
gained 500g per week or more. Gestational weight gain in second and third 
trimester was also associated with offspring concentrations of triglycerides, 
HDL, apoA1 and IL-6, which was fully explained by offspring adiposity.179 
Previously we have also found that maternal weight gain in early pregnancy 
was associated with increased adiposity levels in offspring, independent of 
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birthweight or infant growth.162 We also observed that gestational weight 
gain was associated with a higher increase in growth of LVM in infancy.160 
Thus it seems that increasing maternal adiposity levels in early pregnancy 
are associated with increased adiposity levels in offspring, which is 
subsequently associated with increased cardiac size. 
Obese individuals not only have an increase in fat mass, but also in 
lean mass. 180 In children, this increased lean mass, rather than increased 
adipose tissue, explains most of the variability in heart mass.22 Previously, 
we observed that specific adiposity measures, conditional on BMI, were 
inversely associated with LVM, suggesting that lean mass is a better 
predictor of heart mass than fat mass.74 The increase in lean mass increases 
the total body oxygen consumption, which may in turn lead to increased 
stroke volume and cardiac output.181 A study in 281 children observed that 
obesity was associated with eccentric and concentric LVH. Children with 
concentric LVH showed the worst cardio-metabolic profile.175 Obesity in 
childhood was the most important risk factor for eccentric LVH in 
adulthood in 824 young adults.182 Similar results were observed in a study 
that tracked childhood BMI to adulthood.183 Our results suggest that 
maternal obesity is associated with eccentric LVH, but not concentric 
remodeling in offspring. The associations were fully explained by childhood 
BMI.  
Altogether, we did not find evidence to support the hypothesis that 
maternal obesity leads to cardiac hypertrophy through direct intra-uterine 
programming effects. In our study, the association between maternal 
obesity and gestational weight gain with LVM, LVMi and AOD seems to be 
explained by shared genetic or shared lifestyle factors that lead to increased 
childhood BMI or programming of child BMI, which in turn leads to 
increased cardiac size. However, it is still possible that there is 
programming of the myocytes, but that the effects of the programming 
show at a different stage of life, as is seen in the transient cardiac 
hypertrophy in children born of diabetic mothers.172 It could also be 
possible that we need more specific cardiac imaging methods such as strain 
imaging or more specific geometry measures to identify subtle effects on 
the cardiac structure and function. Thus far, previous studies and our 
results suggest that interventions focused on reduction of maternal 
prepregnancy BMI and gestational weight gain may lead to reduced risks of 
childhood adiposity and subsequent cardiac adaptations.161  
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CONCLUSION 
We observed that both maternal and paternal prepregnancy BMI are 
associated with cardiac structures in offspring. Gestational weight gain in 
early pregnancy was also associated with cardiac structures, independent 
from prepregnancy BMI. All associations were fully explained by childhood 
BMI. Our results suggest that maternal prepregnancy BMI influences 
cardiac structures through shared family-based and lifestyle related 
characteristics and genetic factors leading to higher childhood BMI. 
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SUPPLEMENTAL MATERIAL 
Table S3.1.1 Non-response analysis for childhood follow-up data at 6 years 
(N=7,200) 
 
Characteristics 
Follow-up at 6 
years 
N=4,868* 
Lost to follow-
up at 6 years 
N=2,332 
P-
value 
Maternal characteristics    
Age, median (95% range), yrs 30.9 (19.9, 39.4) 29.0 (18.5, 38.3) <0.01 
Education, N. higher education (%) 2198 (46.3) 767 (34.5) <0.01 
Parity, N. nulliparous (%) 2830 (58.1) 1249 (53.6) <0.01 
Total calorie intake, mean (SD), 
kcal 2052 (551) 2035 (593) 0.31 
Folic acid supplements use, N. Yes 
(%) 3861 (79.3) 1620 (69.5) <0.01 
Alcohol consumption during 
pregnancy, N. Yes (%) 2140 (43.9) 1274 (54.6) <0.01 
BMI, mean (SD), kg/m2 23.6 (4.2) 23.7 (4.6) 0.32 
Height, mean (SD),cm 168 (7.4) 167 (7.4) <0.01 
Weight, mean (SD), kg    
 Prepregnancy 66.5 (12.6) 66.0 (13.3) 0.17 
 Early pregnancy 68.9 (12.8) 68.5 (13.3) 0.24 
 Mid-pregnancy 75.9 (12.7) 75.2 (13.7 <0.05 
 Late-pregnancy 81.2 (12.7) 77.1 (13.4) <0.01 
Paternal characteristics    
Age, median (95% range), yrs 33.2 (22.2, 46.8) 31.7 (20.2, 45.5) <0.01 
Paternal education, N, higher 
education (%) 1737 (52.4) 547 (47.2) <0.01 
BMI, mean (SD), kg/m2 25.3 (3.4) 25.4 (3.7) 0.52 
Infant characteristics    
Ethnicity, N. Non-European (%)  1734 (35.6) 1051 (45.1) <0.01 
Males, N. (%) 2442 (50.2) 1069 (51.4) 0.17 
Gestational age at birth, median 
(95% range), wks 40.1 (35.9, 42.3) 39.9 (33.4, 42.4) <0.01 
Birth weight, mean (SD), g 3434 (545) 3384 (581) <0.01 
Ever breastfeeding, N. Yes (%) 3565 (92.7) 1109 (90.2) <0.01 
Abbreviations: yrs, years; N, number; SD, standard deviation; wks, weeks. 
Values represent means (SD), medians (95% range) or numbers of subjects (valid %). 
Differences in subject characteristics between groups were evaluated using one-way-
ANOVA-tests or Kruskal-Wallis tests for continuous variables and Chi-square tests for 
proportions. * Children with cardiac abnormalities were not excluded from non-response 
analysis.   
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Table S3.1.3 Associations of paternal body mass index with left ventricular 
hypertrophy (N=4,426) 
 Eccentric left 
ventricular 
hypertrophy (odds 
ratio) N=138 
Concentric 
remodelling (odds 
ratio) N=428 
Paternal model   
Basic modela 1.29 (1.07. 1.55)** 1.04 (0.93, 1.17) 
Confounder modelb, f 1.31 (1.08, 1.58)** 1.04 (0.93, 1.17) 
Mediator modelsc   
Infant characteristicsd 1.26 (1.04, 1.53)* 1.02 (0.91, 1.15) 
Childhood BMIe  1.15 (0.94, 1.40) 1.02 (0.90, 1.14) 
Combined paternal 
and maternal model 
  
Basic modela   
Maternal BMI 1.18 (0.98, 1.42) 0.92 (0.81, 1.04) 
Paternal BMI 1.24 (1.03, 1.50)* 1.06 (0.95, 1.19) 
Confounder modelb, f, g   
Maternal BMI 1.21 (1.00, 1.48) 0.93 (0.81, 1.06) 
Paternal BMI 1.25 (1.03, 1.52)* 1.06 (0.94, 1.19) 
Mediator modelsc   
Maternal weight gain   
Maternal BMI 1.20 (0.98, 1.47) 0.93 (0.81, 1.06) 
Paternal BMI 1.25 (1.03, 1.52)* 1.06 (0.94, 1.19) 
Infant characteristicsd   
 Maternal BMI 1.17 (0.95, 1.42) 0.92 (0.81, 1.05) 
 Paternal BMI 1.22 (1.00, 1.48) 1.04 (0.92, 1.17) 
Childhood BMIe   
 Maternal BMI 1.21 (1.00, 1.48) 0.93 (0.81, 1.06) 
 Paternal BMI 1.25 (1.03, 1.52)* 1.06 (0.94, 1.19) 
Values are odds ratios (95% confidence interval) from logistic regression models that reflect 
the risk for hypertrophy per SDS change in maternal and paternal prepregnancy BMI, 
compared to children with normal left ventricular structure (N=3,860). Abbreviations: LVM 
left ventricular mass; LVMi left ventricular mass index (left ventricular mass/ height2.7); 
RWT relative wall thickness (2 left ventricular posterior wall thickness/left ventricular 
diameter, age adjusted); SDS standard deviation score; BMI body mass index; aBasic model 
is adjusted for child sex and age. bConfounder model is additionally adjusted for: maternal 
age, educational level, alcohol use during pregnancy, folic acid use during pregnancy, total 
calorie intake during pregnancy, breastfeeding and ethnicity child. cIntermediate models 
are confounder models adjusted for each potential intermediate. dInfant characteristics are: 
birth weight, gestational age at birth and infant growth (change in weight SDS between 
birth and 24 months). eChildhood BMI: adjusted for sex- and age- specific BMI SDS. 
fPaternal confounder model is adjusted for paternal age and paternal education instead of 
maternal age and maternal education. gCombined paternal and maternal confounder model 
is adjusted for all previously mentioned confounders. *P<0.05; **P<0.01.  
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ABSTRACT 
Background: Adiposity is associated with larger left ventricular mass in 
children and hypertrophy in adults. The role of body fat distribution in 
these associations is not clear. 
Objective: We examined the associations of body fat distribution and 
overweight with cardiac measures obtained by cardiac Magnetic Resonance 
Imaging (cMRI) in school-age children.  
Methods: In a population-based cohort study among 2,836 children aged 
10 years, we used anthropometric measures, Dual-energy X-ray 
absorptiometry (DXA) and MRI scans to collect information on body mass 
index (BMI), lean mass index (LMI), fat mass index (FMI), and abdominal 
visceral adipose tissue index (VATI). Indexes were standardized on height. 
Cardiac measures included right ventricular end-diastolic volume 
(RVEDV), left ventricular end-diastolic volume (LVEDV), left ventricular 
mass (LVM), and left ventricular mass-to-volume ratio (LMVR) as marker 
for concentricity. 
Results: All body fat measures were positively associated with RVEDV, 
LVEDV and LVM, with the strongest associations for lean mass index (all 
p-values <0.05). These associations were only partly explained by blood
pressure. Obese children had 1.12 SDS (95% CI 0.94, 1.30) larger LVM and
0.35 SDS (95% CI 0.14, 0.57) higher LMVR than normal weight children.
Conditional on body mass index, higher lean mass index was associated
with higher RVEDV, LVEDV and LVM, while higher fat mass measures
were inversely associated with these cardiac measures (all p-values <0.05).
Conclusion: Higher childhood body mass index is associated with a larger
right and left ventricular size. These associations are explained by higher
lean mass. In childhood, lean mass may be a stronger determinant of heart
growth than fat mass. Fat mass may influence cardiac structures at older
ages.
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ABSTRACT 
Background: Pericardial adipose tissue in adults is associated with 
cardiovascular disease. We examined the associations of pericardial 
adipose tissue with cardiac structures and cardiovascular risk factors 
among both normal weight and overweight children.  
Methods: We performed a cross-sectional analysis in a population-based 
cohort study among 2,892 children aged 10 years (2,404 normal weight 
and 488 overweight/obese). Pericardial adipose tissue mass was estimated 
by magnetic resonance imaging (MRI) and indexed on height3. Left 
ventricular mass (LVM) and left ventricular mass-to-volume ratio (LMVR) 
were estimated by cardiac MRI. Cardiovascular risk factors included 
android adipose tissue percentage obtained by Dual-energy X-ray 
absorptiometry, blood pressure, and glucose, insulin, cholesterol and 
triglycerides concentrations. Adverse outcomes were defined as values 
higher than the 75 percentile.  
Results:  The median pericardial adipose tissue index was 3.6 (95% range 
1.6- 7.1) among normal weight children and 4.7 (95% range 2.0- 8.9) 
among overweight children. In the full group, a one-standard deviation (1-
SD) higher pericardial adipose tissue index was associated with higher 
LMVR (0.06 SDS (95% Confidence Interval (CI) 0.02, 0.09)) but not with 
LVM. Also, a 1-SD higher pericardial adipose tissue index was associated 
with increased odds of high android adipose tissue (Odd Ratio (OR) 2.08 
(95% Confidence Interval (CI) 1.89, 2.29)), high insulin concentrations 
(OR 1.17 (95% CI 1.06, 1.30)), an atherogenic lipid profile (OR 1.22 (95% 
CI 1.11, 1.33)) and clustering of cardiovascular risk factors  (OR 1.56 (95% 
CI 1.36, 1.79)). Pericardial adipose tissue index in was not associated with 
blood pressure and glucose concentrations. As compared to the full group, 
the associations showed largely the same directions but tended to be 
weaker among normal weight than among overweight children.   
Conclusions: Pericardial adipose tissue is associated with cardiac 
adaptations and cardiovascular risk factors already in childhood in both 
normal weight and overweight children.   
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General discussion 
 
INTRODUCTION 
Cardiovascular disease is a major public health burden worldwide. In 2015, 
an estimated 17.7 million people died from cardiovascular disease. This is 
over 30% of all global deaths.227 In the Netherlands, cardiovascular disease 
accounts for 27% of all deaths.228 The burden of cardiovascular disease 
usually affects people later in the life course. Therefore, most studies focus 
on cardiovascular risk factors in adults. However, the origins of 
cardiovascular disease could lie in the earliest phase of life.  
Circumstances in pregnancy, around birth and in infancy could 
trigger developmental pathways that increase the chance of short-term 
survival. But, if these past circumstances don’t match with the situation 
later in life, this could have adverse effects on health.153 Adults who were 
born with a low birth weight, a sign of suboptimal in utero nutrition, 
followed by an affluent childhood, indicated by increased childhood weight 
gain, were at increased cardiovascular risk in adulthood.3 The effects of 
suboptimal fetal nutrition can already be observed in childhood. Offspring 
of mothers with gestational hypertensive disorders have higher childhood 
blood pressure.229 Not just undernutrition in utero, but also overnutrition 
could condition the structure, physiology and functioning of various organ 
systems.5  
Not only factors during pregnancy and infancy, but also later in 
childhood could affect adult cardiovascular disease risk. Many traditional 
cardiovascular risk factors, such as obesity, lipid levels and blood pressure 
track from childhood to adulthood.16 But increased childhood risk factors 
also influence adult cardiovascular health independently of adult obesity 
and blood pressure.35, 36 The prevalence of obesity in both adults and 
children is increasing worldwide.230 Obesity in adults is associated with 
higher all-cause mortality, with cardiovascular disease as the most 
important cause of death, followed by diabetes, kidney disease and 
cancer.231 Since childhood obesity is associated with adult obesity and 
cardiovascular health, the increasing rates of childhood obesity are 
worrying. It is therefore important to understand the mechanisms by which 
early life factors influence later obesity and cardiovascular health, in order 
to start prevention of cardiovascular disease as early as possible. 
The main aim of the studies presented in this thesis was to identify 
early-life growth and adiposity measures related to cardiac structure and 
adverse cardiovascular outcomes in childhood. We also aim to identify 
critical periods in early life for these associations. This chapter provides a 
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general discussion of the main findings of the studies in this thesis, 
discusses general methodological issues and provides suggestions for 
future research.     
 
INTERPRETATION OF MAIN FINDINGS 
Growth 
Tracking 
As stated previously, cardiovascular disease could have its origins in early 
life. Studying cardiovascular risk factors in childhood, such as BMI, lipid 
levels, blood pressure and cardiac structure within a normal population can 
be useful, if these risk factors tend to be stable over time. If a child has a 
blood pressure in the higher range than its peers, and this stays during 
adolescence and into adulthood, then the blood pressure level in childhood 
can possibly predict the cardiovascular health in adulthood. Therefore, it is 
important to study the stability of rank order of different cardiovascular 
risk factors.  
 Longitudinal studies have shown moderate to high tracking 
coefficients for BMI and cholesterol levels, medium tracking of triglycerides 
levels and blood pressure, and low tracking of fasting insulin and insulin 
resistance from young childhood to adulthood.16, 232 Tracking of clustering 
of cardiovascular risk factors is high, children who have multiple risk 
factors in the higher ranges in childhood, are more likely to remain in the 
higher range of those cardiovascular risk factors in adulthood.233, 234 Left 
ventricular mass tracks from childhood into young adulthood.17, 18, 25 Results 
from studies in this thesis (Chapter 2.1) suggest that not only left 
ventricular mass, but also aortic root diameter and left atrial diameter track 
between the ages of 6 weeks and 10 years. Tracking became stable after the 
age of 24 months. The tracking coefficients we observed were low to 
moderate. Although these results are interesting and show that larger 
cardiac size in childhood might influence later cardiovascular health, these 
results are not strong enough to warrant routine echocardiography in 
childhood to identify children at risk for adult cardiovascular disease, who 
might benefit from early intervention. The predictive value of childhood 
cardiac size on later cardiovascular health remains unclear. Since other risk 
factors, mainly BMI, are easier to measure and show stronger tracking, they 
are more likely candidates for routine measuring in a child health setting 
focused on prevention of later cardiovascular disease.  
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Conclusions on tracking 
• Cardiac structures track moderately from early infancy into 
school-age 
• Cardiac structure might be determined early in life and influence 
cardiovascular health later in life 
 
Fetal and infant growth 
Fetal growth restriction is associated with cardiovascular disease later in 
life.3 Children who are born small, but experience fast growth in infancy 
and early childhood have a greater risk of cardiovascular disease in later 
life. 3, 14 However, an observational study on birth weight showed that not 
only low birth weight, but also high birth weight places individuals at risk 
for higher blood pressure and overweight in childhood.42 Therefore, fetal 
and infant life seem to be critical periods for development of cardiovascular 
health.  
  
Fetal and infant growth and vascular health 
The effects of fetal growth and birth weight on blood pressure in later life 
have been studied often. Although most studies find an effect of low birth 
weight on increased blood pressure later in life, the effect estimates 
reported are small, especially in the larger observational studies. Also, 
many studies don’t adequately adjust for current body size or other 
confounders.105 When studying birth weight and later growth patterns, it 
becomes clear that both birth weight, and infant or childhood growth are 
independently associated with increased blood pressure later in life. 
However, the association of infant and childhood growth with blood 
pressure is stronger than that of birth weight.106 In line with these results, 
in the studies presented in this thesis (Chapter 2.2) we observed 
independent associations of both birth weight and increased infant weight 
gain with higher blood pressure in childhood. Weight gain in infancy 
showed the strongest effect estimates, and could therefore be more 
important in predicting blood pressure values across the life course than 
birth weight. A possible mechanism by which suboptimal fetal growth 
could lead to increased blood pressure, is through impaired elastin 
synthesis, and subsequently stiffer arteries and increased blood pressure.108 
In the studies presented in this thesis, we examined the associations of early 
growth with pulse wave velocity, a measure of arterial stiffness. However, 
we did not observe any associations with this measure. 
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Conclusions on fetal and infant growth and vascular health 
• Both birthweight and infant weight gain are associated with 
increased childhood blood pressure 
• Infant weight gain could be more important than birth weight in 
predicting blood pressure across the life course 
 
Fetal and infant growth and cardiac health 
The in utero environment not only affects the vessel structure and 
functioning, but also has an effect on cardiac structure and function. 
Children with fetal growth restriction show altered cardiac structure, with 
more global shaped cardiac ventricles.11 In preterm adults, increased left 
ventricular mass, altered cardiac shape and lesser function have been 
observed.104 In contrast to these studies, we observed (Chapter 2.2) that 
lower gestational age and lower birth weight were associated with smaller 
aortic root diameter and lower left ventricular mass in childhood at the age 
of 6 years, relative to childhood body size. Children with higher birth 
weight had larger relative aortic root diameter and left ventricular mass. 
Children with higher birth weight also have higher lean mass later in life.114 
Lean mass is a major determinant of cardiac size in childhood, which could 
explain why we observed that higher birth weight was associated with 
increased cardiac size in childhood.22 However, we also observed that fetal 
growth deceleration followed by infant growth deceleration was associated 
with larger left ventricular mass. This has also been observed in adults, were 
a low weight at the age of 1 year was associated with left ventricular 
hypertrophy in adulthood.46 In fetal life, cardiac growth is mainly 
determined by myocardial cell hyperplasia, while after birth this switches 
to myocardial cell hypertrophy.7 Possibly, growth in utero affects cardiac 
size through altered hemodynamics, which can affect the maturation and 
sarcomere structure of cardiomyocytes.19-21 This could affect the size and 
function of the cardiomyocytes and the heart around the time of birth, and 
program cardiomyocyte development after birth. Therefore, different 
mechanisms related to fetal growth and infant growth might be at play and 
cause increased left ventricular mass. It remains unclear how these 
different mechanisms of increased left ventricular mass affect later 
cardiovascular health. 
 
Conclusions on fetal and infant growth and cardiac health 
• Higher birth weight is associated with relatively larger aortic root 
diameter and left ventricular mass in childhood, this could be 
mediated by higher lean mass 
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• Fetal growth deceleration followed by infant growth deceleration 
is also associated with relatively larger left ventricular mass; this 
might be caused by a different mechanism  
 
Infant growth and childhood growth 
Infant growth and cardiometabolic health 
As stated previously, rapid infant growth is associated with adult obesity, 
increased blood pressure and adverse lipid profiles.44, 123, 235 Most studies use 
change in length or weight between two time points as indicators of 
growth. However, more detailed growth patterns can be derived from 
longitudinally collected anthropometric measures. For most infants, BMI 
increases after birth till around 9 months, after which it declines, and 
rebounds again around the age of 6 years.45 From repeatedly measured 
anthropometrics in infancy, we can determine at what age this BMI peak 
was reached, and how high the maximum BMI was (Figure 4.1). We can 
also calculate peak weight velocity, which is the greatest weight growth in 
infancy. In the days after birth, newborns first tend to lose some 
bodyweight, after which they reach the peak weight velocity within the first 
month of life. Fast growth in the first month after birth, measured by higher 
peak weight velocity, was associated with higher blood pressure, weight 
circumference and BMI in adulthood.120  
 
Figure 4.1 Body Mass Index curve in early life 
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Previous work in the Generation R study showed that higher peak weight 
velocity and BMI peak were associated with higher childhood BMI, body 
fat percentage, and abdominal adiposity.45 Other childhood studies have 
shown that peak weight velocity was also associated with higher blood 
pressure in childhood, independent of current BMI.131 Timing and 
magnitude of BMI peak were associated with childhood blood pressure, 
although timing of BMI peak was mediated through current BMI.132 In the 
studies discussed in this thesis (Chapter 2.3), we observed that peak weight 
velocity was associated with higher blood pressure, and that the association 
of higher BMI peak with higher blood pressure was mediated through 
current BMI. We did not observe any consistent associations of infant 
weight velocity patterns with metabolic factors, such as triglycerides, 
cholesterol or insulin concentration.  
 
Conclusions on infant growth and cardiometabolic health 
• Peak weight velocity is associated with higher blood pressure in 
childhood 
• A higher BMI peak in infancy is associated with higher childhood 
blood pressure, but this can be explained by childhood BMI 
 
Fetal, infant and childhood growth and cardiac structure 
In this thesis I previously discussed the effects of fetal and infant growth on 
childhood left ventricular mass and aortic root diameter at the age of 6 
years. In the studies discussed in this thesis (Chapter 2.4), we also 
examined the effects of fetal, infant and childhood growth on cardiac 
structure in more detail at the age of 10 years. In adults, cardiac remodeling 
resulting in left ventricular hypertrophy is associated with cardiac disease 
and mortality.26, 27 Besides left ventricular mass, left ventricular geometry 
is important. More concentric remodeling, in which the ratio between mass 
and volume is increased, is also associated with cardiac disease and 
mortality.27, 28 Since right ventricular size is associated with cardiac disease 
independently of left ventricular mass, in the studies discussed in this 
thesis, we also examine right ventricular volume.30 In this thesis, we 
observed that fetal growth in length and weight were associated with larger 
left and right ventricular volumes, and left ventricular mass in childhood, 
relative to childhood size. We did not find strong effects of infant height or 
weight gain on cardiac structure, but the period after 24 months seemed 
important. Children who gained more height, had larger ventricular 
volumes and mass, relative to their current size. Children who gained less 
height, but more weight, showed smaller volumes and mass. The ratio 
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between mass and volume was greater in these children, indicating 
increased concentricity of the left ventricle. This is in line with another 
study, which showed that both birth weight, and current weight were 
associated with left ventricular mass in adolescents, and that obesity was 
associated with concentric remodeling patterns.136 The differences of 
childhood growth on cardiac structure might be explained by differences 
in body composition, which will be discussed more extensively in the next 
section.  
 
Conclusions on fetal, infant and childhood growth and 
cardiac structure 
• Both fetal and childhood growth are critical for development of 
cardiac dimensions 
• Children who are smaller at birth and shorter and heavier in 
childhood have increased concentricity of the left ventricle 
 
Fetal hemodynamics as possible mechanism relating fetal growth to cardiac 
health  
As stated previously, one of the possible mechanisms of altered cardiac 
structure related to fetal growth retardation could be hemodynamical 
changes in the fetus. Fetal nutrition and hemodynamics depend on 
placental function. Changes in placental vascular resistance may lead to 
fetal growth and hemodynamic adaptations.145 An adverse fetal 
environment leads to redistribution of blood flow to the upper parts of the 
body at expense of the trunk, this is called ‘brain sparing’.143 This in turn, 
leads to altered blood flow through the left and right ventricle, the flow 
through the left ventricle increases, and more blood is pumped to the brain 
circulation.144 The increased pressure on the left ventricle, increasing the 
wall stress, in combination with chronic hypoxia and undernutrition have 
been suggested as possible mechanism why fetal growth retardation leads 
to more globular shaped ventricles in childhood.149 Within the Generation 
R study, it was previously observed that increased third-trimester placental 
vascular resistance was associated with decreased fetal growth.147 In the 
studies presented in this thesis (Chapter 2.5), we observed that higher 
uterine artery resistance and a stiffer, less compliant right ventricle in fetal 
life were associated with childhood right ventricular function. Fetal left 
cardiac output was associated with lower childhood left ventricular 
function and altered cardiac structure. The population under observation 
consisted of relatively healthy pregnancies. Possibly, the effects of fetal 
environment on cardiac structure are more pronounced in the more 
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compromised pregnancies, or show in different periods of the life course. 
Also, other factors might influence the relation between fetal environment 
and cardiac structure. For example, a study on cardiac structure in preterm 
born adults showed that breast feeding could attenuate the negative effects 
of the preterm birth on cardiac structure.236 Therefore, it remains 
important to study the effects of fetal environment, and other factors 
during fetal life, in infancy and childhood and how they affect cardiac 
development and cardiovascular health throughout the life course. 
 
Conclusions on fetal hemodynamics and cardiac structure 
• Fetal growth is associated with fetal hemodynamical changes, 
which could influence later cardiac structure and functioning 
 
Adiposity 
 
Maternal obesity and child cardiac size 
In the previous paragraphs we have mainly discussed fetal growth 
restriction, but we have not extensively discussed overnutrition in utero. 
Maternal obesity during pregnancy is associated with adverse metabolic 
profiles in the offspring with increased insulin resistance, adverse body 
composition and lipid profile, and subclinical inflammation.161, 168, 169, 237 
These associations might be caused by shared genetic predisposition, 
shared environment and lifestyle factors, or by direct intra-uterine 
processes. Maternal obesity leads to high maternal plasma concentrations 
of nutrients which cross the placenta. These might cause changes in 
appetite control, neuroendocrine functioning and energy metabolism of 
the developing fetus and thus program for later obesity and an adverse 
cardiovascular profile.47, 170 Excessive weight gain in early pregnancy might 
have similar effects.162, 179 The offspring heart might be directly involved as 
well. Maternal obesity is associated with congenital heart disease in the 
offspring.155 Animal studies have shown that offspring of obese mice 
develop cardiac hypertrophy, independent of offspring weight or diet.157 
Hyperinsulinemia in the fetus caused by the overnutrition could lead to 
increased mitogenic activity of insulin on cardiomyocytes.158 In the studies 
discussed in this thesis (Chapter 3.1) we observed that prepregnancy BMI 
and weight gain in early pregnancy were associated with larger left 
ventricular mass and aortic root diameter. However, the association of 
paternal BMI with these outcomes was of similar strength, suggesting not 
a direct intra-uterine effect, but a shared genetic or lifestyle effect.238 Also, 
after adjusting for child BMI, the effect on cardiac size disappeared, 
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suggesting that maternal and paternal BMI are associated with child BMI, 
which in turn is associated with cardiac size.  
 
Conclusions on maternal obesity and child cardiac size 
• We did not observe a direct intra-uterine effect of maternal BMI 
or gestational weight gain on childhood cardiac size 
• Shared genetics with both parents or family lifestyle might affect 
childhood cardiac size through childhood BMI 
 
Childhood body composition and cardiovascular health 
Obesity is a very important risk factor for cardiovascular disease in 
adulthood.184 Obesity in childhood is associated not just with obesity in 
adulthood, but also with cardiovascular disease, irrespective of adult size.35, 
239, 240 Obesity and overweight are determined by BMI. This measure is very 
useful to identify people at risk in the general population, but it is not a 
very precise measure. BMI cannot distinguish between lean mass and fat 
mass. Adipose tissue is more strongly associated with cardiovascular health 
than lean mass. When examining different adipose tissue depots, visceral 
adipose tissue is more pathological than subcutaneous adipose tissue.51, 186, 
241 In obesity, usually lean mass, fat mass and abdominal fat mass are all 
increased.192, 193 To understand the mechanisms by which obesity leads to 
cardiovascular disease, it is important to study body composition.  
 
Body composition and cardiac health 
In this thesis, we have studied the associations of body composition with 
cardiac structure (Chapter 3.2). Previous literature in adults has shown 
that adiposity in the hip region was associated with an increase in both left 
ventricular mass and volume, which is called eccentric remodeling.52 
Central obesity was also associated with concentric remodeling, in which 
the mass-to-volume ratio was increased.52 Eccentric remodeling is 
associated with heart failure, while concentric remodeling is also associated 
with stroke and coronary heart disease.27 Studies in children show that 
obesity is associated with increased left ventricular mass and volume.174 In 
line with these results, we observed that higher BMI was associated with 
larger left ventricular mass and volume. In children, one of the main 
determinants of cardiac size is lean body mass.22 Indeed, when we 
examined body composition independent of BMI, we observed that lean 
body mass was associated with larger cardiac mass and volume, while 
higher fat mass was associated with relatively smaller cardiac mass and 
volume. Lean body mass is associated with an increase in blood volume, 
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leading to a higher preload and thus an increase in volume and mass. 
Adipose tissue is less metabolically active, and will not lead to these 
hemodynamical changes.23 Concentric remodeling was often thought to be 
caused by hypertension.242 However, in obese adults concentric remodeling 
has been observed independently of blood pressure or of aortic stiffness.197, 
243 Possibly another mechanism, on top of the hemodynamic effects is 
involved, using adipokine-mediated mechanisms.243 Higher concentricity 
was associated not only with more abdominal adiposity, but also with 
insulin resistance and inflammation.198  
Concentric remodeling is already present in obese children.56 We also 
observed more concentricity of the left ventricle in the obese children, but 
we did not observe an association with visceral adipose tissue.   
 
Conclusions on body composition and cardiac health 
• Childhood obesity is associated with larger cardiac structures 
• Lean mass may be a stronger determinant of cardiac size than fat 
mass 
 
Pericardial adipose tissue and cardiometabolic health 
Higher visceral adiposity causes endocrine and immune responses that 
affect cardiovascular structure and function directly and through 
worsening of other cardiovascular and metabolic risk factors.191 Pericardial 
adipose tissue is a visceral adipose depot, directly attached to the heart. It 
consists of epicardial adipose tissue, and paracardial adipose tissue.206 
Besides the endocrine and immune responses of visceral adipose tissue that 
affect cardiovascular health, pericardial adipose tissue might also affect 
cardiac health directly, because of its closer proximity to the heart. In 
coronary artery disease, pericardial adipose tissue released inflammatory 
factors that could influence insulin resistance and cardiovascular 
functioning.220 In adults, higher pericardial adipose tissue is associated 
with cardiovascular disease, but studies are not consistent on the role of 
general and visceral adipose tissue in these observed associations.53, 54 
Pericardial adipose tissue was associated with cardiac structure, and with 
numerous cardiovascular and metabolic risk factors, such as insulin 
resistance, atherogenic lipid profile, hypertension and metabolic 
syndrome.53, 55, 216, 217 Again, it was unclear if these associations were 
independent of general and visceral obesity. In obese children studies have 
shown that pericardial adipose tissue was associated with cardiac structure, 
blood pressure, triglycerides and HDL cholesterol.207, 222 In line with the 
current literature, we observed that both pericardial adipose tissue and 
 CHAPTER 4 
 209 
measures of cardiac structure were larger in overweight and obese children 
(Chapter 3.3). The absence of a similar relationship in strata of normal 
weight and overweight children suggests that general adiposity may explain 
this association. Pericardial adipose tissue was associated with an 
adverse body fat distribution and unfavorable lipid concentrations, 
independently of general obesity. It remains unclear if pericardial adipose 
tissue is mainly a marker for increased visceral adipose tissue, or if it exerts 
direct pathological effects to cardiovascular health as well in childhood. 
Since pericardial adipose tissue can be easily visualized with 
echocardiography, it can possibly have a role as a measure of visceral 
adipose tissue in routine screening for risk prediction. Independently of the 
possible mechanisms and causality, it remains clear that adiposity in 
childhood is associated with an adverse cardiovascular phenotype, and 
prevention or early treatment of adiposity in childhood could possibly 
influence later cardiovascular health. 
 
Conclusions on pericardial adipose tissue and 
cardiometabolic health 
• Obesity is associated with pericardial fat mass 
• Pericardial fat mass is not associated with cardiac mass and 
concentricity, independently of general obesity   
• Pericardial fat mass is associated with adverse body fat 
distribution and unfavorable lipid concentrations, independently 
of general obesity 
 
METHODOLOGICAL CONSIDERATIONS 
Specific strengths and limitations for the studies presented in this thesis 
have been described in Chapter 2 and Chapter 3 of this thesis. In the 
following paragraphs, general methodological considerations regarding 
selection bias, information bias and confounding are discussed.  
 
Selection bias 
Selection bias is the bias in the estimated associations observed, when the 
association between determinant and outcome of interest is different in the 
participants than in the non-participants. Selection bias may occur because 
of selective non-response at baseline, or selective loss to follow-up. Of all 
children eligible at birth, response to participate in the Generation R Study 
was 61%. This non-response is not likely to be random. Participating 
women more often belonged to the Dutch ethnicity than would be 
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expected from population numbers of the study area. Highest finished 
education and household income suggested a higher socioeconomic status 
in participants than in non-participants.58 Percentages of preterm birth or 
low birth weight were lower than expected from the population figures, 
suggesting a more healthy study population.244 This selection towards a 
more affluent and healthy population could lead to bias in etiological 
association studies if the selection mechanisms are related to both 
determinant and outcome measures. However, several studies have shown 
that in cohort studies, associations are not strongly influenced by selection 
at base-line.101, 245 The more homogenous study population could affect 
generalizability of our findings and reduce statistical power. Selection bias 
can also occur due to loss to follow up if associations of those remaining in 
the analyses are different in those who were lost to follow up. At the age of 
10 years, children were invited to our dedicated research center for 
anthropometrics measures, echocardiography and cardiovascular 
measurements. This also entailed a separate visit for more detailed body 
composition and cardiac structure imaging by MRI. In total, 76% of the 
original cohort participated in this follow-up, of whom almost 80% visited 
the research center.59 A lower percentage of children participated in blood 
measurements, due to non-consent for venous puncture. Participation in 
the MRI studies was lower because of later start of the MRI study. 
Unsuccessful abdominal or cardiac MRI scans were due to logistical or time 
constraints, or to low quality of imaging. Mothers of children who did not 
visit the research center more frequently had unhealthy lifestyle habits and 
were less well educated than the total study population. Similar differences 
were observed in mothers of children who did and did not participate in 
the MRI studies. Overall, this selective loss to follow up could lead to bias 
in the associations presented in this thesis, but this bias is difficult to 
quantify.  
 
Information bias 
Information bias is a bias that can arise from misclassification in a study of 
determinant or outcome measurements.246 Non-differential 
misclassification occurs when the determinant status is not related to the 
outcome status, and vice versa, this can lead to an underestimation of 
observed effect estimates. In differential misclassification the determinant 
status is related to the outcome status and this leads to biased results, 
which can be under- or overestimations. Exposure data in our study were 
collected longitudinally and before assessment of the outcomes. Parents 
and data-collectors were unaware of the research questions under study. 
This makes differential misclassification unlikely. However, non-
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differential misclassification might have occurred in the studies discussed 
in this thesis. In some of the studies we examined fetal growth as 
determinant of cardiovascular health. Pregnancy dating was performed 
using ultrasound measurements at the first visit. This method neglects 
variation of growth in the first trimester and as a consequence growth 
variation in second and third trimester might be underestimated and 
random measurement error might have occurred in pregnancy duration 
estimation. In some of the studies we examine the associations between 
anthropometrics, body composition and cardiac structure. Although the 
time difference between the two visits was less than 2 months for the 
majority of the children, and we adjusted all our analyses for this time 
difference, some non-differential misclassification might exist and have 
diluted the observed effect estimates in our cross sectional studies or in 
studies where MRI imaging was later standardized on anthropometrics. In 
most of the studies the determinants and outcome were assessed using 
medical records, or standardized hands-on assessments of body 
composition and cardiovascular measures, which makes differential 
misclassification less likely.  
 
Confounding 
A confounding factor is an extraneous variable associated with both the 
determinant and the outcome, and this variable is not an intermediate 
variable in the causal pathway between the exposure and the outcome.246 
If a confounding factor is not taken into account, this might bias the effect 
estimate of the association observed. To take into account confounding, all 
our analyses were adjusted for multiple potential confounders. Covariates 
were usually selected based on previous studies, or a change in effect 
estimate of more than 10%. As in any observational study, residual 
confounding might still be an issue. Some of the unmeasured confounding 
can relate to parental or child diet, activity, fitness or sedentary behavior. 
Also, information on some of the confounding factors was self-reported and 
measurement error could have occurred. This residual confounding could 
have led to under- or overestimation of observed associations.  
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FUTURE RESEARCH 
As stated previously, cardiovascular disease is a major public health burden 
worldwide and an important cause of premature death, which can partly be 
influenced by modifiable lifestyle factors.227 Childhood cardiovascular risk 
factors not only track into adulthood, but also influence later 
cardiovascular health directly.233, 234 In this thesis we discussed some 
maternal, fetal, infant and childhood factors that impact childhood 
cardiovascular health. These results provide more insight into the 
development of cardiovascular disease and cardiovascular risk factors. 
However, the effect estimates we observed were often small and of limited 
clinical importance for the individual. They remain important in a 
developmental perspective, and possibly also in population health. 
Although the observed associations were often small, the combination of 
all these small differences could transfer to larger cardiovascular risk in 
later life. It is therefore important to perform long-term follow up studies 
from early life into adulthood in order to examine how growth patterns in 
early life and body composition in childhood, and the differences in 
cardiovascular measures we observed in childhood relate to later 
cardiovascular risk factors and cardiovascular disease.  
 
Fetal and childhood exposures 
Because of the observational design of the Generation R Study, we can only 
observe associations, and cannot conclude on causality of these 
observations. To establish causality, experimental study designs are 
necessary. Since randomized controlled trials are not possible in relation to 
fetal growth retardation in humans, animal studies in mice or sheep are 
often used to study this topic. In animal models an adverse fetal 
environment can be created for example by feeding a protein limited diet 
to the pregnant animal, or by surgically restricting placenta function.6, 19 
Although useful insights into mechanisms by which fetal growth 
retardation leads to cardiovascular adaptation have been obtained by 
animal studies, we can never be sure if these experimental designs relate 
directly to the in utero situation in humans and if these changes in cardiac 
structure and function relate to cardiovascular disease. Randomized 
controlled trials in which the placental function in humans is 
experimentally reduced is not possible, but there might be some 
medications that can improve placental function, and thus improve later 
cardiovascular health in childhood. Some therapeutic options currently 
under study in animal or human studies aiming to increase placental 
function are sildenafil, adenovirus-mediated delivery of vascular 
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endothelial growth factor, metformin, statins, insulin like growth factor, 
and artificial oxygen carriers.247, 248 Since most experiments are preclinical, 
hopefully in the upcoming years therapeutic options to treat the 
dysfunctional placenta will become available. Lifestyle intervention studies 
focusing on improving cardiovascular health of pregnant women could be 
useful to determine if lifestyle changes in or before pregnancy can help in 
increasing cardiovascular health of offspring in the general or the at risk 
population. Since randomization or intervention of many of the studied 
exposures in this thesis will not be possible, more detailed assessment of 
these exposures might provide further insight into possible mechanisms or 
associations by which cardiovascular health and structure are affected. 
Further studies will need more information on placenta function, first 
trimester fetal growth, hemodynamic adaptations and fetal and newborn 
cardiac function. One possible method is by using 3D ultrasound images in 
a virtual reality system to develop new imaging markers for placental 
vascular development.249  
Infant and childhood exposures, such as breastfeeding, diet and 
exercise can also affect cardiovascular health. In preterm born adult who 
received donor breast milk, cardiac structure was less modified than in 
preterms who received formula feeding.236 Diet and exercise not only have 
beneficial effects on weight, but also on body composition.225 They also 
benefit cardiac structure and cardiovascular health.250, 251 Interventions 
aiming to change lifestyle can be difficult to implement or have small 
effects. However, starting with healthier habits early in life might have 
great effects. Interventions don’t need to be life changing, small changes 
can also be beneficial and can also be implemented in the school 
environment. For example, children walking or running for one mile day in 
school seem to benefit and have improved cardiovascular health and 
fitness.252 
 
Cardiac measures 
Main childhood outcomes studies in this thesis were blood pressure, left 
ventricular mass and left ventricular mass-to-volume ratio. Measures of 
cardiac structure might provide further insight into the underlying 
mechanisms linking early life exposures with cardiac alterations and later 
cardiovascular disease. In adults, left ventricular hypertrophy and 
concentricity are associated with cardiovascular disease.28 Cardiac 
hypertrophy can be physiological and pathophysiological. Hypertrophic 
remodeling takes place in order to decrease ventricular wall stress in 
response to various stimuli. Physiological stimuli can be postnatal growth, 
pregnancy, or exercise. This physiological hypertrophy is mainly mild, the 
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volume of the ventricle increases with a coordinated increase in wall 
thickness. Cardiomyocytes grow in both length and width.253 After removal 
of the stimulus, the ventricular volume and wall thickness decrease again. 
In sedentary people following an exercise training program the ventricular 
mass increased by 45% in two weeks.251 Pathophysiological remodeling can 
be observed in patients with myocardial infarction, valvular disease and 
metabolic syndrome. The ventricular volume is reduced, while the wall 
thickness is increased. Cardiomyocytes grow more in thickness than in 
length. Later ventricular dilation takes place with lengthening of 
cardiomyocytes, resulting in contractile dysfunction and cardiac failure.253 
This type of remodeling is accompanied not only by the changes in 
cardiomyocytes, but also with increased fibrosis, type 1 collagen levels, 
myofibroblast activation, cardiomyocyte death, insufficient increase of the 
capillary network and activation of fetal genes.253  
In the studies discussed in this thesis we observed that taller, but 
lean children had highest cardiac mass. This is probably physiological in 
response to a larger body, more lean mass or higher cardiac fitness. In 
contrast, the relatively smallest hearts were observed in shorter children 
with weight gain. Since they also showed increased concentricity, this could 
possibly be an early sign of pathophysiological remodeling. Since it is 
difficult to distinguish physiological and pathophysiological remodeling in 
the study design we used, more research is necessary to understand the 
pathways of cardiac remodeling in childhood, whether remodeling is 
physiological, when will it become pathophysiological and how this relates 
to later cardiac disease. Possibly there is a role for more detailed measures 
of cardiac geometry or function. We studied ejection fraction, but this is a 
crude measure of cardiac function. Even in cardiac failure, this measure can 
still be within normal limits.254 Strain analyses derived from 
echocardiography or MRI could possibly provide more information on 
cardiac function and hold prognostic information.177 This method 
differentiates between active and passive movement of myocardial 
segments and evaluates myocardial function, such as longitudinal 
myocardial shortening.177 A study in children with fetal growth retardation 
has showed that longitudinal strain was decreased, while circumferential 
strain was increased. This was also accompanied by changes in cardiac 
geometry.21 The children had smaller ventricles that were more spherical. 
This is also present in adults who were born preterm.104 In obesity more 
conically shaped ventricles have been observed.199 Both are associated with 
cardiac failure.203 A more detailed analyses of cardiac geometry, for 
example by creating 3-dimensional images from cardiac MRI in populations 
at risk for cardiac disease could possibly give insight into adverse 
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remodeling patterns.255 It would then become possible to study these 
remodeling patterns in large population based studies in both children and 
adults and learn if there is any predictive value of cardiac geometry early in 
life.  
 
CLINICAL IMPLICATIONS 
Worldwide, the burden of cardiovascular disease remains massive.227 In the 
Netherlands, cardiovascular disease is accountable for 27% of deaths.228 
The associations of cardiovascular risk factors, such as hypertension, 
hyperinsulinemia, adverse lipid profile, metabolic syndrome and obesity on 
cardiovascular morbidity and mortality are well-known.227 Also, adverse 
cardiac geometry and greater left ventricular mass in late adulthood are 
associated with cardiovascular events.28 We already know that 
cardiovascular risk factors track from childhood to adulthood, and that 
cardiovascular disease might originate in early life. From this thesis, we 
have identified several maternal, fetal and childhood factors that might 
influence cardiac structure and cardiovascular health in childhood. Growth 
and weight gain patterns in fetal life, infancy and childhood influence later 
cardiovascular health. Obesity, body composition and pericardial fat in 
childhood are already associated with adverse cardiovascular risk profiles. 
Fetal life and early childhood are critical periods for cardiac structure and 
cardiovascular health of children. 
  The associations we observed were often small, but might be 
important on a population level. Possibly, they can contribute in 
identifying at risk individuals or populations. They are also important for 
the development of intervention strategies that focus on promoting a 
healthy lifestyle early in life. Weight loss in adolescents and adults 
improves cardiovascular health.195, 256 However, weight loss or life style 
changes are very difficult to achieve for most people. Prevention should 
start earlier in life. A good time to start would be in the preconception 
period. Future parents might be more motivated and when future parents 
start to live healthier, the lifestyle changes might promote better health in 
pregnancy. Hopefully, the lifestyle changes will last, and thus influence 
infant and childhood growth and health. Some interventions should focus 
on healthy prepregnancy weight and habits, but concluding from this 
thesis, infant and childhood growth are also very important. In the 
Netherlands we have a unique system of child well centers, routinely 
measuring child anthropometrics. They are ideally situated for screening of 
children at risk for adverse growth patterns, obesity and cardiovascular 
disease. However, funding and evidence-based, long-term, family-oriented 
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interventions are often lacking. More interventions should be researched 
and funding should be made available to implement the already existing 
interventions. Interventions could focus on healthy diet, lifestyle, sedentary 
time and physical activity for the whole family.    
 
CONCLUSION OF THIS THESIS 
Findings from this thesis suggest that early-life growth and adiposity 
related factors are associated with cardiac structure and adverse 
cardiovascular outcomes in children. Although the associations were 
small, they might be important on a population level. Both fetal life and 
early childhood are critical periods for later cardiovascular health.  
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Summary 
Chapter 1 describes the background and hypothesis for the studies 
presented in this thesis. Cardiovascular disease is a major public health 
problem worldwide and might originate in early life. The developmental 
origins hypothesis suggests that adverse exposures in fetal and postnatal 
life might lead to cardiovascular adaptations. This enables the individual to 
survive in the short term, but these adaptations can also predispose 
individuals to cardiovascular disease later in life. This is supported by 
experimental studies in animals and by large observational studies in 
humans. The effects on the cardiovascular system are already present in 
childhood. Not only fetal life, but also early postnatal life is important for 
cardiovascular health. Common risk factors for cardiovascular disease, 
such as blood pressure, lipid levels and obesity track from childhood to 
adulthood. Thus, cardiovascular disease might originate in early life. Both 
an adverse fetal environment and an affluent postnatal environment seem 
to adversely affect cardiovascular health from childhood to adulthood. 
Identifying the risk factors and the sensitive periods in early life and the 
mechanisms through which early life affects cardiovascular health are 
important for future preventive strategies to ensure cardiovascular health 
later in the life course. Therefore, studies presented in this thesis were 
designed to identify fetal, infant and childhood factors associated with 
cardiovascular health outcomes in childhood. The studies were particularly 
focused on the role of growth and adiposity in specific early-life periods. 
In Chapter 2 studies on fetal, infant and childhood growth on 
cardiovascular outcomes are described. In Chapter 2.1 we observed that 
cardiac structures track moderately from early infancy into school-age. 
Tracking was stronger from 24 months of age into school-age. Moderate 
tracking of cardiac structures suggests that cardiac structures are at least 
partly determined in early life, but if this related to cardiac disease should 
be further studied. The influence of growth patterns in fetal life and infancy 
on cardiovascular health was discussed in Chapter 2.2. We observed that 
both birthweight and infant weight gain were associated with increased 
childhood blood pressure. Infant weight gain could be more important 
than birth weight in predicting blood pressure across the life course. Higher 
birth weight was also associated with larger cardiac structures in childhood. 
A possible mediation mechanism might be in place, where these children 
have a higher lean mass and thus larger cardiac structures. Fetal growth 
deceleration followed by infant growth deceleration was also associated 
with larger left ventricular mass, but this might be caused by a different 
mechanism. In Chapter 2.3 we have studied the associations of infant 
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growth velocity patterns with cardiometabolic health in childhood. Peak 
weight velocity was associated with higher blood pressure in childhood. A 
higher BMI peak in infancy was also associated with higher childhood 
blood pressure, but this was explained through higher childhood BMI. 
Thus, faster infant growth places an individual not only at risk for increased 
blood pressure, but also for later adiposity. We examined the effects of fetal, 
infant and childhood growth on cardiac structure in more detail at the age 
of 10 years (Chapter 2.4). Both fetal and childhood growth, but not infant 
growth were critical for the development of cardiac dimensions. Children 
larger at birth, but taller and leaner in childhood had larger cardiac mass, 
but no adverse geometry. Children who were smaller at birth, and shorter 
and heavier in childhood had increased concentricity of the left ventricle. 
How these differences in cardiac structure relate to cardiac disease remains 
to be studied. In Chapter 2.5 we studied the effects of fetal hemodynamics 
on childhood cardiac structure and function. An adverse fetal environment 
not only influences fetal growth, but also fetal hemodynamics. We 
observed that increased placental resistance and fetal cardiac blood flow 
redistribution may have long term effects on cardiac function and 
structure.  
 In Chapter 3 we presented studies on the associations between 
maternal and child obesity and body composition on cardiovascular health. 
Chapter 3.1 discussed the associations between maternal obesity, 
gestational weight gain and childhood cardiovascular health. Maternal 
obesity and weight gain in early pregnancy, and paternal obesity were 
associated with larger childhood cardiac structures. However, we did not 
observe a direct intra-uterine effect of maternal BMI or gestational weight 
gain on childhood cardiac size, the associations were explained by 
childhood BMI. Shared genetics with both parents, or family life style might 
affect cardiac size through childhood BMI. In Chapter 3.2 we observed that 
childhood obesity was associated with larger cardiac structures. However, 
differences in body composition might be important. Lean mass was a 
stronger determinant of cardiac size than fat mass. Obese children also 
showed more concentricity of the left ventricle, which might place them at 
increased risk for cardiac disease in later life. Pericardial adipose tissue was 
examined in Chapter 3.3. We observed that obesity was associated with 
pericardial fat mass. Independently of general obesity, pericardial fat mass 
was not associated with larger cardiac mass or concentricity. However, 
higher pericardial fat mass in children was associated with an adverse body 
fat distribution and unfavorable lipid 
concentrations independently of general obesity, possibly influencing 
cardiovascular health across the life course.  
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 In Chapter 4 we provide a general discussion, in which the studies 
described in this thesis were described in a broader context. Also, 
implications and suggestions for future research were discussed. In 
conclusion, findings from this thesis suggest that early-life growth and 
adiposity related factors are associated with cardiac structure and adverse 
cardiovascular outcomes in children. Future studies should focus on how 
changes in cardiac structure and cardiovascular outcomes in childhood 
relate to cardiovascular disease risk in adulthood. Preventive strategies 
should start early in life and focus on (pre)pregnancy weight and habits. 
Since not only fetal life, but also early childhood is an important critical 
period for later cardiovascular health, preventive strategies and early 
interventions in early childhood might be effective in improving 
cardiovascular health. 
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Samenvatting 
Hoofdstuk 1 beschrijft de achtergrond en hypothese voor de studies die 
gepresenteerd worden in deze thesis. Hart- en vaatziekten zijn een enorm 
probleem voor de volksgezondheid wereldwijd en ontstaan waarschijnlijk 
in het vroege leven. De `developmental origins´ hypothese stelt dat 
ongunstige blootstellingen in de foetale en postnatale periode kunnen 
leiden tot aanpassingen aan hart en vaten. Op de korte termijn zorgt dit 
ervoor dat het individu in leven blijft, maar op de lange termijn kunnen 
deze aanpassingen juist zorgen voor verhoogde vatbaarheid voor hart- en 
vaatziekten. Deze hypothese wordt ondersteund door experimentele 
studies in dieren en door grote observationele studies in mensen. De 
effecten van ongunstige blootstellingen vroeg in het leven zijn al zichtbaar 
in de kindertijd. Niet alleen de foetale periode, maar ook het de vroege 
postnatale periode zijn belangrijk voor cardiovasculaire gezondheid. 
Bekende risicofactoren voor hart- en vaatziekten, zoals hoge bloeddruk, 
lipidenniveaus, en obesitas tracken van de kindertijd tot in volwassenheid. 
Hart- en vaatziekten ontstaan dus mogelijk al in het vroege leven. Een 
nadelige foetale omgeving en een overvloedige postnatale omgeving lijken 
een negatief effect te hebben op gezondheid van hart en vaten vanaf de 
kindertijd tot aan volwassenheid. Het identificeren van risico factoren en 
de gevoelige periodes vroeg in het leven, en de mechanismen over hoe 
factoren in het vroege leven de latere gezondheid beïnvloeden zijn 
belangrijk voor het ontwikkelen van preventie strategieën en bevorderen 
van cardiovasculaire gezondheid later in het leven. Daarom zijn de studies 
die gepresenteerd worden in deze thesis gericht op het identificeren van 
foetale, zuigeling en kind factoren die samenhangen met cardiovasculaire 
gezondheid op de schoolleeftijd. De studies richten zich in het bijzonder 
op de kritische periodes in het vroege leven.   
In Hoofdstuk 2 werden studies over de groei in de foetale periode, 
zuigelingentijd en kindertijd en het effect op cardiovasculaire uitkomsten 
beschreven. In Hoofdstuk 2.1 zien we dat hartstructuren redelijk tracken 
van de vroege zuigelingenperiode tot aan de schoolleeftijd. Het tracken was 
het sterkste tussen 24 maanden en schoolleeftijd. Redelijk tracken van 
hartstructuren suggereert dat afmetingen van hartstructuren ten minste 
deels al vroeg in het leven worden bepaald, maar hoe dit samenhang met 
hart- en vaatziekten behoeft meer onderzoek. De invloed van 
groeipatronen in de foetale en zuigelingenperiode op cardiovasculaire 
gezondheid is besproken in Hoofdstuk 2.2. We observeerden dat 
geboortegewicht en zuigelingen gewichtstoename beiden samenhangen 
met verhoogde bloeddruk op de kinderleeftijd. Gewichtstoename in de 
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zuigelingenperiode is mogelijk belangrijker in het voorspellen van 
bloeddruk over de levensduur dan geboortegewicht. Hoger 
geboortegewicht hing ook samen met grotere hartstructuren op 
kinderleeftijd. Mogelijk speelt hier een mediërend mechanisme, waarbij 
deze kinderen een hogere vetvrije massa hebben en dus een groter hart. 
Foetale groei deceleratie gevolgd door deceleratie van gewicht in de 
zuigelingenperiode hing ook samen met een grote massa van het linker 
ventrikel, maar dit kan ook veroorzaakt worden door weer een ander 
mechanisme. In Hoofdstuk 2.3 hebben we de associaties van 
zuigelingengroei en zuigelingengroei snelheid met cardiometabole 
gezondheid bestudeerd. Maximale snelheid van gewichtstoename hing 
samen met hogere bloeddruk op de kinderleeftijd. Een hogere BMI-piek in 
de zuigelingenperiode ging ook samen met hogere bloeddruk op de 
kinderleeftijd, maar dit werd verklaart door hogere kinderleeftijd BMI. 
Snellere groei als zuigeling verhoogt dus niet alleen het risico op hoge 
bloeddruk, maar ook voor overgewicht. De effecten van foetale, zuigelingen 
kindergroei op hartstructuren hebben we in meer detail bestudeerd op de 
leeftijd van 10 jaar (Hoofdstuk 2.4). Foetale en kindergroei, maar niet 
zuigelingengroei, waren belangrijk voor de ontwikkeling van de 
hartafmetingen. Kinderen die groter waren bij de geboorte, en langer en 
slanker als kind hadden relatief grotere hartstructuren. Kinderen die juist 
kleiner waren bij de geboorte, en in de kindertijd minder snel groeiden, 
maar juist wel in gewicht meer aankwamen, hadden een grotere 
concentriciteit van het hart. Hoe deze veranderingen in hartstructuur 
samenhangen met hart- en vaatziekten moet verder onderzocht worden. In 
Hoofdstuk 2.5 hebben we gekeken naar de effecten van foetale 
hemodynamica of hartfunctie en structuur op kinderleeftijd. Een 
ongunstige foetale omgeving heeft niet alleen invloed op de groei van de 
foetus, maar ook op de foetale hemodynamica. We observeerden dat 
verhoogde weerstand in de placenta, en redistributie van bloedstroming 
door het foetale hart lange termijn effecten kunnen hebben op functie en 
structuur van het hart.  
In Hoofdstuk 3 presenteerden we de studies over de associaties 
tussen moeder en kind overgewicht en lichaamssamenstelling op 
cardiovasculaire gezondheid. Hoofdstuk 3.1 bediscussieerde de 
associaties tussen maternaal overgewicht, gewichtstoename vroeg in de 
zwangerschap, en gezondheid van hart en vaten op kinderleeftijd. 
Maternaal overgewicht, gewichtstoename vroeg in de zwangerschap en 
paternaal overgewicht waren geassocieerd met grotere hartstructuren in 
het kind. We zagen echter geen direct intra-uterien effect van maternaal 
BMI of gewichtstoename op hartafmetingen van het kind. De associaties 
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werden verklaard door BMI van het kind. Gedeelde genetica met de ouders, 
of familie levenswijze hebben mogelijk effect op hartafmetingen via BMI op 
kinderleeftijd. In Hoofdstuk 3.2 hebben we gezien dat obesitas op de 
kinderleeftijd samen hing met grotere hartstructuren. Waarschijnlijk zijn 
verschillen in lichaamssamenstelling van belang. Vetvrije massa was een 
sterkere voorspeller van hartafmetingen dan vetmassa. Kinderen met 
obesitas hadden een meer concentrisch hart, wat een hoger risico geeft op 
latere hartziekten. Pericardiale vetmassa was onderzocht in Hoofdstuk 
3.3. Obesitas ging samen met hogere pericardiale vetmassa. Onafhankelijk 
van algehele obesitas hing hogere pericardiale vetmassa niet samen met 
grotere hartstructuren. Daarentegen hing hogere pericardiale vetmassa in 
kinderen wel samen met een nadelige lichaamsvetverdeling en 
lipidenconcentraties in het bloed, wat een verhoogd risico op latere hart- 
en vaatziekten kan geven. 
In Hoofdstuk 4 bieden we de algehele discussie, waarin de studies 
die beschreven worden in deze thesis in een bredere context worden gezet. 
Ook bespreken we de implicaties en suggesties voor verder onderzoek. In 
conclusie suggereert deze thesis dat groei in het vroege leven en factoren 
samenhangend met adipositas zijn geassocieerd met hartstructuur en 
nadelige cardiovasculaire uitkomsten in kinderen. Toekomstige studies 
zouden zich kunnen richten op hoe deze veranderingen op kinderleeftijd 
samen hangen met later risico op hart- en vaatziekten. Preventie 
strategieën zouden vroeg in het leven moeten starten, en zich richten op 
gezond gewicht en gewoonten net voor en tijdens de zwangerschap. Omdat 
niet alleen de foetale periode, maar ook de vroege kindertijd een 
belangrijke periode is voor de ontwikkeling van een gezond hart en vaten, 
zouden preventie en interventie strategieën in de vroege kindertijd ook 
effectief kunnen zijn in het verbeteren van latere cardiovasculaire 
gezondheid.  
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Dankwoord 
Eindelijk mag ik het dankwoord schrijven. De laatste loodjes. Of eigenlijk 
niet, want ik moet nog best wel wat doen aan de lay-out of aan papers die 
die al dan niet onder revisie zijn, of aan het regelen van een feestje, en een 
drukker, en een lekenpraatje en ik weet niet eens wat nog meer allemaal. 
Afijn, het dankwoord is het laatste wat jullie lezen, of misschien wel het 
enige. Want een dankwoord leest toch net iets makkelijker dan 3 
hoofdstukken in academisch Engels. En als je geluk hebt wordt je zelfs nog 
vernoemd. Tip: op bladzijde 222 begint de Nederlandse samenvatting, dus 
als je indruk wil maken en wil doen of je mijn hele proefschrift hebt gelezen, 
zou ik daar verder gaan lezen. Voel je zeker niet verplicht om alle 
hoofdstukken door te nemen. Hoewel ik met veel plezier 6 jaar aan dit 
project heb gewerkt, vind ik het zelf ook best saai om alles terug te lezen. 
Een spannende detective, historische roman of een fantasyboek leest toch 
lekkerder weg.  
 
Het dankwoord schrijf ik alleen, maar aan de rest van dit 6-jaars epos 
hebben behoorlijk veel mensen een bijdrage geleverd. Daarom wil ik graag 
de ruimte nemen om iedereen hier te bedanken. Als eerste natuurlijk de 
Generation R deelnemers en hun ouders. De oudste deelnemers zijn 
inmiddels al bijna volwassen. Het is ongelofelijk dat jullie ouders dit traject 
met jullie zijn ingegaan en dat jullie nog steeds mee willen doen. Zonder 
jullie zou er geen data zijn geweest voor mij en mijn collega’s om te 
onderzoeken. En hoe langer jullie meedoen, hoe specialer deze database 
wordt. Met deze schat aan informatie maken jullie nog vele generaties 
onderzoekers gelukkig. En hopelijk kunnen wij dan weer bijdragen aan de 
gezondheid van jullie toekomstige generaties.  
 
In het bijzonder wil ik mijn promotoren bedanken: prof. dr. Jaddoe en prof. 
dr. Helbing. Beste Vincent, het begon ruim 6 jaar geleden met een 
sollicitatie in het toen nog gloednieuwe NA-gebouw samen met dr. Janine 
Felix. Er werd beneden zelfs nog gebouwd. De laatste paar keren dat ik in 
het Erasmus MC was, zaten de liften wederom ingepakt vanwege alle 
verbouwingen, dus zoveel is er ook weer niet veranderd. Ik was net 
afgestudeerd en had mijn diploma nog niet eens ontvangen. Maar mijn 
wetenschapsstage in het buitenland was me zo goed bevallen, dat ik verder 
wilde met onderzoek doen. Het Generation R project leek perfect te passen 
bij mijn interesses. Jullie hadden een mooi project voor me, er werden hart 
MRI´s gemaakt. Ze hoefden alleen maar gemaakt en gescoord te worden. 
We hadden er alle vertrouwen in dat we in 3.5 jaar wat mooie manuscripten 
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zouden kunnen schrijven. 6 jaar verder kunnen we concluderen dat ik iets 
meer tijd nodig had. Dat lag zeker niet aan jou, Vincent, het is ongelooflijk 
hoe snel ik reacties kreeg met commentaar op papers, of met nieuwe 
ideeën. Helaas duurde het toch allemaal iets langer, en was het heel veel 
meer werk dan ik van tevoren had ingeschat om alle hart MRI data op orde 
te krijgen. En daar komt ook nog eens bij dat ik niet op zondagnacht om 3 
uur aan het werk ging en je nuttige commentaar dus pas op 
maandagochtend weer zag. Beste Janine, ik schreef dat ik mijn promotoren 
ging bedanken in deze paragraaf, maar toch wijd ik hier een regeltje aan 
jou. Jij hebt me enorm geholpen met de start van mijn traject, en hoewel 
ons eerste project niet in deze thesis staat, ben ik je wel dankbaar. Beste 
Wim, niet betrokken bij mijn project vanaf mijn eerste werkdag, maar wel 
vanaf de start van mijn projecten waarbij het hart betrokken was. Hartelijk 
dank voor uw hulp bij het verbeteren van de hartscans, het beoordelen en 
scoren van de scans, en uw nuttige input op cardiologisch gebied voor mijn 
manuscripten.  
 
Beste prof. dr. Reiss, dank voor uw bereidheid zitting te nemen in de kleine 
commissie en het secretariaatschap op u te nemen. Prof. dr. Roseboom en 
prof. dr. van Rossum, hartelijk dank voor het plaatsnemen in de kleine 
commissie en het beoordelen van het proefschrift. Prof. dr. Steegers-
Theunissen, dr. Gaillard, dr. Roest en dr. Kavousi, hartelijk dank voor uw 
bereidheid mijn proefschrift door te nemen en met mij hierover in discussie 
te willen gaan.  
 
Graag wil ik ook alle co-auteurs bedanken voor hun onmisbare input in 
mijn manuscripten: dr. Duijts, dr. Felix, prof. dr. Franco, prof. dr. Hofman, 
dr. de Jonge, dr. Taal, prof. dr. van der Lugt, prof. dr. Vernooij, prof. dr. 
Steegers, dr. van der Geest, dr. van Osch-Gevers, dr. Gaillard, dr. Gishti, M. 
Kooijman, C. Kruithof, S. Vogelezang, T. Marinkovic, G. Jelic, W. van 
Genuchten, dr. Santos; thank you all for your fruitful and pleasant 
collaboration.  
 
Prof. dr. Bouvy en dr. Witteman, jaren en jaren geleden, als eerstejaars 
geneeskunde student hebben jullie me de kans gegeven aan de slag te gaan 
als data-coördinator voor jullie onderzoeksproject. Dit was niet alleen een 
leuke bijverdienste, maar vooral heel erg nuttig en leerzaam. Mijn eerste 
echte stappen in de wondere wereld van de wetenschap. Hartelijk dank. Dr. 
Kroupina, you ended up with me at the end of my medical studies for my 
research internship. Not only did I learn to live by myself in a strange city, 
in a far-way country, you taught me loads about early mental health and 
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attachment. This knowledge comes in very handy in my current job in 
youth health care. You were the one that stimulated me to continue doing 
research after graduating. Thank you, and all the best to the Adoption 
Clinic team, I enjoyed my time with you guys immensely.  
 
Veel dank gaat uit naar de verschillende Generation R medewerkers: de 
focusdames, het MRI-team, data-management en het secretariaat. Speciale 
dank gaat uit naar Ronald, Patricia, Claudia en Marjolein: voor alle hulp 
met verzamelen, opslaan, opsturen en controleren van data, formulieren en 
het regelen van aanstellingen en overeenkomsten. 
 
Mijn PhD-collega´s binnen Generation R: ik kom al een tijd niet meer over 
de vloer bij het Erasmus MC, en velen van de collega´s waar ik mee ben 
begonnen, zijn al lang uitgewaaid. Toch nog dank voor de theepauzes, 
lunches, koekjes, verjaardagen, etentjes, borrels, uitjes en wat dan al niet 
meer. Speciale dank voor de groep die me opving toen ik vriendloos in 
Rotterdam kwam wonen en met wie ik kon borrelen of voetbal kijken: 
Ryan, Strahinja, Willem, Martijn, Olta en Ronald. Zonder jullie waren mijn 
eerste maanden in Rotterdam een stuk saaier geweest. En Frans is jullie ook 
dankbaar, want ik kijk nog steeds graag voetbal. Mijn paranimfen en ex-
kantoorgenootjes: Olta, jij mocht me begeleiden en inwerken. Ik vergeet 
nooit meer dat je me moest helpen met mijn eerste abstract: of we iets 
konden schrijven voor een congres, deadline was overmorgen en ik stond 
2 hele dagen ingedeeld op het focuscentrum. Lea, ook jij werd later mijn 
kamergenootje. Als kamergenootjes deel je al snel meer dan alleen 
gesprekken over onderzoek. Het was een eer om bij jullie twee paranimf te 
mogen zijn, en gelukkig kunnen jullie mij nu ondersteunen. Hopelijk gaan 
we in de toekomst minder kletsen over promoveren, en nog meer genieten 
van onze toekomst en vriendschap. Guannan, you also become our roomie. 
Although I didn´t know you very well before, we soon came to love your 
positive energy and quirkiness. It was an honor to be part of your wedding 
and your life, and I wish you all the best in the future. Whether in the 
Netherlands, China or somewhere else, I will try to stay part of your magical 
princess world.  
 
Lieve vrienden, familie en schoonfamilie. Bedankt voor jullie steun door de 
jaren. Sandra en Rob: dik, rijk en arrogant lijkt nog niet echt te lukken. 
Misschien moeten we onder het genot van een diner, high tea of wafels met 
slagroom en M&M´s maar nieuwe doelen opstellen. Ik stel voor als 
toekomstdoelen: meer etentjes, high tea en wafels. Geraldine en Malou, 
mijn geneeskunde buddy´s, fijn dat jullie me altijd gesteund hebben. En 
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dat het door jullie werkverhalen en uren lijkt alsof ik het lekker rustig heb. 
Nu ik mijn PhD eindelijk heb afgerond, moeten we toch zeker weer een 
keer een reisje, weekendje of dagje kunnen plannen. Inge, mijn 
lievelingsnichtje, bedankt dat je mijn haar en nagels gaat doen, ook al wil 
ik mijn nagels niet laten doen. Dat we nog vele eettentjes mogen 
ontdekken, en ik verwacht binnenkort ook weer tijd te hebben voor een 
bioscoopbezoek, of een workshop bonbons maken ofzo. Het schijnt dat 
mijn vrije vrijdagen en weekenden straks weer vrij zijn, en niet gevuld met 
thesiswerk. Wim en Betty, bedankt voor het hartelijk welkom in Den Haag, 
het tonen van interesse in dit proefschrift, mijn onderzoek en werk en voor 
het zorgen voor de plantjes als we weer eens op vakantie zijn. En natuurlijk 
voor het creëren van Frans.  
 
Het loopbaantraject richting wetenschapper begon niet pas 6 jaar geleden. 
Ik weet niet meer precies wat en wanneer mijn eerste stappen waren, maar 
mogelijk begon het met het leren lezen aan de ontbijttafel toen ik een jaar 
of 4 was: melk, hagelslag, relativiteitstheorie. Bedankt paps en mams, jullie 
hebben me altijd gesteund en gezorgd dat ik kon leren, studeren en reizen. 
Bedankt voor alle liefde, steun en goede zorgen. En voor het helpen met 9 
keer verhuizen. Of juist me onderdak bieden als ik door coschappen in het 
buitenland tijdelijk zonder woonruimte zat. Iris en Erik, ik kan jullie niet 
echt bedanken dat jullie mijn grote zus en kleine broer zijn, daar kunnen 
jullie ook niks aan doen. Maar, ik had geen betere broer en zus kunnen 
wensen, en ben blij dat jullie me vroeger ook ooit dwongen om sociaal te 
zijn en te spelen, als ik weer eens een leeso was (1leeso: (de; m, v; meervoud: 
leeso´s) (Helleweikes, Nederland, informeel) bijvoeglijk naamwoord: 
samenvoeging van lezen+aso). En jullie snappen tenminste dat goed werk 
tijd nodig heeft en dat sommige studies nou eenmaal 6 jaar kunnen duren.  
 
Frans, niet lang na de start van dit PhD-traject leerde ik je kennen. Jij hebt 
me gered uit Rotterdam (jouw woorden), en me naar Den Haag gebracht. 
Dank voor alle steun, het motiveren als ik geen zin had, het meedenken als 
ik mijn laptop uit het raam wilde gooien als Word niet wilde luisteren en 
het ervoor zorgen dat ik niet te lang achter mijn computertje bleef werken. 
Ja, ik kom zo chillen op de bank, bijna klaar. Love you, 1000 miljoen2+.  
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